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Abstract 
Evaluation of health programmes is essential to assist programme managers in decision-making 
and accountability to the population they serve. Additionally, regular monitoring and evaluation 
of TB/HIV collaborative activities are used as a means to assess quality, effectiveness and 
coverage of services; yet little attention has been given to this in most developing countries. In 
the southern region of Ethiopia, since the inception of the TB/HIV collaborative activities in 
2005, there has not been any formal evaluation pertaining to the implementation status of 
integrated TB/HIV services at routine program level. However, a series of TB/HIV reviews 
underlined many challenges that have adversely affected the implementation nationally. 
However, studies conducted on the quality of TB and HIV/AIDS services tend to be broad and 
not targeted to the integrated TB/HIV program and therefore, it was necessary to assess the 
implementation status in a more focused way with a vision to determine its adequacy or 
otherwise and make appropriate recommendations to improve integrated TB/HIV services in the 
town. 
Aim: To assess the implementation of integrated TB/HIV activities in the health facilities of 
Hawassa town administration 
Study design: Cross sectional study 
Study population: All health facilities, health managers, and records of TB and HIV patients in 
Hawassa town administration 
Sample population: The study population encompassed TB and HIV clinics, managers of each 
health facility, and sampled records of individual clients/patients enrolled in the HIV/AIDS/TB 
treatment and care program, from each health facility in the year 2009/10. 
Data collection: Face-to-face interviews with facility managers, observation of the rooms in 
which TB/HIV services are rendered and a review of patient records, were undertaken. 
Analysis: Descriptive statistics with frequencies and percentages were used for analysis of 
facility based resource inputs, TB case finding and management, and HIV case finding and 
management practices. Indicator variables extracted from the record review were transformed 
into scales (0 or 1) and weighted to reflect the levels of TB/HIV service quality, integration and 
resources input. After weighting, experts’ opinion was used to set a cut off level (75%) to 
categorize the relative service quality received by individuals and the level of integrated care 
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provided by facilities into “adequate” or “inadequate”. Bivariate analysis was done to assess the 
effect of independent predictor variables on outcome variables. We used a– P value of 0.1 on 
bivariate analysis as the cut off point for inclusion of variables into the multivariate analysis. 
Prevalence ratios, adjusted prevalence odds ratios, and 95% confidence intervals were used to 
present outcomes. 
Results: Availability of resource inputs for HIV/AIDS care was inadequate in half of the 
facilities in Hawassa town whereas, laboratory infrastructure for TB/HIV care was adequate in 
all facilities. Most (91%) HIV/AIDS patients had their CD4 count and weight (96%) measured 
at baseline. However, the trend declined over time and the practice was better in hospitals than in 
health centres. HAART status was a strong predictor of CD4 count improvement and 
improvement in CD4 count was found to be a strong predictor of body weight gain. TB case 
finding and management practices in HIV/AIDS clinics were found to be adequate in the health 
facilities in Hawassa town. Ninety five percent and 86% of HIV positive patients were screened 
for TB at baseline and at the last clinical visit respectively, of which 98%, 93% and 81% of 
patients co infected with TB and HIV were provided with DOTS, CPT and ART respectively. 
However, only 11% of HIV positive patients without active TB were provided with IPT. Only 
HAART status was found to be a strong predictor of TB case finding. Quality of HIV/AIDS care 
in health facilities in Hawassa town was adequate. Availability of at least a minimum number of 
staff and being on HAART were found to be strong negative and positive predictors of quality 
respectively. Overall, 91% of patients on HAART were retained in care at the end of the year 
(alive and on treatment), 6% were retained and 3% died. 
Resources for the TB program were deficient in our study area. Three out of four facilities had 
inadequate overall input resources required for good quality TB care and the fourth barely 
managed to achieve adequate status. However, laboratory infrastructure and availability of forms 
and registers were adequate in all the facilities. There was a high degree of HIV case finding and 
a high prevalence (17%) of HIV among TB patients. Despite this, the overall HIV care provided 
was inadequate, with only 64% and 73% of TB/HIV co-infected patients being provided with 
HAART and co-trimoxazole respectively and 22% of TB/HIV co-infected patients not enrolled 
in HIV care. Among sputum positive TB patients good quality TB care was found to be a strong 
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predictor of successful treatment outcome Our study also showed consistently very high quality 
TB service provision in the town despite the lack of required resources. 
Conclusion and Recommendations: The study showed that there was relatively good quality 
provision of TB and HIV services despite inadequate input resources and that quality of care was 
positively associated with good outcomes. The study also indicated that HAART benefited 
patients substantially and hence earlier initiation could be the way forward. We recommend that 
to further improve quality of care one stop shopping services (availing both anti-TB and HIV 
care at the same service point within a clinic) be established. In addition, we recommend 
improved patient monitoring, especially for Pre-ART patients, be established. 
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I. Introduction 
Globally, tuberculosis (TB) was the second highest cause of death amongst adults with only 
Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) being 
higher (WHO, 2005). Globally, 9.2 million new cases and 1.7 million deaths occurred from TB 
in 2006 (WHO, 2008) and HIV/AIDS accounted for 2.6 million new HIV infections and 1.8 
million deaths in 2009 (UNAIDS, 2010). Although the continent of Africa accounts for only11% 
of the world's population, more than a quarter of the global TB burden is represented in Africa 
(WHO, 2005). This was partly the result of the rapidly expanding HIV/AIDS epidemic 
especially in Sub Saharan Africa which has also been accompanied by an estimated fourfold 
increase in the number of TB cases in the past decade (WHO, 2003). TB is often the first and 
most common opportunistic infection in HIV infected individuals (WHO, 2004e). As a result, the 
World Health Organization (WHO) regional committee for Africa declared tuberculosis as a 
public health emergency in the African region (WHO, 2005). The close epidemiologic 
association between TB and HIV has placed the control of both diseases high on the global 
public health agenda. 
 
In light of this, the WHO interim policy recommended a dual strategy for the control of the two 
epidemics (WHO, 2004b). However, despite the demonstrated effectiveness of the joint approach 
in providing comprehensive prevention, care and support services at all levels and improving 
health services for the benefit of people living with HIV/AIDS and/or TB (WHO, 2004c), TB 
and HIV/AIDS programmes continue to implement activities independent of each other 
(Gunneberg, et al. 2008). In an attempt to improve the above situation, resources being allocated 
for collaborative TB/HIV activities had been increasing, with a national scale-up of TB/HIV 
activities operative in several countries, but little attention was given to routinely assessing the 
programme performance (WHO, 2004a). As a result, there is a growing need to monitor these 
activities and evaluate their impact in order to inform future expansion of the most effective 
approach. In addition, implementation of TB/HIV activities are widely variable in different 
settings depending on the prevalence of the diseases and the health system structure, therefore it 
is necessary to conduct operational research in various settings to contribute to the body of 
TB/HIV knowledge. 
 
 
 
 
14  
II. Background information 
 
2.1. TB/HIV services and health service structures 
 
2.1.1. Overview of TB/HIV situation in Ethiopia 
Ethiopia, ranked number seven out of the top 22 high TB disease burden countries globally, had 
an incidence rate of 168 and 379 per 100 000 population for sputum positive pulmonary and all 
forms of TB respectively, and a prevalence rate of 643 per 100,000 population in 2006 (WHO, 
2008). The TB notification rate has also been rising in the past decade, and accounted for 40% of 
deaths among HIV patients in 2007 (FMOH, 2007d). Hence, TB was a leading cause of 
morbidity, the third highest cause of hospital admission, and the second cause of mortality. 
Among other factors, the rapid spread of HIV was believed to be the major cause behind the 
increase in the TB disease burden. According to a recent estimate, the country had an HIV 
prevalence of 2.1 percent with approximately one million people living with HIV/AIDS (FMOH, 
2007b). 
 
In response, Ethiopia established a TB/HIV Advisory Committee (THAC) in 2002 and launched 
a TB/HIV collaborative initiative at 9 pilot sites, which expanded nationally to more than 330 
health facilities in 2005 (FMOH, 2007a). Activities performed during this period includes: 
sensitization of policy makers and stakeholders, advocacy communication and social 
mobilization activities, assessment and selection of sites, training of health workers, provision of 
supplies, and revision of the TB manual to include TB/HIV activities and development of 
TB/HIV implementation guidelines (FMOH, 2007a). 
 
A national health facility survey conducted in 2005 in Ethiopia to primarily assess the capacity 
of health facilities and infrastructure to respond to the burden of the HIV/AIDS  epidemic 
revealed limited coverage of ART services (13%) but better TB treatment services (93%). It also 
showed wide regional disparities in the distribution of services in decreasing order of Addis 
Ababa, Amhara, Oromia and Southern Nations and Nationalities People Region (SNNPR) 
regions, whereas, the overall values for indicators of service for basic HIV testing and clinical 
services was consistently low (EHFS, 2005). 
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Likewise, a more recent study by FMOH in 2009 which assessed the quality of HIV/AIDS 
services provided in health facilities in the country; showed gaps in all indicators used to assess 
the quality of services related to HIV services. These gaps were variable across facilities with 
regards to inputs required, actual care provided and outcome of services. It also recommended 
that health facilities devise a mechanism to engage in an improvement process (FMOH, 2009). 
Similarly, another study aimed at assessing quality of Tuberculosis care in public health facilities 
showed that almost 44% of TB care providers were not trained. In addition, daily TB care 
services were unavailable in 23% of facilities and a significant proportion of TB patients 
interrupted treatment (47%) (Mengiste, et al. 2009) Thus, with the increasing case load of both 
TB and HIV/AIDS, and the diagnostic challenges in an already overstretched health care system 
with inadequate resources and limited skills, it was necessary to continuously monitor the quality 
of TB/HIV care as part of the component of the TB/HIV program evaluation on a regular basis. 
 
2.1.2. Overview of Southern Nations and Nationalities People Regional State (SNNPRS) 
region, health service structure and TB/HIV services 
The SNNPRS region is divided into 13 administrative sub regions called zones, eight special 
districts, and one town administration. Each of the zones are further divided into a total of 133 
districts. In 2007, the region had a total of 4910 health facilities, (4615 government, 85 Non- 
Governmental Organizations (NGOs) and 210 privately owned). Of the total government health 
facilities, 13 were hospitals, 180 were health centres, and 4425 were health posts and health 
stations (FMOH, 2007a). The DOTS program was started in the region in 1994 and had 100% 
coverage. All government and one NGO hospital as well as 30 government and 4 NGO health 
centres initiated TB/HIV collaborative activities in 2005. According to the single point estimate 
the region had an adult HIV prevalence of 1.7 % in 2010 (FMOH, 2007b) and the projected HIV 
prevalence was not expected to decrease soon (FMOH, 2006a). Similarly, the number of 
registered TB patients had increased from 8,339 in 1997 to 22,692 in 2007 in the southern region 
(FMOH, 2007c). Data from the regional health office showed that the TB/HIV co infection rate 
was estimated to be 20% and the estimated TB case detection rate in the region was 40 % 
(FMOH, 2007c). 
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2.1.3. Overview of Hawassa town administration, health structures and TB/HIV services 
Hawassa town administration, together with the 14 districts form the Sidama Zone in SNNPR of 
Ethiopia, was a TB/HIV pilot site. Hawassa town is also the capital of SNNPRS. The regional 
statistics indicates that the local town administration covers an area of 1, 747 square kilometres 
and had a total population of 53, 737 (SNNPR statistics office). The health facilities serving this 
area were, Hawassa hospital, Hawassa health centre, 8 private health institutions located in 
Hawassa town, Bushulo health centre and Tula health centre with 15 health posts located in the 
rural areas. 
 
The hospital and the three health centres implemented integrated TB/HIV activities. Service 
provision was structured in a way that there were separate TB clinics, and HIV clinics in each of 
the health facilities where integrated TB/HIV services were provided. These services include; at 
the TB clinic: HIV testing and counselling of TB patients, provision of Co-trimoxazole for co- 
infected patients, anti-tuberculosis directly observed treatment (DOT) provision and referral for 
highly active antiretroviral treatment (HAART) initiation; and at the antiretroviral therapy (ART) 
clinic: TB screening of HIV positive patients, provision of isoniazid preventive therapy (IPT), 
and initiation of HAART to TB/HIV co-infected patients if eligible. TB/HIV collaborative 
activity was coordinated by one person either a doctor/health officer or a nurse, who is in charge 
of planning, coordinating implementation of TB/HIV activities, monitoring and evaluation, and 
strengthening referral linkages among various entry points. The health posts were primarily 
involved in prevention activities, defaulter tracing and TB suspect referral; while the private 
clinics were primarily involved in TB diagnosis and referral. Data from the district health office 
showed that the annual number of TB cases in 2008 was 500 and the number of HIV/AIDS 
patients enrolled in care in the same year was 1200 for the district (Hawassa Town 
Administration Health Bureau, 2008). 
 
2.2. The problem 
It is known that for programmes to be successful, implementation alone may not be sufficient, 
but regular monitoring and evaluation (M & E) is needed to identify problems and make 
corrective actions alongside.   However, since the start  of TB/HIV  collaborative activity in 
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SNNPRS region there has not been any objective program evaluation conducted. A series of 
TB/HIV reviews had underlined that a shortage and high turnover of skilled staff; substandard 
storage facilities; poor inventory system of drug control and a shortage of medical equipment, 
had seriously affected the implementation of TB/HIV activities (FMOH, 2007a). In addition, the 
same source noted that TB/HIV data recording and reporting systems nationally was 
substandard. The situation was likely to be no different in Hawassa town administration. Apart 
from this, there was limited M & E capacity at all levels in terms of personnel and logistics. The 
Ethiopian health facility survey tried to provide baseline information on the capacity of the 
health sector in the country to provide both basic and advanced level HIV/AIDS services, which 
could be used as a tool to monitor and evaluate the TB/HIV components of the national strategic 
framework, however, it was not primarily focusing on TB/HIV care and tended to be more 
general (EHFS, 2005). Similarly, the two local studies provided an overall assessment of the 
quality of HIV/AIDS and TB services in the country but tended to be more national and not 
specific to integrated TB/HIV services (FMOH, 2009; Mengiste, et al. 2009). Furthermore, all 
the studies identified wider geographic disparities and the need for continuous assessment 
following the improvement process model. In view of this, it was necessary to assess the 
implementation of TB/HIV collaborative activity in a more focused way within specified 
geographic locations such as in Hawassa town administration, with a vision to determine its 
adequacy or otherwise and make appropriate recommendations to develop adapted solutions to 
improve TB and HIV care in the district 
 
2.3. Rationale for the study 
This study attempted to demonstrate to service providers, facility leaders and district TB/HIV 
coordinators the existing areas of strengths and weaknesses in the implementation of 
collaborative TB/HIV activities in health facilities, and outline a set of feedbacks and 
recommendations to address any identified shortcomings, if any, for future programme 
improvement. 
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III. Literature review 
 
3.1. Relationship between TB and HIV 
The Human Immunodeficiency Virus increases susceptibility to infection with Mycobacterium 
Tuberculosum, and increases the risk of progression to TB disease, thereby increasing the 
incidence and prevalence of TB. It also increases the likelihood of re-infection and relapse of TB 
(FMOH, 2007a), because untreated HIV infection leads to progressive immunodeficiency and 
increased susceptibility to infections (WHO, 2001). On the other hand the onset of tuberculosis 
in HIV infected patients causes a marked release of pro-inflammatory cytokines that activates 
CD4+ T-lymphocytes and macrophages harbouring latent HIV infection, which leads to 
increased HIV replication and consequent accelerated disease progression (Badri, et al., 2001). 
Therefore, the synergy between TB and HIV/AIDS is strong and exacerbates both diseases when 
HIV is introduced into high TB prevalence populations. In this context, concerted and urgent 
action would be required against both diseases simultaneously. 
 
3.2. Rationale for integration 
Dual intervention against the two diseases results in decreased incidence of TB; reduced TB case 
fatality rate and improvement in patient outcomes regarding TB (Abdul Karim et al, 2000; 
Antonuccia et al., 2000); besides improving the overall care of people infected with HIV (WHO, 
2001). Dual intervention also helps to improve general health service delivery through enhanced 
referral networks, better use of resources, improved staff capacity and improved staff morale. It 
also contributes to reducing the stigma attached to TB and HIV because of fear of terminal 
diseases (WHO, 2004c). In addition, integration is considered to be simple and sustainable for 
initiation and delivery of dual HIV and TB care to large numbers of patients in the context of 
existing under-developed health care delivery systems (Abdul Karim, et al., 2000) The existing, 
established infrastructure that was available in many developing countries to provide treatment 
for patients with TB, provide an existing clinical infrastructure to incorporate general HIV care 
and antiretroviral therapy by reducing the cost through the efficient and effective use of available 
health care infrastructure, since the necessary resources for separate care such as new buildings, 
staff and health care infrastructure were not readily available. Besides, use of already existing 
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structures and systems would make the new program part of the existing system, subsequently 
leading to more sustainable implementation regardless of external support. 
 
3.3. Resources in integrated TB/HIV program 
Availability of resources is a key factor in the successful implementation of TB/HIV 
collaborative activities, and in this regard, human resources play a great role because primary 
care systems would need to provide a more complex intervention than has ever been expected of 
them. However, resources were often in very short supply in low and middle income countries 
(Hongoro, and McPake, 2004). The situation was exacerbated by the growing epidemic of HIV 
which resulted in the loss of lives of many health professionals, increased staff absenteeism, and 
decreased staff morale because of challenges in diagnosis and increased morbidity and mortality 
amongst their patients. This was compounded by an insufficient health infrastructure such as 
limited space and poor laboratory services (Migliori, et al., 2006). For an integrated strategy to 
work, existing services in the TB clinics such as TB screening, diagnostic and treatment as well 
as patient monitoring services, would require upgrading and supplementation with additional 
resources such as additional medical examination equipment, laboratory services such as culture 
facility and Complete Blood Count (CBC) and cluster of differentiation (CD4) count machines, 
trained staff in diagnosing complex TB/HIV cases, and renovated rooms to allow more space for 
counselling. (Abdul Karim et al, 2000). In addition, integration of TB and HIV care may put 
additional pressure on an already overstretched TB treatment delivery systems (Abdul Karim et 
al, 2000). Experience from Malawi and South Africa on the implementation of integrated 
TB/HIV activities at national and local level has also witnessed resources and staffing problems 
as a challenge (Friedland, et al., 2007). The number of available health workers required given 
the existing client load was too low in almost all health facilities in Ethiopia, the proportion of 
staff per population was 1:37,996 for doctors; 1:63,785 for health officers, and 1:4,725 for nurses 
(FMOH, 2007c). A review of the 2002-2006 Health Sector Development Programme (HSDP) II 
strategic plan in Ethiopia had also revealed shortages and high turnover of qualified staff at 
programme and patient management levels, inadequate training on TB/HIV, provider initiated 
testing and counselling (PITC), inadequate laboratory, pharmacy and finance management, and a 
lack of efficient diagnostic tools (culture, skin test, X-Ray) as major challenges to an integrated 
TB/HIV service implementation. Shortage of supplies such as IPT and co-trimoxazole preventive 
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therapy (CPT) for prophylaxis, poor infrastructural set up, shortage of funding and inefficient 
absorbing capacity added further challenges (FMOH, 2007a). These emphasized the stronger 
need to respond to the crisis of health workforce attrition and strengthening of the health systems 
to improve TB/HIV services besides provision of additional financial resources. 
 
3.4. TB/HIV management information systems 
Information systems are important for measuring and improving health care quality (Joyner, and 
Rogers, Undated), because good quality information is needed on which to base policy and 
management decisions, particularly where resources are limited. However, health service 
delivery related information systems were weak in many developing countries (Kumalo, 2006). 
Even in countries with encouraging progress on health information systems such as South Africa, 
the problem of retaining managers at the various level of the health system needed to optimally 
use the available information for informed decision making persisted (Kumalo, 2006). In 
general, health information systems were at the very early stage in Ethiopia, particularly for the 
integrated TB/HIV programme as it was a new initiative. Consequently, TB/HIV data recording 
and reporting systems were not up to the expected standard in terms of completeness, accuracy, 
availability and timing. Nationally, it was consistently observed that TB/HIV data was of poor 
quality (incomplete, inaccurate, delayed and or absent), and not analysed at the site of collection 
(FMOH, 2007a). The same source mentioned lack of computerized recording and reporting, 
weak feedback mechanisms, inadequate supportive supervision and review meetings at all levels. 
The lack of external evaluation of the programme, and absence of monitoring and evaluation 
tools were also listed as challenges for the TB/HIV programme in Ethiopia. In addition, health 
workers were being overburdened with excessive data and reporting demands due to multiple, 
poorly coordinated systems which often duplicate data collection efforts and fail to deliver 
timely, accurate and complete data (Kumalo, 2006). Abouzahr and Boerma (2005) attribute 
international donors’ information demands as a reason for this primarily because they prioritise 
the urgent need for data over long term development of information system capacity within the 
country. This is because of the high demand for data for accountability purposes that donors 
require. In order to obtain this, they implement their own data collection system which is easy 
and less costly, but is parallel to government structures and does not respond to the government’s 
needs. On the other hand, supporting the host government health information system, which 
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often requires more technical and financial investment, would result in a strong one-channel 
reporting system that can yield reliable information which responds optimally to both donors’ 
and governments’ needs. This requires designing standard tool for monitoring and evaluating 
collaborative TB and HIV activities (WHO, 2004c). 
 
3.5. TB/HIV Quality of Care 
A recent study on quality of TB care and its association with patient adherence to treatment in 
eight districts of Ethiopia revealed an association of untrained providers (44%) and TB service 
unavailability (23%) with treatment interruption by TB patients (47%). It was noted that in 
facilities where daily TB care was unavailable, patients were more likely to have missed daily 
doses of TB medications [AOR 4.2; 95% CI (1.6, 10)] (Mengiste, et al. 2009). 
Prompt and accurate diagnosis and effective treatment are essential for good patient care and 
tuberculosis control (Hopewell, et al., 2006; Migliori et al., 2006). It is also shown that 
improving the national TB programme quality is essential to mitigate the resurgence of TB in the 
era of HIV; however the overall global efforts to ensure people living with HIV/AIDS have 
adequate access to high-quality TB prevention, diagnostic and treatment services were 
insufficient (WHO, 2008). Despite this, the perception of sufficient quality differs between 
countries and sectors because of different value systems. For example, in health care, the 
perception of the needs of a client or community varies with the different views and perspectives 
of the patient, service provider and society, and the social, political and economic environment 
of the country which leads to differences in perception of quality (WHO, 2004f). It also differs 
between facilities and care providers which is explained by distinct differences in structural and 
process aspects of tuberculosis management. Structural factors include basic infrastructure to 
provide services such as examination room, medical equipment, supplies, drugs and health care 
providers; whereas process factors are entirely patient specific such as hospital and clinical 
practice including nursing care, patient and environmental hygiene, (Hongoro, et al.  2005; 
Chang, et al., 2007). In view of this, the International Standard of Tuberculosis care (ISTC) was 
developed to help improve the quality of care of all TB cases regardless of age or sex, addressing 
all types of TB patients including those co-infected with HIV. The purpose of standardized care 
is to describe a widely accepted level of service that all practitioners should seek to achieve in 
managing patients and to facilitate the effective engagement of all providers in delivering high 
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quality care. The basic principles of care are the same worldwide, a diagnosis should be 
established promptly and accurately; standardized treatment regimens of proven efficacy should 
be used, together with appropriate treatment support and supervision; the response to treatment 
should be monitored; and the essential public health responsibilities must be carried out 
(Hopewell et al., 2006; Migliori et al., 2006). Equally important as a standard of care is access to 
appropriate care for patients who are co-infected with TB and HIV including access to ART 
(Colin, et al., 2006). 
 
 
3.6. TB case finding and management in HIV patients 
Before the advent of HAART and Isoniazid Preventive Therapy (IPT) for HIV infected people, 
efforts to control tuberculosis among HIV-infected people had mainly focused on implementing 
the DOTS strategy for tuberculosis control (WHO, 2001). However, HIV/AIDS has greatly 
complicated TB case detection and disease control; (Lawn, and Wood, 2005). Therefore, the 
conventional approach of passively waiting for patients with advanced symptomatic disease to 
make their way to microscopy centres for diagnosis had minimal positive outcome 
(Cunningham, and Perkins, 2007). Instead, the expanded scope of the new strategy for 
tuberculosis control for countries with either an overlapping TB and HIV epidemic or where 
there is an increasing HIV rate which may fuel the TB epidemic, comprises interventions against 
tuberculosis (intensified case-finding and cure and tuberculosis preventive treatment) and 
interventions against HIV (and therefore indirectly against tuberculosis) which includes 
providing condoms, STI treatment, safe injecting drug use (IDU) and highly active antiretroviral 
treatment (HAART) (WHO, 2003). 
 
Assessment of wide scale routine implementation in South Africa on TB/HIV activity in 2005 
revealed that only 16% of HIV-positive patients were screened for TB, of which 44% were found 
to have active TB, and only 4% of HIV-positive patients were started on isoniazid preventive 
therapy (IPT) (Colin et al., 2006). Another study in Rwanda had shown that between June and 
July of 2006, 377 patients attending HIV clinics were screened for TB at their initial or follow up 
visits, of which 80 patients were TB suspects and of these nine (11%) were diagnosed to have 
active TB (ICAP, 2007). Likewise, a preliminary review of pilot sites in Ethiopia showed that of 
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the 2760 TB suspects, 852 (30%) were diagnosed with active TB, but no figure was found on TB 
screening and IPT provision as the recording system was immature (FMOH, 2006b). However, 
the Ethiopian national TB/HIV strategic plan had decided to screen all people infected with HIV 
for active TB (FMOH, 2007a). 
 
3.7. HIV case finding and management in TB patients 
In countries where TB is a common presentation of AIDS, the existing TB program provides an 
efficient opportunity for identifying those patients who are HIV-infected and those eligible for 
HAART (Abdul Karim et al, 2000). However, data suggests that the total coverage of HIV 
testing and counselling for TB patients was still very low with 12% of TB cases globally and 
22% in African regions being tested for HIV (WHO, 2008). However, the same source noted that 
among 11 African countries with over 50% of the world’s HIV-positive TB cases that reported 
data for all years 2002–2006, the percentage of notified cases that were tested quadrupled, from 
8% to 35% over the five-year period. Rwanda (76%), Malawi (64%) and Kenya (60%) achieved 
the highest testing rates, which were also ahead of the 51% target set for the African Region in 
the Global Plan to stop TB, 2006 -2015. 
 
In this regard, though Ethiopia started to implement TB/HIV collaborative activities at a wider 
scale since 2005, only 2.6% of notified TB cases were tested for HIV (WHO, 2008). This 
represents a major missed opportunity as the above patients were already in the health care 
system and extrapolating from the high global (40%) TB/HIV co-infection rate, it is likely that 
many of them would have HIV (WHO, 2008). To our knowledge, except for one hospital based 
study that showed a low rate of HIV testing (35%) among TB patients in the southern region in 
2005 (Jerene, et al., 2007), there has not been subsequent wide scale assessment of this in 
Ethiopia. In view of this and because the national TB/HIV strategic plan targeted to offer HIV 
counselling and testing service to 100% of newly diagnosed TB patients; to test 80% of newly 
diagnosed TB patients for HIV; and to provide co-trimoxazole preventive therapy (CPT) for all 
HIV-infected TB patients (FMOH, 2007a), it was important to assess the performance of the 
facilities nationally. 
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3.8. Evaluation of health programs 
Program evaluation is a systematic gathering, analysis and reporting of data to assist in decision- 
making (Joyner, and Rogers, date accessed). It also helps program managers to be accountable to 
the population they serve and often to donors, senior managers and political office bearers 
(WHO, 2004a). In addition, programmes, countries and donors also need to demonstrate progress 
towards global targets such as the Millennium Development Goals (MDGs) (TB incidence 
should be falling by 2015) and the Stop TB Partnership targets (to halve rates of prevalence and 
mortality by 2015 compared with their levels in 1990) (WHO, 2006a). To respond to these, 
programme evaluations need to use standard indicators to ensure comparability across countries 
and over time (Global Fund, 2004). This helps to direct resources to regions or sub-populations 
with greater needs and to identify areas for intensification or reduction of effort. In the context 
of the TB/HIV programme, monitoring and evaluation provides the means to assess delivery, 
coverage, access, comprehensiveness, integration, efficiency, effectiveness and quality of 
collaborative TB/HIV activities (WHO, 2010). Of particular interest to our setting was process 
evaluation which is designed to assess the content, scope and quality of the TB/HIV programme 
which had already been implemented and was being scaled up nationally (Global Fund, 2004). In 
addition process evaluation would give us information about client satisfaction and perception, 
anticipated needs and services (WHO, 2010). Monitoring and evaluation is generally planned 
and performed by staff in the TB and HIV programs or by general health service staff, but in 
some instances, particularly for detailed program evaluation or review, external consultants or 
experts are recruited to help (WHO, 2004a). 
 
In this aspect, data suggests steadily increasing collaborative TB/HIV activity in many high 
burden countries over time. For instance, 7% of all TB patients were tested for HIV in 2005, 
representing a three-fold increase since 2004 and 184 000 people living with HIV were screened 
for TB in 2005, twice the number than in 2003; however, the level of activity was still far from 
the global milestones (Gunneberg, et al., 2008). This was due to a combination of slow 
implementation and lack of necessary tools and systems for capturing activity data. In addition, 
conflicting demands for different information from external agencies placed an unnecessary 
burden on programmes already burdened by a poor monitoring and evaluation capacity (WHO, 
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2004a). While there has been progress in scaling up of TB/HIV activities in Ethiopia, a lack of 
monitoring information has resulted in an inability to show the exact level of the implementation 
status and whether the collaborative TB/HIV activity has contributed to the control of the two 
epidemics. Experience from Cambodia showed that integrated TB/HIV activity can lead to 
increased TB screening and HIV testing rates (Kanara, et al., 2008). It was therefore imperative 
to assess the TB/HIV program in Ethiopia. 
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IV. Aim 
To assess the implementation of an integrated TB/HIV programme in the health facilities of 
Hawassa town administration 
 
 
 
 
 
V. Objectives 
• To assess the availability of adequate input in terms of personnel/staffing, infrastructure, 
equipments, drugs and supplies, health systems procedures and information systems for 
TB/HIV in the health facilities in Hawassa town administration. 
• To assess the HIV case finding and management practices in TB clinics of  health 
facilities in Hawassa town administration in 2009/10. 
• To assess the TB case finding and management practices at HIV clinics of  health 
facilities in Hawassa town administration in 2009/10. 
• To assess the quality of care within the HIV/AIDS and TB services and factors associated 
with good quality of care both at individual patient and facility level in Hawassa town 
administration. 
• To assess the extent to which TB and HIV case detection, treatment and care are 
integrated, and factors affecting the level of integration of HIV and TB services at the 
facility and individual patient level in Hawassa town administration. 
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VI. Methodology 
 
6.1. Study design 
A cross sectional study design based on quantitative methods using a retrospective review of 
records, facility observations and interviews of facility managers using a structured questionnaire 
was used. 
We chose a quantitative approach because, the quantitative approach gives an objective measure 
of the programme implementation status and allows comparability of findings across time and 
regions, which was very pertinent to our study, as the purpose was to foster programme 
performance improvement through ongoing monitoring and evaluation across time by district 
health authorities. In addition, the study intended to use routine health service data plus a simple 
structured questionnaire to interview people to get information about the services. The cross 
sectional study design is an appropriate study design to describe health service delivery status as 
well as health care needs of the population using routinely available data or using data obtained 
in special surveys (Beaglehole, Bonita and Kjellstrom, 2002). It’s also an appropriate design to 
get a snapshot of the health and service delivery status of a programme (Raj, 2002), which is in 
line with what our study intended to conduct for the time being. Above all, periodic cross 
sectional studies are recommended by health authorities to measure changes and to evaluate 
interventions by repeating the same survey in different time periods (Raj, 2002) which also 
coincides with the purpose of this study as it aimed to demonstrate that district health authorities 
can regularly assess/audit and monitor progress of their programmes as well as compare them 
with national and international milestones. Moreover, as we were measuring the status of 
program implementation including programme input, process and outcome variables at the same 
time, a cross sectional study design is the most appropriate method. The cross-sectional study is 
simple, economical and can (Beaglehole, Bonita and Kjellstrom, 2002) be regularly carried out 
by the district health officers themselves, allowing them to assess their programme performances 
after the study is complete and to also track improvement measures they have taken, based on the 
identified gaps and lessons learnt. Hence if this study had sufficient validity, it could be 
replicated at regular intervals by district health officers in all areas of Ethiopia. 
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6.2. Study Area 
The study was conducted in Hawassa town administration in Southern Nations Nationalities and 
Peoples Region of Ethiopia, because the researcher was interested in implementing the results in 
his home town. 
 
6.3. Study population 
The study population included all TB and HIV clinics of all health facilities in Hawassa town 
administration; managers of each health facility; and records of individual clients/patients 
enrolled in HIV/AIDS treatment and care, and the TB program in the year 2009/10. 
 
6.4. Sample size and Sampling procedures 
All four government health facilities (which included one hospital and three health centres) were 
chosen for the study and a facility manager from each of the facilities were selected for 
interviewing. 
The sample size for the review of records of clients/patients in HIV and TB clinics  was 
calculated using the “statcalc” tool of Epi-Info version 3.5.1, statistical package for estimating 
sample size using single population proportion. In estimating the likely level of the outcome 
measurement we used the proportion of patients who received a quality level above the 
mean/median as a factor. Thus a population proportion of 50% is taken assuming that 50% and 
above of the patients would receive a high quality service for both HIV and TB services, with an 
accepted error of 5% and a confidence level of 95%. In estimating the study population, we used 
the total number of patients seen over the last one year at all of the clinics: thus for HIV clinics 
we used the total number of HIV patients enrolled in HIV care in the year of 2009/10 in HIV 
clinics of all selected facilities in the town administration - which amounted to 1000 patients. 
Similarly, the total number of TB patients enrolled in DOTS program in all the selected health 
facilities in the town in the year of 2009/10 - which amounted to about 500 patient charts, were 
taken as our study population. In addition, we added 10% to the calculated sample size in 
anticipation of unavailability of patients’ charts in the clinics. Based on the above assumptions, 
the sample size was 306 patients’ records from the HIV clinics and 240 patients’ records from 
the TB clinics. The above numbers were shared among the four health facilities proportionate to 
their HIV and TB patient loads respectively 
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From a sampling frame of all newly enrolled HIV/AIDS and TB patients in HIV and TB clinics 
in the year of 2009/10, the respective numbers of sampled patients’ records were randomly 
selected from a list of patients’ records. This was carried out by inserting lists of all patients from 
HIV and TB registers that were enrolled in the given year (2009/10) into the Excel sheet and 
assigning numbers to each, afterwards the estimated sample charts were selected randomly. If the 
patient’s record was not available at the time of selection or if it did not fulfil the inclusion 
criteria the next chart would be chosen, and if the next chart was unable to fulfil similar criteria 
as noted below, it would be considered as unavailable and the next chart would be selected. 
 
Inclusion criteria: TB clinic: Patients registered for DOTS between Sep, 2009 – Aug, 2010 and 
treated with first line therapy 
HIV clinic: Newly enrolled patients between Sep, 2009 – August, 2010. This 
group was chosen because inclusion of newly enrolled patients would give the latest picture of 
TB/HIV care and taking a full one year period would avoid any difference in seasonal practice 
and would give a comprehensive picture of the TB/HIV care at any given period within the year. 
In addition it would give patients enrolled around the end of the data collection period (Aug, 
2010) a full one year course of observation/follow up which allowed assessment of the one year 
treatment outcome for HIV care and was sufficient time to assess the final TB treatment outcome 
Exclusion criteria: pregnant women on PMTCT. This is because, pregnant women have varying 
managements (some may take full course of HAART while others may take combination drugs 
(AZT and NVP) or single dose neverapine) which would require different follow up schedules 
and they have additional care components such as pregnancy follow ups, delivery and postnatal 
services which needed to be included in the comprehensive service package. 
Transferred out patients in both TB and HIV clinics were not considered as it was difficult to get 
the treatment follow up measures and their treatment outcomes. 
 
In addition patients aged less than 18 years in both TB and HIV clinics was not considered as 
they required varying treatment regimens and follow ups with continued dose adjustments which 
makes their management different from those of adults. 
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6.5. Data collection method 
Data was collected after September 2011. This would give at least a one year follow up period 
for the cohort of patients that were enrolled at the last month of the sampling period. The data 
collection was made through the use of an adapted TB/HIV audit tool 
The methods were: 
• Face-to-face interviews with facility managers in each facility on issues such as staffing and 
health service provision. A structured questionnaire with close ended questions prepared in 
English and translated into Amharic was used. To check the correctness of the translation, it 
was then back translated by another person. Prior to use in the study it was also pre-tested 
and revised wherever necessary. 
• Observation of the rooms for availability of furniture, equipment, drugs and supplies, and 
materials for TB/HIV information systems 
• Record reviews was conducted using a structured data extraction form prepared in English. 
• Patients initially receiving HIV care: Data extracted from patients’ folders to assess 
quality of HIV care included completeness of patients details, identification and of care 
giver’s contact details, basic investigations done, staging of patient, provision of 
medicines such as ARTs, follow up appointment and other outcome measures such as 
weight, CD4 count and functional status. In order to assess the integration of TB/HIV 
services within the general HIV clinical services and the extent to which TB case 
detection and management are integrated into the HIV service the following were 
measured: IPT and Co-trimoxasole provision 
• Patients initially receiving TB care: Data extracted from TB registers, to assess quality 
of TB care included completeness of client details, identification and completeness of 
care giver’s contact details, patient category, completeness of patient drug regimen, 
sputum smear result registration and treatment outcome. Provision of HIV test, as well as 
enrolment into HIV care, ART initiation and CPT provision was measured to assess the 
integration of TB/HIV services within the TB clinics and the extent to which HIV care 
was integrated into the TB service 
The  researcher  administered  the  facility  manager  interviews  and  conducted  the  required 
observation of the health facilities. Data from patient records was collected by trained research 
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assistants. The researcher conducted a two days training session for four research assistants. A 
data collection guideline was prepared to assist research assistants to have a standardized 
definition and understanding of the data they would be collecting and this was complemented 
with a training manual used to train them. These helped standardize the data collected by the 
research assistants. They were recruited based on their experience on data collection/research 
and their background in public health with a minimum education level of diploma in respective 
fields. Next, they were trained by the investigator on the use of the data collection tools and 
guidelines including methodology to be employed in the process of data collection and the 
observance of ethical issues. The first day of the training course was held in the class room, 
while on the second day the training included practice under field conditions at a health centre at 
another district where the tool was piloted. This occurred under close supervision and feedback 
from the researcher. The training was conducted after the questioner was pretested and finalized. 
 
 
During the data collection period, data was reviewed daily by the research assistants for 
completeness, consistency and accuracy, where incomplete, incorrect and missing data was 
checked back to the source/register or folder using the code label to identify the source of data. 
Prior to data entry, the data was reviewed by the principal investigator to help identify any 
residual incomplete or incorrect data that had passed the onsite review and if there was any that 
specific data would be discarded from entering analysis. To assist this, all the data collection 
questionnaires and logs included dates, codes and signature of the research assistant who 
completed the form. In addition, logs were kept on site for tracking data to be collected, 
completed and submitted for data entry (here also logs at data entry was kept for receipt, data 
entry, returned for cleaning and duplicate data entry). 
 
 
During data entry, checks were made into the database that restricted the entry of data that was 
not present in the subset of values reducing the chance of adding error. Sample duplicate data 
entry was used to assure data quality and data exploration was done to identify and correct any 
fraudulent data. Following all the quality control checks and identification of certain poor quality 
data, data cleaning was done through correction of incomplete, missing and inconsistent data at 
 
 
 
 
32  
the site of data collection or removal of poor quality data from analysis if was not possible to 
correct it. The completed data was analysed using SPSS version 21. 
 
6.6. Variables 
1. Dependent variables 
TB/HIV integration (individual level/facility level) 
TB/HIV quality of care (individual level/facility level) 
HIV treatment outcomes 
Improvement in CD4 count 
Improvement in body weight 
TB treatment outcomes 
HIV case finding and management practice 
2. Independent variables: 
Facility level: 
Service inputs: personnel 
Infrastructure, 
Supplies and supply management system, 
Health system procedures 
Information education & communication materials 
Job aids 
Overall facility input 
Type of facility: health centre 
Hospital 
 
 
Individual level: Age 
Sex 
Education 
Marital status 
Residence 
Employment 
HAART treatment status 
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TB status 
CD4 count 
TB type 
HIV status 
 
6.7. Data management and Data analysis 
Variables were grouped and descriptive statistics with frequencies and proportions, were used for 
analysis of facility based input factors such as staffing patterns; health systems; availability of 
infrastructure, drugs and supplies and materials on TB/HIV information systems in the facilities, 
as well as for the individual patients’ treatment outcomes. In the HIV/AIDS clinics, treatment 
outcomes were measured by the CD4count, functional status and survival across time periods (at 
six months and one year) while in TB clinics, treatment outcomes were measured by standard 
outcome measures of tuberculosis treatment (cure rate, treatment success rate, defaulter rate, 
death rate and failure rates) 
 
 
Data from the record review of patients in the HIV and TB clinics was used to perform 
descriptive statistics with frequencies and proportions for TB case finding and management 
among HIV patients and HIV case finding and management among TB patients. 
 
 
The quality of TB/HIV services was calculated from indicator variables extracted from the 
record review of services in the HIV and TB clinics (Tables 13 and 25). In this calculation, 
facility level input factors were not included as direct quality measurement indicator variables 
because the presence of these facility levels input factors were assumed to contribute to service 
delivery indicators that would ultimately result in the direct estimate. The quality grading was 
done by a method of coding whereby the facilities and services received at individual level were 
categorized into two groups based on the points given to the levels of activities across the various 
sections of service. This was computed after transforming the various points given to the level of 
services within the HIV and TB clinics to 0 or 1 scale (unit transformation for yes/no). The 
scores given to each question in the folder review under the respective clinics of HIV and TB 
was summed up to form a single score value for each chart or patient on TB/HIV related 
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services. Since we used a newly adapted TB/HIV tool and there had not been any cut off level 
set by the national TB/HIV guidelines to categorize levels of quality at individual patient level 
and facility level in our setting, we used experts’ opinion to set a cut off level after weighing the 
levels of TB/HIV service given to individuals and offered by health facilities. After thorough 
consultation with selected district TB/HIV coordinators, facility managers and TB/HIV service 
providers who are experts in TB/HIV program we set a cut off level of 75% to categorize the 
relative service quality received by individuals and provided by facilities into two. For individual 
level quality of care received, service quality score levels below the cut- off level was labelled as 
“inadequate quality” and those at and above the cut- off level was termed as “adequate quality”. 
In a similar manner facilities with a 75% or more score for preparedness based on inputs being 
present was assessed as being “adequately prepared” and those with less were deemed 
inadequately prepared 
 
Similarly, data from the folder review of the TB and HIV clinics was used to assess integration 
of TB/HIV services in each of the clinics; specifically we used two key indicators of integration: 
HIV testing offered among TB patients and TB screening offered among HIV positive patients in 
TB and HIV clinics respectively. Again, a score of 75% for patients receiving integrated care 
was chosen as a cut off level to categorize the clinics into two categories. TB/HIV integrations 
level below the cut- off level was labelled as “insufficient integration” and those above the cut- 
off level was termed as “relatively good integration”. 
 
Factors affecting level of integration was seen from two angles, these were: facility level factors 
(type of facility, service inputs) and individual patient level factors. The facility level summary 
input factors were personnel/staffing, infrastructure, drugs and supplies, health system and 
materials on TB/HIV information systems whereas, individual patient level factors included age, 
sex, educational status, marital status, residence, employment, HAART treatment status, TB 
status, TB type and HIV status and CD4 count. All the above factors/variables were used as 
independent variables to perform univariate and bivariate regression analysis to dependent 
variable of quality or integration 
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Univariate analysis was done on all the independent variables (both facility level and individual 
patient level factors) with facility level quality of care (as dependent variable). Whereas, 
bivariate regression analysis was performed on those variables which show a significant 
association with the dependent variable on bivariate analysis 
 
6.8. Validity 
The questionnaire and data extraction tool has face validity. The tools were adapted from the 
Ethiopian National TB/HIV guidelines, WHO monitoring and evaluation tool for TB/HIV 
programmes and South African National Standard TB/HIV/STI integrated audit tool, to ensure 
that it suits the existing setup of health services in Ethiopia/Hawassa. As the researcher selected 
questions from the above tools rationally cover the factors and outcomes to be measured, face 
validity had reasonably been ensured. In order to ensure content validity, a panel of experts in the 
fields of TB/HIV and program management including district TB/HIV coordinator, facility 
managers, and health professionals working at the TB/HIV clinics (Doctors and Nurses) assessed 
the content of the tools to determine their relevance and comprehensiveness data collection was 
done in a standardized manner. The use of simple random sampling for selection of 
patients’/clients’ records would eliminate selection bias, a sufficiently large sample size was 
used. 
Inclusion of all types of HIV/AIDS patients, either on ART or not allowed a comprehensive 
assessment of service delivery. In line with this, inclusion of patient enrolled throughout the year 
– would avoid seasonal variation of patient service delivery, if any. 
 
6.9. Reliability 
Reliability of the folder reviews was done by re-assessing 5% of the folders and comparing it to 
the original assessment using the kappa test. The kappa result ranges in value from 0 to 1, the 
higher the score the more reliable the generated scale is. In our case, we used 0.7  as  an 
acceptable reliability coefficient (Joseph and Rosemary, Undated). 
 
6.10. Generalizability 
The results obtained can be generalized to the study population only. 
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6.11. Piloting 
The questionnaire was piloted in a health centre which was similar to the health centres in the 
sample and was located in the same zone but in an adjacent district. The population it served also 
had a similar health status, socioeconomic status and cultural background. The review of records 
was tested amongst six patient’s registers and folders after which adjustments were made before 
final implementation of the study. 
 
 
The pilot study helped to understand the difficulties in using the tools (both from the data 
collector’s and patient’s perspective) and it also assessed the extent of training needed for its 
effective independent use, and it was used to estimate the time needed to complete the clinic 
assessment. 
 
6.13. Ethical considerations 
Ethical approval was requested from the ethics committees of the University of the Western 
Cape and Ethiopian Health Research Ethics Review Committee/the SNNPR Regional Health 
Bureau. Prior to conducting the data collection, permission to access patients’ records was 
obtained from the health facility managers. Before being interviewed, facility managers were 
told about the study and assured confidentiality for their participation and informed written 
consent was obtained before the start of the interview. Code numbers were given for each 
interview form (a serial number on the form and code for location) to keep anonymity of data; 
the codes were noted on both documents, but consent forms (which contain the client’s name and 
signature) were kept separate from questionnaires. 
 
There was no specific risk or benefits for individuals from participating in the study as the 
interview was with facility managers and not with TB/ HIV service providers. Participants were 
allowed to withdraw at any stage without having to provide reasons for their withdrawal. 
In order to keep confidentiality of patient medical records, names of individuals from the records 
were not taken and names of hospitals did not appear during data analysis and presentation. 
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The study would help the investigators, the district and the facility TB/HIV teams learn more 
about the implementation status of TB/HIV collaborative activities in health facilities in Hawassa 
town administration. The findings of the study would therefore help government and other 
organizations to plan for possible intervention measures. 
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VII. Results 
7.1. Introduction to results 
Service provision in Hawassa town administration is structured in a way that there are separate 
TB clinics, and HIV clinics in each of the health facilities. However, integrated TB/HIV services 
are provided at each of these clinics. Thus, the study reports HIV clinic and TB clinic activities 
separately. The study findings are presented using univariate analysis of facility inputs; 
descriptive statistics of patient background characteristics and outcome variables, with bivariate 
and multivariate analysis of independent and outcome variables. 
 
7.2. Sample realization 
The planned sample size for the review of records of patients in the HIV and TB clinics was 306 
records from the HIV clinics and 240 records from the TB clinics. After getting the total number 
of patients’ seen in each facility for the period of Sep 2009 to Aug 2010, the above sample 
record numbers were shared among the four health facilities proportionate to their HIV and TB 
patients loads, in the specific period respectively. Unfortunately, some of the patients’ records 
were not available for various reasons: some were transferred out to other facilities, other records 
did not fulfil the inclusion criteria, and in some the subsequent patients’ records were either 
unavailable or did not fulfil the inclusion criteria. As a result we were able to obtain 284 records 
from HIV clinics and 238 records from TB clinics that were available and fulfilled the inclusion 
criteria. Access to patients’ folders was made using medical registration numbers obtained from 
the electronic data base in the HIV clinics with the help of the data clerks and we then traced the 
charts for review. Challenges encountered in getting patients records were: some patients had 
clinic visits on the day we extracted their charts so we had to postpone the record review to 
another day; some providers were suspicious that the record review would mess up their chart 
order and content; some clinics’ had very little space to move around in to get the records 
(especially in the hospitals) so we had to wait until service delivery was less busy; some clinic 
providers were not cooperative as they wanted to take part in the data collection despite the 
limited resources the study had to involve and pay all the clerks in the clinic for assisting with 
the data collection process. 
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7.3. HIV/AIDS clinic 
This section includes results from facility managers’ interviews, observations of HIV clinics, and 
a review of records of patients in the HIV clinics. The results includes the univariate analysis of 
facility inputs such as the training profile of health professionals, the availability of a minimum 
staff number, infrastructure and supplies, lab infrastructure for TB/HIV care, supplies and supply 
management system, health system procedures, information education and communication 
materials, job aids, and forms and registers (table A - G in Annex); individual patient 
background characteristics in HIV clinics, and descriptive statistics of outcome variables such as 
change in CD4 count, change in weight, performance of TB case finding, survival, and quality of 
HIV care delivered. In addition, it includes bivariate analysis using facility characteristics and 
individual patient background characteristics with the above outcome variables, and variables 
that showed a P value of 0.1 or less (in order to include as many variables as possible) in the 
bivariate analysis, were included in the multivariate analysis. 
 
Table one shows the training profile of health professionals working in the HIV/AIDS clinics in 
the four facilities in Hawassa town administration. In one out of four facilities providers received 
inadequate training in all the required training parameters necessary to perform their duties, 
whereas training was adequate in each of the three other facilities. Each input variable was 
calculated from its own parameters using 75% present as a cut off level. Thus, in a specific 
facility input item if a facility had 75% of parameters and above it was classified as having 
adequate input and scored “1”, if not as inadequate and scored “0”. This classification was 
further coded as 1 and 0 values respectively. Then the above score is inserted into a summary 
composite score to calculate the overall input. Accordingly, a facility that had 75% and above 
score on summation of the various input variables would be classified as having adequate overall 
input and if less it would be classified as inadequate overall input. 
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Table 1. Training Profile of Health Professionals Currently Working in HIV/AIDS Clinics 
of Health Facilities in Hawassa Town Administration, 2010/11 
 
 
 
Training profile of health professionals 
Score “1” if >/= 75%; score “0” if < 75% 
Facility W Facility X Facility Y Facility Z 
Proportion  of  physician  trained  on  HIV  clinical (1/1) (1/1)  
NA 
 
NA management “1” “1” 
Proportion of physician trained on TB/HIV (1/1) “1” 
(1/1) 
“1” 
 
NA 
 
NA 
Proportion of physician trained on HIV counseling (1/1) (1/1)  
NA 
 
NA and testing “1” “1” 
Proportion   of   Nurse   trained   on   HIV   clinical (3/3) (1/1) (2/2) (2/3) 
management “1” “1” “1” “0” 
Proportion of Nurse trained on TB/HIV (1/3) “0” 
(1/1) 
“1” 
(2/2) 
“1” 
(0/3) 
“0” 
Proportion of Nurse trained on HIV counseling and (3/3) (1/1) (2/2) (0/3) 
testing “1” “1” “1” “0” 
Pharmacy technician/technologist  trained  on basic (3/3) (2/6) (2/2) (2/4) 
ART “1” “0” “1” “0” 
Proportion  of  HMIS  officer/data  clerk  trained  on (2/2) (1/1) (1/1) (0/0) 
HMIS “1” “1” “1” “0” 
Proportion  of  adherence   supporter/s   trained   on (3/3) (1/3) (0/0) (0/0) 
treatment adherence and care and support “1” “0” “0” “0” 
Overall  score  (adequate  >=  75%;  inadequate (8/9) (7/9) (5/6) (0/6) 
<75%) 90% 80% 83% 0% 
 
NB: Health centres are not expected to be staffed with physicians; in place of a physician they 
may have a health officer or BSC degree graduated nurse. So, the overall score is calculated out 
of 6 for some facilities and 9 for others 
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Table two shows the status of health system procedures in the HIV/AIDS clinics. Half of the 
facilities had adequate health system procedures to provide HIV/AIDS care. Of the three 
facilities that had regular supervision of TB/HIV activities none of them had action plans arising 
from the supervision 
 
Table 2. Status of Health System Procedures for HIV/AIDS Care in Health Facilities in 
Hawassa Town Administration, 2010/11 
 
 Fill “1” if its yes and observed or fill “0” if not 
Facility W Facility X Facility Y Facility Z 
Is  HCT  offered  every  week  day  throughout  the 
opening hours of the facility? 
 
1 
 
1 
 
1 
 
1 
Can HIV positive patients routinely be seen every 
day of the week throughout the opening hours? 
 
1 
 
1 
 
1 
 
1 
Does the HIV clinic have a mechanism for defaulter 
tracing? 
 
1 
 
1 
 
1 
 
1 
Is there a quality assurance system at the facility for 
HIV Testing? 
 
1 
 
0 
 
1 
 
0 
Is there a quality assurance system at the facility for 
HIV management and monitoring? 
 
1 
 
1 
 
1 
 
0 
Is there a regular supervision of TB/HIV activity at 
the HIV/AIDS clinic in the facility? 
 
1 
 
1 
 
1 
 
0 
Are   action   plans   arising   from   the   previous 
supervision available? 
 
0 
 
0 
 
0 
 
0 
Overall  score  adequate  >=  75%;  inadequate 
<75% 
6/7 (86%) 5/7 (71%) 6/7 (86%) 3/7 (43%) 
 
The rest of the tables describing the following: availability of minimum staff number, 
infrastructure and supplies, lab infrastructure for TB/HIV care, supplies and supply management 
system, information education and communication materials, job aids and forms and registers are 
shown in the appendix (Tables A – G) 
 
 
 
 
42  
Table three shows a composite score on the adequacy of overall inputs in HIV/AIDS clinics of 
health facilities in Hawassa town administration. Using the various facility inputs listed below 
and setting 75% as a cutoff point, facilities were further classified as having adequate and 
inadequate overall inputs. Each of the facilities were similarly characterized according to the 
composite score for each of the variables as shown in table 1 and 2. Two out of four facilities had 
inadequate overall facility inputs required to provide HIV/AIDS services. A major gap was 
observed in availability of information education and communication materials in three out of 
four facilities and in health system procedures in half of the facilities were deficient. 
 
 
Table 3. Composite score on adequacy of inputs in HIV/AIDS Clinics of Health Facilities in 
Hawassa Town Administration, 2010/11 
 
 
 
 
Facility inputs 
 
Fill “1” if the input is adequate or fill “0” if not 
 
Facility W 
 
Facility X 
 
Facility Y 
 
Facility Z 
Staff training 1 1 1 0 
Minimum staff number 1 0 1 1 
Infrastructure and supplies 1 1 1 0 
Lab infrastructure for TB/HIV care 1 1 1 1 
Supplies and supply management system 1 1 0 0 
Health system procedures 1 0 1 0 
Information Education and 
Communication Materials 
 
1 
 
0 
 
0 
 
0 
Job Aids 1 1 1 0 
Forms and registers 1 1 1 1 
Total input overall score (Adequate >= 
75>=%; inadequate <75%) 
9/9 (100%) 
Adequate 
6/9 (67%) 
Inadequate 
7/9 (78%) 
Adequate 
3/9 (33%) 
Inadequate 
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Table four shows the distribution of socio demographic and health service related characteristics 
of HIV/AIDS patients included in the study. A total of 284 HIV and AIDS charts were reviewed. 
Out of the total of 284 patients records, three charts had missing record on clients sex and marital 
status; 10 had missing records on residence; 16 had missing records on education; 21 had 
missing records on employment status and 6 charts had missing records on patients’ treatment 
status. 
 
Table 4. Background Characteristics of Patients in HIV/AIDS Clinics in Hawassa Town 
Administration, 2010/11 
 
Characteristics Characteristics Number % 
 
 
Age in years 
< 30 118 42% 
>/= 30 166 58% 
Total 284 100% 
Sex Male 99 35% 
Female 182 64% 
Total 281 100% 
Marital status Single 38 14% 
Married 158 56% 
Widowed 42 15% 
Divorced 43 15% 
Total 281 100% 
Residence Urban 224 82% 
Rural 50 18% 
Total 274 100% 
Education Uneducated 60 22% 
Primary 105 39% 
Secondary 66 25% 
Tertiary 37 14% 
Total 268 100% 
Employment Employed 103 41% 
Not employed 150 59% 
Total 253 100% 
Type of facility Hospital 178 63% 
Health center 106 37% 
Total 284 100% 
 
 
Treatment status 
On HAART 152 55% 
Not on HAART 126 45% 
Total 278 100% 
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Table five shows trends and continuity of CD4 count by treatment status and type of facility 
among HIV patients in Hawassa town administration. 
 
Table 5. Trends and continuity of CD4 Count by Treatment Status and Type of Facility 
among HIV Patients in Hawassa Town Administration, 2010/11 
 
 
Group 
 
Variables 
% patients 
tested 
Mean 
CD4 
STD 
deviation 
 
Median 
Inter quantile 
range 
All patients Baseline CD4 91% 361 303 265 130 - 508 
6 months CD4 60% 350 232 300 183 - 429 
1 Year CD4 52% 396 256 345 238 - 503 
Patients 
HAART 
on Baseline CD4 100% 190 133 165 90 - 255 
6 months CD4 78% 257 150 235 152 - 335 
1 Year CD4 65% 317 235 275 199 - 386 
Patients not on 
HAART 
Baseline CD4 81% 628 295 607 423 - 820 
6 months CD4 41% 562 247 518 406 - 681 
1 Year CD4 39% 555 223 504 393 - 704 
Hospital 
patients 
Baseline CD4 99% 335 302 234 117 - 470 
6 months CD4 74% 341 221 300 182 - 418 
1 Year CD4 64% 373 213 325 232 - 479 
Health   centre 
patients 
Baseline CD4 76% 419 298 375 191 - 640 
6 months CD4 36% 380 265 308 190 - 494 
1 Year CD4 32% 474 357 435 256 - 637 
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Table 6. Distribution of CD4 count change at one year follow up of all HIV/AIDS patients 
in Hawassa Town Administration, 2010/11 
 
 
 CD4 count change at one year Frequency Percent % 
All HIV patients Increased 89 60% 
Remain the same or decreased 59 40% 
Total 148 100% 
HIV patients on 
HAART 
Increased 78 79% 
Remain the same or decreased 21 21% 
Total 99 100% 
HIV patients not on 
HAART 
Increased 11 22% 
Remain the same or decreased 38 88% 
Total 49 100% 
 
 
 
 
Table 7. Trends in level of immune status (CD4 Count Level) among HIV positive patients 
in Hawassa Town Administration, 2010/11 
 
  
CD4 count/mm3 
Baseline Six months One year 
Number % Number % Number % 
HIV 
patients 
HAART 
positive 
on 
<200 92 61% 48 41% 25 25% 
200-350 43 28% 46 39% 43 43% 
>350 17 11% 24 20% 31 31% 
Total 152  118  99  
HIV 
patients 
HAART 
positive 
not on 
<200 4 4% 1 2% 1 2% 
200-350 12 12% 8 15% 6 12% 
>350 86 84% 43 83% 42 86% 
Total 102  52  49  
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Table 8. Trends and continuity of weight measurement by treatment status and type of 
facility among HIV Patients in Hawassa town administration, 2010/11 
 
 
 
Group 
 
 
Variables 
 
% patients 
weighed 
 
 
Mean weight 
 
STD 
deviation 
 
 
Median 
Inter 
quantile 
range 
All patients Baseline weight 96% 54 10 53 47 - 60 
6 months weight 77% 56 10 55 48 - 62 
1 Year weight 72% 58 11 56 50 - 65 
Patients on 
HAART 
Baseline weight 98% 54 10 54 46 - 60 
6 months weight 94% 57 11 56 50 - 64 
1 Year weight 91% 59 12 58 50 - 65 
Patients   not 
on HAART 
Baseline weight 94% 54 9 52 48-58 
6 months weight 60% 54 9 52 47-59 
1 Year weight 53% 55 9 52 48-61 
Hospital 
patients 
Baseline weight 95% 55 10 54 47-61 
6 months weight 82% 56 9 55 48-63 
1 Year weight 77% 57 10 57 50-65 
Health 
Centre 
patients 
Baseline weight 98% 53 11 52 46-57 
6 months weight 68% 56 12 54 48-61 
1 Year weight 64% 58 13 56 50-65 
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Table 9. Distribution of weight change at one year follow up among all HIV/AIDS patients 
in Hawassa Town Administration, 2010/11 
 
 Weight change at one year Frequency Percent % 
All HIV positive 
Patients 
Increased 135 67% 
Remain the same or decreased 65 33% 
Total 200 100% 
HIV positive patients 
on HAART 
Increased 99 73% 
Remain the same or decreased 36 27% 
Total 135 100% 
HIV positive patients 
not on HAART 
Increased 36 55% 
Remain the same or decreased 29 45% 
Total 65 100% 
 
Table 10 shows the distribution of functional status among HIV patients on HAART. For 
assessment of functional status data was available for 143, 142 and 136 HIV/AIDS patients at 
baseline, six months and one year period out of the 152 HIV patients on HAART respectively 
where as data for HIV patients not on HAART was available for 125, 76, and 70 patients at 
baseline, six months and one year period out of the 126 HIV patients not on HAART 
respectively 
 
Table 10. Trends in Distribution of Functional Status among HIV patients in Hawassa 
Town Administration, 2010/11 
 
 Functional 
status 
At baseline At six months At one year 
Frequency % Frequency % Frequency % 
HIV   patients 
on HAART 
Working 108 76% 133 94% 135 99% 
Ambulatory 33 23% 9 6% 1 1% 
bed ridden 2 1% 0 0% 0 0% 
Total 143 100% 142 100% 136 100% 
HIV patients 
not on 
HAART 
Working 109 87% 71 93% 66 94% 
Ambulatory 15 12% 5 7% 4 6% 
bed ridden 1 1% 0 0 0 0 
Total 125  76  70  
 
 
 
 
48  
Table 11 assesses the TB case finding and management practice among HIV patients in HIV 
clinics in different facilities and in Hawassa town administration. Half of the facilities in the 
district had poor TB case finding and management practice among HIV patients but overall the 
TB case finding and management practice in the district was good, although isoniazid 
prophylaxis therapy was universally poorly provided. 
 
Table 11. TB Case Finding and Management at HIV Clinics in Health Facilities of Hawassa 
Town Administration, 2010/11 
 
 [% (score)] - Score “1” if >/= 75%; score “0” if <75% 
Facility 
W 
Facility X Facility Y Facility Z District 
% of HIV positive individuals 96% 99 % 97% 85% 95% 
screened for TB at baseline (97/101) (75/76)  (65/67) (33/39) (270/283) 
”1” “1”  “1” “1” “1” 
% of HIV positive individuals 88% 96% 74% 82% 86% 
screened for TB at last clinical visit (90/102) (71/74) (49/66) (32/39) (242/281) 
“1” “1” “0” “1” “1” 
% of HIV positive individuals with 97 % 100% 100% 100% 98% 
active TB provided with DOTs (30/31)  (13/13) (5/5) (4/4) (52/53) 
“1”  “1” “1” “1” “1” 
% of HIV positive individuals with 90% 100% 80% 100% 93% 
active TB provided with (28/31) (13/13) (4/5) (4/4) (49/53) 
Cotrimoxazole “1” “1” “1” “1” “1” 
% of HIV positive individuals with 90% 85% 40% 50% 81 % 
active TB provided with ART (N/%) (27/30) (11/13) (2/5) (2/4) (42/52) 
“1” “1” “0” “0” “1” 
% of HIV positive individuals  
9 
 
% 
 
6% 
 
25% 
 
0% 
 
11% without active TB and no 
contraindication   for   IPT   provided (6/70)  (4/63) (15/59) (0/29) (25/221) 
with IPT “0”  “0” “0” “0” “0” 
Overall  score  out  of  5  (Good  >= 5/6 5/6 3/6 4/6 5/6 
75%; poor <75%) (83%) (83%) (50%) (67%) (83%) 
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Table 12. assesses the outcome of HIV clients by TB status in Hawassa town administration over 
a one year period. The prevalence of active TB among HIV positive clients in the district was 
19% (53/274). Diagnosis of active TB was calculated from the 274 HIV/AIDS clients that 
underwent either baseline and/or last clinical visit TB screening. There were nine clients not 
screened either at baseline or at last clinical visit and one missing record. 
 
Table 12. Survival of HIV Clients by TB Status in Hawassa Town Administration, 2010/11 
 
 
TB status 
 
Total 
Alive and currently 
in care 
 
Dead 
 
Unknown status 
Diagnosed with active TB Number Number % Number % Number % 
Yes 53 42 79% 1 2% 10 19% 
No 221 162 73% 4 2% 55 25% 
TB status Unknown 3 2 67% 1 33% 0  
Total 277 206 74.4% 6 2.1% 65 23.5% 
 
 
Table 13. shows the survival status of HIV/AIDS clients whose treatment status and outcome 
were documented. Out of the 152 HIV/AIDS patients who started on HAART, the one year 
outcome was known/documented for 143 HIV/AIDS clients. Likewise out of the 126 HIV/AIDS 
clients enrolled in pre-ART care, only 69 had documented one year outcomes. 
 
Table 13. Survival status of HIV patients on HAART in Hawassa Town Administration, 
2010/11 
 
HAART treatment status Documented outcome at 1 year Number Percent (%) 
ART patients Alive and on treatment 138 96.5% 
 Dead 5 3.5% 
 Total 143  
Pre-ART patients Alive and in care 68 98.6% 
 Dead 1 1.4% 
 Total 69  
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Table 14 describes the criteria for calculating a total weighted score for quality of HIV services. 
Every activity was equally important with none of the activities being of any greater importance 
than any other activity and each one was scored out of one. Thus, an activity was given a score 
of one if performed and zero if not. The total score was calculated out of 16 for pre ART patients 
and out of 18 for ART patients depending on the number of variables each have. The cut-off 
score dividing adequate and inadequate quality was set at 75%. Thus for Pre ART patients a 
score of >= 12 was classified as adequate quality whereas below 12 as inadequate quality and for 
ART patients a score of >/= 13.5 was classified as adequate quality whereas below 13.5 as 
inadequate quality (See table H in appendix) 
 
Table 14. Criteria for calculating total weighed score for quality of HIV service 
 
Ser. No Criteria Weight score 
1 Recorded of patient contact 1 
2 Recorded care givers contact 1 
3 Hemoglobin test performed at baseline 1 
4 ALT/AST tests performed at baseline 1 
5 Patient staged at baseline using WHO staging 1 
6 Patient staged at least once per year using WHO staging 1 
7 Baseline CD4 count performed 1 
8 CD4 count done in the last six months 1 
9 Functional status assessed at baseline 1 
10 Functional status assessed once per year 1 
11 Patient weight measured at baseline 1 
12 Patient weight measured at last clinical visit 1 
13 ARV eligibility assessed at baseline 1 
14 TB screening performed at baseline 1 
15 TB screening performed at last clinical visit 1 
16 Patient given follow up appointment for the next visit 1 
 Total score for Pre ART care (all patients) 16 
17 Two counseling session given to patients before initiating HAART 1 
18 All necessary investigations performed (CBC and BUN, and Creatinine) 1 
 Total weighed score for ART care (ART clients only) 18 
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Table 15 shows quality of HIV/AIDS care in different facilities in Hawassa town administration 
based on the criteria shown in table 14. There was significant association between individual 
facility and quality of HIV care, P = 0.000. Half of the facilities in the district provided adequate 
quality HIV care and overall, the district provided adequate quality HIV care. 
 
Table 15. Shows quality of HIV/AIDS care in different facilities in Hawassa district 
 
Proportion 
of 
individuals 
who 
received 
HIV 
service 
Facility name District p-value 
Facility W Facility X Facility Y Facility Z 
number % Number % Number % Number % Number % 
Adequate 
quality 
82 80% 69 91% 45 67% 19 49% 215 76% 0.000 
Inadequate 
quality 
20 20% 7 9% 22 33% 20 51% 69 24% 
Overall 
score 
(adequate 
>/= 75; 
inadequate 
< 75) 
 
 
 
“1” 
Adequate 
quality 
 
 
 
“1” 
Adequate 
quality 
 
 
 
“0” 
Inadequate 
quality 
 
 
 
“0” 
Inadequate 
quality 
 
 
 
“1” 
Adequate 
quality 
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Table 16 is a composite table which shows the results of the bivariate analysis comparing socio- 
demographic and health service related factors to quality of HIV services, change in CD4 count, 
change in body weight, TB case finding practice at last clinical visit, and survival of HIV/AIDS 
patients at one year follow up in HIV/AIDS clinics in Hawassa town administration. The 
following variables including: type of facility, educational status, HAART treatment status, staff 
training, availability of minimum number of staff, infrastructure, supplies and supply 
management system, and availability of job aids had shown a positive association with quality of 
service received; sex, marital status, educational status, HAART treatment status, TB treatment 
status, staff training, availability of minimum number of staff, health system procedures, job 
aids, overall facility input, and quality of HIV care had shown a positive association with change 
in CD4 count; HAART treatment status and CD4 level had shown a positive association with 
change in body weight; facility type, HAART treatment status, marital statuses, health system 
procedures, supplies & supply management system, overall facility input as well as quality of 
HIV care had shown statistically significant association with TB case finding practice, and 
facility type, adequacy of staff training, infrastructure, supplies and supply management system 
and job aids, and quality of HIV care had shown statistically significant association with 
HIV/AIDS survival. Of all the variables, “patients treated with HAART” was the only variable 
significantly associated with all outcomes except survival. Individual bivariate tables for each of 
the outcome variables are located in Annexxes Q - U. 
 
Table 16. Composite table on bivariate analysis comparing socio-demographic and health 
service related factors to quality of HIV services, change in CD4 count, change in body 
weight, TB case finding practice at last clinical visit and survival of HIV/AIDS patients at 
one year follow up in HIV/AIDS clinics in Hawassa town administration showing crude 
prevalence ratios and 95% confidence intervals. 
 
 
 
 
53  
 
Variable Group Good 
Quality of 
services 
PR (95% CI) 
Increase in 
CD4 count 
PR (95% CI) 
Increase in 
Body Weight 
PR (95% CI) 
TB case 
finding last 
visit 
PR (95% CI) 
Survival of 
patients at 1 
year 
PR (95% CI) 
Age in years < 30 0.975 
(0.852- 1.116) 
0.857 
(0.651-1.130) 
0.811 
(0.656-1.001) 
1.019 
(0.927-1.120) 
1.028 
(0.986-1.072) >/= 30 
Sex Male 1.054 
(0.923-1.204) 
1.360 
(1.058-1.749) 
1.041 
(0.852-1.271) 
0.977 
(0.883-1.082) 
0.979 
(0.928-1.034) Female 
Marital 
status 
Married + 
Widowed 
0.857 
(0.757- 0.970) 
1.088 
(0.818-1.447) 
0.983 
(0,798-1.209) 
0.944 
(0.859-1.036) 
1.004 
(0.954-1.056) 
Single + 
Divorced 
Residence Urban 1.142 
(0.933-1.399) 
1.166 
(0.713-1.908) 
1.003 
(0.783-1.285) 
1.060 
(0.922-1.219) 
1.064 
(0.969-1.167) Rural 
Education Tertiary + 
Secondary 
1.195 
(1.054-1.354) 
1.394 
(1.070-1.816) 
1.091 
(0.895-1.331) 
1.036 
(0.942-1.139) 
1.001 
(0.958-1.047) 
Uneducated  + 
Primary 
Employment Employed 1.130 
(0.983-1.298) 
1.098 
(0.831-1.450) 
1.026 
(0.835-1.262) 
0.969 
(0.870-1.080) 
1.026 
(0.981-1.074) Not employed 
Type of 
facility 
Hospital 1.405 
(1.190-1.659) 
0.966 
(0.712-1.310) 
0.997 
(0.814-1.221) 
1.186 
(1.059-1.328) 
1.065 
(1.000-1.134) Health center 
Treated  with 
HAART 
Yes 1.780 
(1.510-2.098) 
3.510 
(2.065-5.965) 
1.324 
(1.041-1.684) 
1.257 
(1.133-1.396) 
0.979 
(0.939-1.022) No 
TB status No active TB 0.881 
(0.775-1.001) 
0.671 
(0.532-0.847) 
0.922 
(0.740-1.150) 
 0.999 
(0.949-1.052) Has active TB 
Staff training Adequate 1.642 
(1.183-2.280) 
2.444 (0.446- 
13.413) 
1.280 
(0.874-1.873) 
1.058 
(0.906-1.235) 
1.112 
(0.967-1.279) Inadequate 
Minimum 
number of 
staff 
Yes 0.773 
(0.690-0.866) 
1.346 
(0.983-1.843) 
0.996 
(0.811-1.222) 
0.861 
(0.796-0.931) 
0.959 (0.928 
– 0.992) No 
Infrastructure Adequate 1.642 
(1.183-2.280) 
2.444 
(0.446- 
13.413) 
1.280 
(0.874-1.873) 
1.058 
(0.906-1.235) 
1.112 
(0.967-1.279) Inadequate 
Supplies & 
supply 
management 
Adequate 1.405 
(1.190-1.659) 
0.956 
(0.712-1.310) 
0.997 
(0.814-1.221) 
1.186 
(1.059-1.328) 
1.065 
(1.000-1.134) Inadequate 
Health 
system 
procedures 
Adequate 0.982 
(0.859-1.122) 
1.433 
(1.049-1.958) 
1.097 
(0.901-1.336) 
0.908 
(0.830-0.993) 
1.009 
(0.962-1.058) Inadequate 
IEC 
materials 
Adequate 1.100 
(0.966-1.253) 
1.261 
(0.974-1.633) 
0.993 
(0.809-1.218) 
1.039 
(0.946-1.141) 
1.024 
(0.982-1.067) Inadequate 
Job aids Adequate 1.642 
(1.183-2.280) 
2.444 
(0.446- 
13.413) 
1.280 
(0.874-1.873) 
1.058 
(0.906-1.235) 
1.112 
(0.967-1.279) Inadequate 
Facility input 
(Overall) 
Adequate 0.982 
(0.859-1.122) 
1.433 
(1.049-1.958) 
1.097 
(0.901-1.336) 
0.908 
(0.830-0.993) 
1.009 
(0.962-1.058) Inadequate 
Quality of 
HIV care 
Adequate  2.444 
(0.446- 
13.413) 
1.188 
(0.621-2.273) 
2.089 
(1.616-2.702) 
1.386 
(0.995-1.931) Inadequate 
Change in 
CD4 
Improved   1.402 
(1.077-1.826) 
  
Not improved 
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Table 17 is a composite table which shows the results of the multivariate analysis comparing 
socio-demographic and health service related factors to quality of HIV services, change in CD4 
count, change in body weight, and TB case finding practice at last clinical visit in HIV/AIDS 
clinics in Hawassa town administration. For variables that showed statistically significant 
associations with the outcome variables on bivariate analysis we performed a backwards 
stepwise regression analysis to identify which among the independent variables are most related 
to the dependent variables and to explore the form of these relationships. To include variables 
into the regression analysis we used a p - value of 0.1 as cut off point for all the outcome 
variables except one year survival. Thus, variables which showed a p - value of 0.1 and less on 
bivariate analysis were included in the regression analysis and those that showed a p - value 
above 0.1 were excluded from regression analysis. Although quality of care had a positive 
association with TB case finding, this result was expected as TB case finding is included in the 
composite measure of ‘quality of care’, hence since it is in fact part of the ‘independent’ variable, 
the ‘independent’ variable is not fully independent as a result this variable was not included in 
the multivariate analysis. Whereas, for one year survival all the variables included in the 
bivariate analysis were used to do the regression analysis as there were only two variables 
(facility type and Supplies & supply management) that showed statistically significant but 
borderline association on bivariate analysis. However, none of these variables showed 
associations on multivariate analysis. For the rest of the outcome variables, the following 
associations were shown: HAART treatment and availability of minimum staff number were 
found to be strong predictors of quality HIV care; HAART treatment was also found to be strong 
predictor of CD4 improvement; CD4 count increment was found to be a strong predictor of 
change in body weight; availability of staff, health system procedures and quality of HIV care 
were found to be strong predictors for TB case finding, and quality of HIV care was found to be 
a strong predictor of survival among HIV/AIDS patients. 
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Table 17. Multivariate Analysis Comparing Socio-Demographic and Health Service 
Related Factors to Quality Services, change in CD4 count, change in body weight, TB Case 
Finding at last clinical visit and survival in HIV/AIDS Clinics with adjusted prevalence 
odds ratios and 95% confidence intervals being reported 
 
 
socio-demographic and health 
service related characteristics 
Good Quality 
of services 
Adj POR 
(95% CI) 
Increase in CD4 
count 
Adj POR 
(95% CI) 
Increase in 
Body Weight 
Adj POR 
(95% CI) 
TB case finding 
Adj POR 
(95% CI) 
Age in years < 30   0.700 
(0.330 - 1.485) 
 
> 30 
Sex Male  1.300 
(0.498 - 3.396) 
  
Female 
Education Tertiary + 
Secondary 
 
 
1.441 
(0.574 - 3.620) 
1.183 
(0.482 - 2.901) 
  
Uneducated   + 
Primary 
Marital status Widowed + 
married 
 
 
0.616 
(0.239 - 1.591) 
   
Single + 
Divorced 
Residence Urban     
Rural 
Employment Employed 1.098 
(0.463 - 2.601) 
   
Not employed 
Type of facility Hospital 1.214 
(0.460 - 3.208) 
   
Health center 
Started on 
HAART 
Yes 18.514 
(7.043 - 
48.668) 
13.604 
(4.887 - 37.873) 
1.239 
(0.494 - 3.104) 
7.883 
(2.998 – 
20.731) 
 
No 
Active TB No  2.901 (0.858 - 9.805) 
  
Yes 
Staff training Adequate 1.976 
(0.588 - 6.637) 
   
Inadequate 
Minimum 
number of staff 
Available 0.167 
(0.046 - 0.611) 
  0.587 
(0.105 – 3.284) Not available 
Supplies & 
supply 
management 
system 
Adequate     
2.043 
(0.785 – 5.315) 
 
 
Inadequate 
IEC materials Adequate  0.305 
(0.086 - 1.090) 
  
Inadequate 
Overall facility 
input 
Adequate    0.431 
(0.151 – 1.225) Inadequate 
CD4 change Improved   2.464 
(1.016 - 5.979) 
 
Not improved 
 
NB: multivariate analysis was not done for survival outcome as there were no significant 
associations on bivariate analysis. 
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7.4. TB clinic 
 
This section includes results of interview with facility managers, observation of TB clinics, and 
review of records of patients in the TB clinics. More specifically it includes presentations of 
univariate analysis of facility inputs such as staff training profile, infrastructure and supplies, lab 
infrastructure for TB/HIV care, supplies and supply management system, health system 
procedures, information education and communication materials, job aids, forms and registers 
available in the TB clinics; composite scores of overall TB clinic imputes that categorized them 
into two broad categories (adequate and inadequate inputs); descriptive statistics of individual 
patient background characteristics in TB clinics, and descriptive statistics of outcome variables 
such as, HIV case finding, TB treatment outcome, and quality of TB care delivered. In addition, 
it includes bivariate analysis using facility characteristics and individual TB patient background 
characteristics with the above outcome variables and variables that showed a P value of 0.1 or 
less (in order to include as many variables as possible) in the bivariate analysis were included in 
multivariate analysis. 
 
Table 18 shows the composite score on the adequacy of inputs for the TB clinics of the health 
facilities in Hawassa town administration. Using the various facility inputs listed below and 
setting 75% as a cutoff point, facilities were classified as having adequate or inadequate overall 
inputs. Thus for a specific facility input if a facility had 75% of the parameters and above it was 
classified as having adequate input, if not as inadequate. This classification was further coded as 
1 and 0 values respectively. As explained in the analysis for HIV/AIDS, several items make up a 
specific variable, eg staff training. If greater than 75% of the items in a variable are adequate 
then the composite score for that variable is deemed adequate and given a score of “1”. If 
inadequate it gets a score of “0” (see tables I – O in Appendix). Then the above score for each of 
the variables were inserted into a summary composite score to calculate the overall input for 
each facility. Accordingly, a facility that had 75% and above score on summation of the various 
input variables would be classified as having adequate overall input and if less it would be 
classified as having inadequate overall input. Only one out of four facilities had adequate overall 
facility inputs required to provide appropriate and effective TB services. 
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Three out of four facilities had inadequate inputs for effective TB/HIV services at TB clinics 
Table 18. Composite score on adequacy of inputs in TB Clinics of Health Facilities in Hawassa Town 
Administration, 2010/11 
 
 
Facility inputs 
Facility W Facility X Facility Y Facility Z 
Staff training 0 0 1 0 
Infrastructure and supplies 1 1 0 0 
Lab infrastructure for TB/HIV care 1 1 1 1 
Supplies and supply management system 1 1 0 0 
Health system procedures 1 0 1 0 
Information   education   communication 
materials 
 
0 
 
0 
 
1 
 
0 
Job aids 0 0 1 0 
Forms and registers 1 1 1 1 
Total  input  overall  score  out  of  6 
(Adequate >= 75%; inadequate <75%) 
 
5/8 (62.5%) 
 
4/8 (50%) 
 
6/8 (75%) 
 
2/8 (25%) 
 
 
Table 19, shows the distribution of socio-demographic and health service related characteristics 
of TB patients included in the study in Hawassa town administration. A total of 238 TB patient 
registries were reviewed. Out of these, one registry had missing record on the patient’s sex and 
28 registries had missing records on patients’ residence. The majority of the patients were aged 
30 years and less, and two thirds were male, lived in urban areas, had pulmonary type TB and 
received services from the hospitals. 
 
Table 19. Background characteristic of patients in TB clinics in Hawassa Town 
Administration, 2010/11 
 
Characteristics  
Number 
 
Percent (%) 
Age in years < 30 141 59% 
 >/= 30 97 41% 
Sex Male 152 64% 
 Female 85 36% 
Residence Urban 133 63% 
 Rural 77 37% 
Type of TB Pulmonary 166 70% 
 Extra Pulmonary 72 30% 
Type of facility Hospital 152 64% 
 Health center 86 36% 
HIV test result Positive 37 17% 
 Negative 186 83% 
# 98% of TB patients were tested for HIV 
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Table 20 shows the HIV case finding and management practices amongst TB patients in TB 
clinics at different facilities in Hawassa town administration. Most (3/4) of the facilities in the 
town had good HIV case finding practices amongst TB patients, but the overall management 
practice was poor due to the low percentage of HIV positive TB patients being provided with 
HAART and co-trimoxazole. 
 
Table 20. HIV case finding and Management in TB clinics of Health Facilities in Hawassa 
Town Administration, 2010/11 
 
 [% (score)] - Score “1” if >/= 75%; score “0” if <75% 
Facility W Facility X Facility Y Facility Z District 
% TB patient offered HIV counseling 87% 100% 100% 100% 96% 
(63/72) (80/80) (35/35) (51/51) (229/238) 
“1” “1” “1” “1” “1” 
%  of  TB  patients  tested  for  HIV  at 98% 100% 97% 94% 98 % 
baseline (62/63) (80/80) (34/35) (48/51) (224/229) 
“1” “1” “1” “1” “1” 
% of TB patients HIV positive provided 100% (6/6) 100% 100% (4/4) 100% (4/4) 100% 
with DOTs “1” (23/23) “1” “1” (37/37) 
“1” “1” 
% of TB patients HIV positive enrolled 67%  (4/6) 83% 75%  (3/4) 75%  (3/4) 78 % 
in HIV care “0” (19/23) “1” “1” (29/37) 
“1” “1” 
% of TB patients HIV positive provided 50%  (3/6) 70 % 50%  (2/4) 75%  (3/4) 64 % 
with HAART “0” (16/23) “0” “1” (24/37) 
“0” “0” 
% of TB patients HIV positive provided 33%  (2/6) 78% 100% (4/4) 75%  (3/4) 73% 
with Co-trimoxazole “0” (18/23) “1” “1” (27/37) 
“1” “0” 
Overall score out of 5 (Good >= 80%; (50%) (83%)  5/6 (83%)  5/6 (100%) 6/6 (66.7%) 
poor <80%) 3/56 4/6 
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Table 21 shows the distribution of TB treatment outcomes in Hawassa town administration by 
actual facility, type of facility and HIV status. Ten patients had no record of TB treatment 
outcome. Treatment outcome of TB patients in Hawassa town was good, as 90% of TB patients 
completed their treatment or were cured, 2% had treatment failure, 3% died and 5% defaulted. 
 
Table 21. Distribution of Treatment Outcome of all TB Patients by Type of Facility in 
Hawassa Town Administration, 2010/11 
 
 Total 
TB 
patients 
TB Treatment outcome 
Cured Completed Tx Failed Tx Died Defaulted 
Type of 
facility# 
Hospital 143 43 30% 92 64% 3 2% 5 4% 0 0% 
Health center 85 39 46% 31 37% 1 1% 3 3% 11 13% 
All facilities 228 82 36% 123 54% 4 2% 8 3% 11 5% 
Facility Facility W 64 5 8% 59 92% 0 0 0 0 0 0 
Facility X 79 38 48% 33 42% 3 4% 5 6% 0 0 
Facility Y 35 16 46% 12 34% 1 3% 2 6% 4 11% 
Facility Y 50 23 46% 19 38% 0 0 1 2% 7 14% 
HIV 
status  
of TB 
patients 
## 
HIV positive 36 12 33% 19 53% 2 5.5% 2 5.5% 1 3% 
 
 
 
HIV negative 
 
 
 
178 
 
 
 
66 
 
 
 
37% 
 
 
 
96 
 
 
 
54% 
 
 
 
2 
 
 
 
1% 
 
 
 
5 
 
 
 
3% 
 
 
 
9 
 
 
 
5% 
#9 from the hospitals and 1 from the health center had undocumented TB treatment outcome . 
 
 
## 223 TB patients know their HIV status and of these 9 patients did not have documented TB 
treatment outcomes 
 
 
 
Table 22 describes the criteria for calculating total weighted score for quality of TB services. 
Every activity was equally important with none of the activities being of any greater importance 
than any other activity and each one was scored out of one. Thus an activity was given a score of 
one if performed and a score of zero if not. The total score was calculated out of 8 for all TB 
cases and out of 12 for sputum positive TB cases based on the number of variables these two 
categories have. The cut-off point dividing adequate and inadequate quality was set at 80%. An 
80% cut-off was used as three facilities scored 98% or above and one facility scored 79%, hence 
the 80% cut off allows one to assess why the one facility scored much lower than the others. 
Thus for all TB cases a score of >/= 6.4 was classified as adequate quality whereas below 7.2 as 
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inadequate quality and for sputum positive TB cases a score of >/= 9.6 was classified as adequate 
quality whereas below 9.6 as inadequate quality (See Table P in Appendix). 
 
 
Table 22. Criteria for calculating total weighed score for quality of TB service 
 
 
Ser. No Criteria Weight score 
1 Recorded patient’s contact 1 
2 Recorded care giver’s contact 1 
3 Patient weight recorded 1 
4 Patient categorized 1 
5 Correct initial phase regimen provided 1 
6 Correct continuation phase regimen provided 1 
7 HIV test offered 1 
8 Treatment outcome documented 1 
 Total weighed score for All TB cases 8 
9 Initial sputum smear performed 1 
10 Second month sputum smear performed 1 
11 5th  month sputum smear performed 1 
12 End of treatment sputum smear performed 1 
 Total weighed score for Sputum positive pulmonary TB cases 12 
 
 
 
 
 
 
 
Except for one person TB quality of care for all TB cases in all the four facilities was good. 
Thus we used sputum positive TB patients to do bivariate analysis on quality (as 8% of 
individuals received poor TB care among the sputum positive TB patients). This allowed us to 
see the TB treatment outcomes among the two groups 
 
Table 23 is a composite table which shows the results of the bivariate analysis comparing socio- 
demographic and health service related factors to quality of TB services for sputum positive TB 
patients, to outcome of TB treatment and adequacy of HIV case finding and management 
practice in TB clinics in Hawassa town administration. 
 
 
 
 
61  
 
Table 23. Bivariate Analysis Comparing Socio-Demographic and Health Service Related 
Factors to Quality of TB Services for Sputum positive TB patients (SP+ TB patients), 
outcome of TB treatment and adequacy of HIV case finding and management in Hawassa 
Town Administration, 2010/11 
 
socio-demographic  and  health  service 
related characteristics 
Good quality of 
services among SP+ 
TB patients 
PR (95% CI) 
 
Successful treatment 
outcome 
PR (95% CI) 
Adequate HIV case 
finding and 
management 
PR (95% CI) 
Age in years < 30 1.163 
(1.021 - 1.325) 
1.076 
(0.979 - 1.183) 
0.835 
(0.709 – 0.983) >/= 30 
Sex Male 1.014 
(0.894 - 1.149) 
0.931 
(0.858 -1.011) 
0.953 
(0.803 -1.132) Female 
TB residence Urban 0.955 
(0.843 - 1.080) 
1.162 
(1.031 - 1.309) 
0.648 
(0.567 – 0.742) Rural 
TB type Pulmonary N/A 0.935 (0.861 - 1.014) 
2.138 
(1.588 – 2.879)  Extra pulmonary 
Type of facility Hospital 0.995 
(0.887 - 1.116) 
1.146 
(1.031 - 1.275) 
0.526 
(0.453 – 0.612) Health center 
HIV test Positive 0.987 
(0.846 – 1.153) 
0.946 
(0.823 - 1.275) 
1.190 
(1.004 - 1.409) Negative 
Staff training Adequate 1.044 (0.928 - 1.174) 
0.871 
(0.735 - 1.035) 
1.550 
(1.399 – 1.716) Inadequate 
Infrastructure and 
supplies 
Adequate 0.995 
(0.887 - 1.116) 
1.146 
(1.031 - 1.275) 
0.526 
(0.453 – 0.612) Inadequate 
Supplies and supplies 
management system 
Adequate 0.995 
(0.887 - 1.116) 
1.146 
(1.031 - 1.275) 
0.526 
(0.453 – 0.612) Inadequate 
Health system 
procedures 
Adequate 1.064 
(0.958 - 1.181) 
1.061 
(0.975 - 1.155) 
0.327 
(0.249 – 0.429) Inadequate 
IEC materials Adequate 1.044 (0.928 - 1.174) 
0.872 
(0.735 - 1.035) 
1.550 
(1.399 – 1.716) Inadequate 
Job aids Adequate 1.044 (0.928 - 1.174) 
0.872 
(0.735 - 1.035) 
1.550 
(1.399 – 1.716) Inadequate 
Overall TB input Adequate 1.044 (0.928 - 1.174) 
0.871 
(0.735 - 1.035) 
1.550 
(1.399 – 1.716) Inadequate 
HIV case finding and 
management 
Adequate 0.916 (0.862 – 
0.973) 
1.066 
(0.842 – 1.350) 
 
Inadequate 
Quality of TB 
services among SP+ 
TB patients 
Adequate  2.100 
(0.890 - 4.954) 
0.935 
(0.887 – 0.987)  Inadequate 
NB: classification of outcome of TB treatment is as follows: successful treatment outcome for 
those who cured and completed TB treatment and unsuccessful outcome for those who died 
defaulted or failed treatment. 
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Table 24 is a composite table which shows the results of the multivariate analysis comparing 
socio-demographic and health service related factors to quality of TB services for sputum 
positive TB patients, to outcome of TB treatment and adequacy of HIV case finding and 
management practice in TB clinics in Hawassa town administration. For variables that showed 
statistically significant associations with the outcome variables on bivariate analysis we 
performed a backwards stepwise regression analysis to identify which among the independent 
variables are most related to the dependent variables and explored these relationships. To include 
variables into the regression analysis we used a p - value of 0.1 as cut off point for all the 
outcome variables except quality of TB service for sputum positive TB patients. Thus, variables 
which showed a p - value of 0.1 and less on bivariate analysis were included in the regression 
analysis and those that showed a p - value above 0.1 were excluded from regression analysis. 
Whereas, for quality of TB service for sputum positive TB patients all the variables included in 
the bivariate analysis were used to do the regression analysis as there were only two variables 
(Age and HIV case finding and management) that showed statistically significant but borderline 
association on bivariate analysis. For the rest of the outcome variables, Patient’s age and HIV 
case finding and management practice were found to be strong predictors of quality TB service 
among sputum positive TB patients whereas only quality of Tb services was found to be the 
strong predictor of successful TB treatment outcome. 
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Table 24. Multivariate Analysis Comparing Socio-Demographic and Health Service Related Factors to 
Quality of TB Services among sputum positive TB patients, outcome of TB treatment and adequacy of HIV 
case finding and management with adjusted prevalence odds ratios and 95% confidence intervals being 
reported 
 
 
 
socio-demographic and health service 
related characteristics 
 
Successful 
treatment outcome 
Adj POR 
(95% CI) 
Good quality of 
services in SP+ 
TB patients 
Adj POR 
(95% CI) 
Adequate HIV 
case finding and 
management 
Adj POR 
(95% CI) 
Age in years < 30  8.289 
(0.750 – 91. 606) 
0.529 
(0.232, 1.207) >/= 30 
Sex Male  5.093 
(0.637 – 40.724) 
 
Female 
Residence Urban 1.374 
(0.093 - 20.363) 
 2.012 
(0.115 – 35.124) Rural 
TB type Pulmonary   6.213 
(2.742 – 14.074) Extra pulmonary 
Type of facility Hospital 1.749 
(0.103- 29.729) 
  
Health center 
HIV test Positive  0.873 
(0.071 – 10.786) 
 
Negative 
HIV  case  finding 
and management 
Adequate    
Inadequate 
 
Staff training Adequate 0. 478 
(0.104 - 2.205) 
  
Inadequate 
Quality of services 
for SP+ TB 
patients 
Adequate  
14.590 
(2.400 - 88.692) 
  
Inadequate 
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VIII Discussion 
8.1. HIV/AIDS clinic 
 
8.1.1. Resources for HIV/AIDS care and treatment services 
Resources are key factors in the successful implementation of TB/HIV collaborative activities 
because facilities require a more complex intervention than before, when they were only treating 
HIV or only treating TB. However, these resources are often in very short supply in low and 
middle income countries (Hongoro, McPake & Vickerman, 2004). In our study, the availability 
of a satisfactory level of every type of input resource for TB/HIV care was inadequate in half of 
the facilities in Hawassa town administration. However, this was mainly due to a lack of IEC 
materials and since these are not required in order to provide a seamless high quality integrated 
TB and HIV service, but would rather affect the ability to provide easy to digest information to 
patients, it is likely that the availability of adequate overall inputs (measured as a composite 
value) would not affect the breadth and quality of care, as they should generally be sufficient at 
all facilities, since only IEC materials are lacking. This was borne out by facility inputs having 
no effect on either quality of care, or integration of care (TB case finding), or outcome of care 
(increase in weight, or survival at 1 year) on bivariate analysis. 
 
The finding on the lack of inputs is superficially worse than the Ethiopian national baseline 
HIV/AIDS quality assessment survey, which showed inadequate resource inputs required to 
provide quality antiretroviral treatment services in only 12.5 % (30 hospitals and 25 health 
centers) of the sample of health facilities providing ART services in the country (FMOH, 2009). 
The national study however noted specific gaps in the availability of clinical and implementation 
guidelines, referral forms and basic medical equipment for patient examination. These are all 
resources which are likely to adversely impact on both quality of care and integration of care, 
and ultimately on the outcome of care, hence the lack of resources in the national study had a 
very different implication to that seen in this current study. Notably, although the national study 
looked into very few components of facility input resources and fell far short of providing a 
comprehensive assessment of resources, since a large proportion of facilities had a deficit of key 
resources affecting clinical care, it can be deduced that nationally facilities were poorly prepared 
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to implement effective integrated TB/HIV care at that time. However contrary to this finding, a 
facility based cross-sectional study in a regional referral hospital in the North West region of 
Ethiopia, done at the same time as the national study, showed availability of adequate resources 
except for a shortage of co-trimoxazole (a key medication required for prevention and treatment 
of secondary infections due to HIV) to provide good quality HIV care (Alemayehu, Bushen & 
Muluneh, 2009). The implication is that the availability of resources was not homogenous 
throughout the country, but rather that there were regional pockets where resource availability 
was much greater than in the rest of the country. 
 
In this current study in three out of four facilities, providers received adequate training in all the 
required parameters necessary to perform their duties, had at least the minimum number of staff, 
had adequate infrastructure and supplies, had adequate job aids, and adequate forms and 
registers. This is in line with the above argument where despite the inadequate level of overall 
inputs that resulted from the unavailability of IEC materials, all the remaining components of 
facility inputs consistently showed a positive association with the quality of HIV care. However 
having a minimum number of staff was counter intuitively associated with providing a lower 
quality of care, lower TB case finding practice and less survival outcome. This paradoxical effect 
of having minimally sufficient staff (as compared to insufficient staff) also resulted in the overall 
measure of inputs to facilities not having an association with quality of care provided, as the 
positive effect of the other variables was cancelled by the negative effect of the staffing levels. 
This negative effect of better staffing is almost certainly due to the inadequate measurement of 
whether a facility had sufficient staff or not. Sufficiency of staff was measured based on whether 
there was sufficient staff present according to a set norm for the type of health facility and did 
not at all take into account the utilization of the facilities and hence the actual workload of the 
facilities. Therefore, a facility which had the norm level of staff could quite easily have had a 
higher workload than the facilities with staff levels below the norm. 
 
Laboratory infrastructure for TB/HIV care was adequate in all the health facilities in Hawassa 
town administration, reflecting adequate physical resourcing of the facilities, which is probably 
consequential upon dedicated funding having been available to resource facilities to care for HIV 
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and TB patients (Justman, Koblavi-Deme, Tanuri, Goldberg, Gonzalez & Gwynn, 2009). This is 
shown in other settings such as in Nigeria where all laboratories in facilities providing 
HIV/AIDS care and treatment services supported through PEPFAR were renovated and 
upgraded to provide a sustainable high quality laboratory system (Abimiku et al., 2010). In 
Ghana, HIV/AIDS program funds had generously supported and improved laboratory 
infrastructure and equipment, supplies and services (Adjei, Nazzar, Seddoh, Blok & Plummer, 
2011). This provision of TB/HIV specific resources is contrasted with the provision of general 
supplies and the supply management system, which was only adequate for half of the facilities. 
This discrepancy plausibly reflects the lower level of resourcing of general services as opposed 
to those specifically geared towards diagnosis and cure of TB and HIV. 
 
Similarly, half of the facilities had inadequate health system procedures; specifically there was 
no quality assurance system in half of the facilities and action plans arising from previous 
supervision visits were nonexistent in all of the facilities. Each of them represents the process 
aspect of quality which by itself is an integral aspect of the general health system. This further 
indicates that even within the HIV/AIDS program, a large part of the support is inclined to 
specific sections such as laboratory infrastructure which is the structural component of quality, 
with less investment in the process part which would also be needed to improve not only the 
HIV/AIDS program but also to the general health service/system. This asymmetrical investment 
in specific structural resources rather than in health system/service strengthening, is in contrast to 
the argument that HIV/AIDS resources if designed and implemented with the additional goal of 
achieving broader health benefits, may serve as a catalyst for the establishment of a more 
effective and responsive health system (Elsadir and Abrams, 2007). 
 
8.1.2. Continuity of care, follow up and treatment outcome of HIV/AIDS clients 
Establishing good chronic HIV care requires an effective patient monitoring system, which 
measures key indicators of good individual patient care and of program success (WHO, 2006b). 
Our study finding showed that most HIV/AIDS patients had their CD4 count (91%) and weight 
measurement (96%) done at baseline. The monitoring trend for both parameters however 
declined over time and the decline was more pronounced for pre-ART patients as opposed to 
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patients on HAART. Our study finding was similar to a national cross-sectional study in 2009 
which showed an 89% baseline CD4 count but a decline to 51% at one year (FMOH, 2009). 
 
Most of these patients who did not get their CD4 counts done were being cared for at the health 
centres and this is probably because health centres did not have CD4 count machines and needed 
to transport samples to the nearby hospitals. The challenges faced in transporting the samples 
were that there was no dedicated inter-facility transport service and hence staff had to use public 
transportation to get the samples to the hospital. Making matters worse was the anecdotally 
noted prioritization of samples from the hospitals for CD4 testing, with samples received from 
health centers being tested after the hospital tests were completed. Additionally a purported low 
compliance of patients returning to receive their CD4 results, may partially explain the lower 
levels of monitoring exhibited by the staff (EHNRI, 2012). 
 
All (100% of) patients on HAART had their baseline CD4 count done compared to only 80% of 
the pre-ART patients, which reflects the protocol that a patient should not be commenced on 
HAART without doing a baseline CD4 count and indeed the value of the CD4 count is the most 
important criterion for commencing HAART. Similarly more patients on HAART had their 
weight measured at baseline (98%), six months (94%) and one year (91%) compared to clients 
on pre-ART (94%, 60%, 53% respectively). This might be because providers could be reluctant 
to monitor pre-ART clients as they might look healthy, or that more focus might be given to the 
monitoring of ART patients by supervisors. 
 
The greater emphasis given to the care of patients on HAART is also shown by the provision of 
higher quality services and improved TB case finding to HIV patients on HAART than to those 
who are on pre-ART. This difference in practices added to the beneficial effect of HAART 
medication itself, may have contributed to the observed marked improvement in CD4 count and 
weight among HAART patients as compared to pre-ART patients. As noted for monitoring 
above, it seems that there are clearer case management protocols for those on HAART than those 
not on HAART and higher priority is given to those on HAART, as there is also greater 
managerial and supervisory concern regarding the care of HAART patients. The reportable 
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indicators in the national HIV/AIDS program focus on HAART patients (they include lost to 
follow ups, deaths and numbers of patients on HAART) as opposed to pre-ART patients. Thus 
once the patient is classified as pre-ART, providers are less likely to follow them up as carefully 
as they do for patients on HAART. Since supervisors and managers are accountable to the 
performance of the facility based on the above national indicators, they would naturally prioritise 
HAART patients. Such prioritization would include thorough patient evaluation, monitoring drug 
adherence, defaulter tracing and educating of patients on HAART, all of which would allow 
frequent patient encounters with the health service and subsequently increase the likelihood of 
the monitoring of their CD4 counts, TB screening, prophylaxis provision, weight measurement, 
and nutritional and positive living advice provision. In addition HAART patients have a much 
more frequent routine follow-up schedule (every week for two weeks, then every two weeks 
until the 4th week, then every four weeks until the 3rd month, then every two months) as opposed 
to pre-ART patients that have a much less intensive follow-up schedule (it was every 6 months 
initially but then was later revised to be every 3 months in 2007 as outlined in the national 
guidelines (FHAPCO, 2007). This further would allow them to have more frequent contact to the 
health service and hence make it more likely that they would receive the above monitoring. 
 
The effect of the difference in care is also shown by the proportion of patients that showed an 
increase in CD4 count. Seventy nine percent of patients on HAART as opposed to only 22% of 
patients not on HAART showed an increased CD4 count at one year of follow-up. Likewise, 
three fourths of patients on HAART as compared to slightly more than half of the clients in pre- 
ART care had gained weight at one year. However, the overall decline in patient monitoring in 
both groups indicates a lack of continuity in patient monitoring as a whole and may warrant 
system wide improvements. 
 
Of the HIV positive patients on HAART, 11% had CD4 count greater than 350 and 16% of HIV 
patients not on HAART had CD4 count less than 350. This is because some patients were 
clinically staged using WHO staging in the health centres (at which facilities there is a delay in 
receiving CD4 Results) and then got their CD4 count results later. Patients with a healthy clinical 
appearance were then not commenced on HAART, despite their CD4 being low enough to 
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require HAART (less than 350), which indicates that HAART initiation assessment is done 
fairly well at the first visit, but becomes less pronounced at subsequent visits. A similar finding 
was observed in a hospital based cross-sectional study that showed more than a quarter (29%) of 
HIV-infected patients who should have been started on HAART, did not start ART (Alemayehu 
et al., 2009). This is borne out by the decreasing level of testing for CD4 during pre-ART care 
over time. 
Overall, HIV/AIDS patients in Hawassa town administration present to the health system at a 
relatively late stage of the disease. This is seen by the baseline median CD4 count of 265 (IQR 
130 – 508) for all HIV positive patients. Making the situation even worse, patients started 
HAART relatively late (the median CD4 count for those who initiated HAART was 165 (IQR, 
90 - 255)) given the recommended 350 CD4 count cut-off level to commence HAART treatment 
for most patients (WHO stages III and IV), and despite the fact that most HIV/AIDS patients 
(91%) had their CD4 measured at baseline. However, our study finding showed earlier 
presentation of patients than a national study (baseline median CD4 count 125 (IQR 68-189)) 
(FMOH, 2009) and a study in Cameroon (baseline median CD4 count of 105 (IQR 42 – 167)) 
(Sieleunou, Souleymanou, Schonenberger, Menten & Boelaert, 2009). When looking at the 
distribution by type of facility, HIV/AIDS patients presented to the health system at an earlier 
stage in health centres (median CD4 375 with IQR 191 – 640) as compared to hospitals (234 
with IQR 117 – 470), which is consistent with the role of the health centre as the first point of 
contact for testing and, if shown to be positive, caring for people with HIV and TB. 
In spite of late presentation for care, delayed treatment initiation and declining patient 
monitoring, HAART initiation had led to an acceptable improvement in median CD4 count 
(from 165 with IQR 90 – 255) at baseline to 235 (IQR 152 – 335) and 275 (IQR 199 – 386) at six 
months and one year respectively); increased body weight (patients on HAART gained more 
weight (5kg) than those on pre-ART care (1 kg) at one year follow up); and elevated functional 
status (among HAART patients there were 23% ambulatory but not able to work and 1% bed 
ridden patients at baseline, but 99% became able to work one year later). This shows an initial 
immunological and clinical improvement after treatment with HAART, confirming its 
effectiveness and the probable reasonably good adherence in the early phase of treatment. 
Comparable improvement was found in the national baseline study from a median CD4 count 
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125 (IQR 68-189) at baseline to 242 (IQR 161-343), 269 (IQR 185-380) at six months and one 
year, and an increase in proportion of patients with working functional status from 60% at 
baseline to 84% and 86% at six months and one year (FMOH, 2009). A similar change in CD4 
count was observed in a Cameroonian study that showed a gain in CD4 of 136 at six months and 
150 at 12 months from the baseline value of 105 and a comparable increase in body weight 
compared to baseline with an average weight gain of 6.3 kg at one year (Sieleunou et al., 2009) 
 
HIV/AIDS patients, who are male, have higher educational level, and those treated with HAART 
had improved CD4 count at one year, but paradoxically HIV patients with active TB had a 
greater improved CD4 count than those without active TB, suggesting that the focus given to 
integrated TB/HIV care might have biased providers to give undue emphasis to the care of these 
patients with TB and HIV, than to the rest. This is supported by the fact that more HIV patients 
with TB (86.7%) received good quality HIV services as opposed to HIV patients without TB 
(76.4%) and that more HIV patients with TB had better survival (79% alive at one year) as 
opposed to HIV patients without TB (73% alive at one year), although the associations did not 
show statistical significance. Likewise, facilities with adequate overall facility input and health 
system procedures had a statistically significant improvement in one-year CD4 count. On 
multivariate analysis, HAART treatment status was found to be a strong predictor of CD4 
improvement, indicating that HAART is the key to improvement in patients’ immune status and 
has a far greater effect than any other facility input or individual patient characteristics, and 
hence requires very close monitoring by providers and program managers. 
 
Similarly, HAART treatment and improvement in CD4 counts were found to have statistically 
significant association with body weight gain among HIV/AIDS patients. However, on 
multivariate analysis, change in CD4 count was found to be a strong predictor of body weight 
gain. This is consistent with the fact that immunological improvement is a strong predictor of 
overall clinical improvement (Goujard et al., 2006). It may also indicate that other parameters 
that make HAART more successful (such as drug adherence and good nutrition) may also be 
essential to result in improved immune status and subsequent clinical improvement (Evans et al., 
2013; Berhe, Tegabu & Alemayehu, 2013) or CD4 improvement might just reflect the causal 
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effect of HAART treatment, with CD4 improvement simply being an intermediate variable in the 
causal pathway between providing HAART and weight gain. 
 
8.1.3. TB case finding and management among HIV/AIDS patients 
The dramatic spread of HIV has been accompanied by a major increase in the number of new 
cases of tuberculosis (WHO, 2009). Between 2005 and 2011 implementation of collaborative 
TB/HIV activities saved millions of lives, but much more needs to be done to achieve universal 
access to these life saving measures and to eliminate HIV associated TB deaths (WHO, 2011). 
Accordingly, the federal ministry of health of Ethiopia has been implementing intensified TB 
case finding since 2005. In our study, the TB case finding and management practice was 
adequate in the health facilities in Hawassa town. Ninety five percent and 86% of HIV positive 
patients were screened for TB at baseline and at their last clinical visit respectively, and the vast 
majority of patients co -infected with TB and HIV were provided with DOTS, CPT and ART (at 
levels of 98%, 93%, 81% respectively). Taken together these findings signify a very good 
performance in TB case finding and management, as it nearly achieved the national TB/HIV 
strategic plan target of screening all HIV/AIDS patients for TB and providing DOTS and CPT to 
all TB/HIV co infected patients in the HIV clinics (FMOH, 2007a). 
 
The TB screening of patients with HIV practice in our study (95%), is much better than the 
routinely reported national performance (44%) (FHAPCO, 2012), higher than that in a national 
study in Ethiopia (68%) (FMOH, 2009) and higher than the performance in South Africa (76%) 
(Chehab, Vilakazi-Nhlapo, Vranken, Peters & Klausner, 2013). However, a similar level of 
performance was observed in Rwanda after a nationwide implementation of intensified TB case 
finding among HIV patients upon enrolment for HIV care, that increased from 77% to 94% from 
2006 to 2011 (Uwinkindi et al., 2014). This is in line with the observation above where greater 
focus was put on TB/HIV care which is clearly beneficial to the care of co infected patients and 
should be reproduced in the care of all HIV patients (including those not on HAART) and at 
other TB/HIV entry points such as TB clinics where the HIV case finding and management 
practice performance was relatively low. Our finding is consistent with the large global increase 
in TB screening among people living with HIV and provision of IPT in 2010, which occurred 
subsequent to increased dedicated funding for TB in several developing countries (WHO, 2011). 
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However, only 11% of HIV positive individuals without active TB were provided with Isoniazid 
Prophylactic Therapy (IPT) which is way below the national and global target of 50% (FMOH, 
2007a), which reflects a greater focus on treatment of TB than prevention of TB. Indeed the low 
level national and global target for TB prophylaxis echoes this lack of emphasis on prevention. 
However the high TB treatment levels achieved suggests that if the policy becomes more focused 
towards prevention of TB, then this is likely to translate into as high a level of prophylaxis 
against TB as there is for treatment of TB. Although the provision of IPT was low, it was slightly 
higher than the national performance of 6.6% (FHAPCO, 2012) and a wide national study that 
showed 5% IPT provision (FMOH, 2009). Much higher IPT performance is seen in South Africa 
where 46% of HIV patients with no TB were offered IPT (Chehab et al., 2013).The finding on 
IPT provision indicates significant missed opportunities to prevent TB, given the high prevalence 
of TB among HIV patients. Besides, the apparently low importance placed on TB prophylaxis 
(or perhaps because of this low importance), the limitation in availability of IPT may also 
partially explain the observed low IPT prophylaxis levels. Indeed previous national TB/HIV 
program meetings noted a lack of data with which to estimate IPT demand for the purpose of TB 
prevention in HIV patients and note that most of the Isoniazid available at facilities was procured 
as part of DOTs package for TB treatment purposes, rather than via IPT requests, and was not 
enough to provide medication for the HIV patients who required IPT. 
 
Adequate supplies and supply management systems, type of facility and HAART status had 
statistically significant associations with TB case finding practices. Patients seen in Hospitals 
and patients on HAART underwent better TB case finding and management. Again this reflects 
the better care provided to patients on HAART compared to those not on HAART, for the same 
reasons as stated above. On the other hand the observed difference by facility type was also 
expected because hospitals may have a better capacity to diagnose TB since HIV makes the 
presentation of TB atypical (Gupta, Lawn, Bekker, Caldwell, Kaplan & Wood, 2013) and hence 
requiring additional diagnostic tests such as X-rays, which were not present in health centres. Or 
it may simply reflect greater adherence to the policy guidelines regarding TB case finding at the 
hospitals. 
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As in quality of HIV service, the paradoxical effect of having minimally sufficient staff (as 
compared to insufficient staff) as with having minimally adequate health system procedures (as 
opposed to adequate health system procedures) resulted in a negative association with TB case 
finding practices. Whereas having adequate supplies and a supply management system had a 
positive effect on TB case finding. However, on multivariate analysis, only HAART treatment 
status was found to be a strong predictor of TB case finding. 
 
Although quality of care had a positive association with TB case finding, this result was expected 
as TB case finding is included in the composite measure of ‘quality of care’, hence since it is in 
fact part of the ‘independent’ variable, the ‘independent’ variable is not fully independent and to 
the extent that TB case finding is part of the measurement of ‘quality of care’, a positive 
association is both expected and fully explained. 
 
8.1.4. Quality of HIV/AIDS services 
The Donabedian model of quality which includes three aspects: structural, process and outcome 
was used in our study. The process factors constitute ingredients of HIV/TB care delivered to 
patient by service providers; structural factors include the organizational and managerial factors 
at health facilities that define the availability, accessibility and convenience of HIV/TB care to 
patients while as the name implies treatment outcomes are regarded as outcomes of structural 
and/or process factors (Donabedian, 2003). In our study we used process aspects as measure of 
“quality of service delivered to patients” and we assessed structural factors as measure of 
“facility resource input”. Facility inputs were also used as independent variable to see its effect 
on quality of service delivered and treatment outcomes. 
 
Quality of HIV/AIDS care in Hawassa town administration was adequate in half of the health 
facilities. Patients who received HIV/AIDS services in the hospitals had better quality services 
than those who received it in the health centres and this association was confirmed on bivariate 
analysis, but this result was not significant on multivariate analysis. This may be because 
hospitals did better work-up of patients at enrolment, had better monitoring, had better capacity 
to perform TB screening and management, and had more highly qualified and trained staff. The 
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fact that two thirds of the patients included in this study were seen at the hospitals made the 
overall quality of HIV/AIDS care provided in the town, adequate. A hospital based study in 
Northern Ethiopia that assessed quality of HIV/AIDS services using three components - 
structure, process and outcome, showed that a significant proportion of patients had missed 
important components of care recommended by the national guidelines, resulting in gaps in 
process and outcome (Alemayehu et al., 2009). The same study noted that a better quality of care 
was provided to patients at enrollment than during follow up. A similar finding was observed in 
a wider national study which showed a gap in the level of quality for each quality indicator 
which varied from region to region (FMOH, 2009). In the absence of an effect of overall facility 
inputs on quality of HIV service in our study, the finding of good quality HIV service in the 
town as a whole may indicate reasonably good practices around processes involved in quality of 
care, since our variables that make up quality of care are all process variables. On the other hand, 
the variation by type of facility indicates the need for more focus in the health centers with 
regards to quality of HIV/AIDS services. 
 
Patients on HAART received markedly better quality HIV/AIDS services than patients not on 
HAART, with a high adjusted prevalence odds ratio (18.5). This, as noted before, reflects a bias 
towards implementing HIV amelioration services, which in turn reflects the large degree of 
systemic support for care aimed at minimising the effect of HIV infection and curing TB. On 
multivariate analysis, HAART treatment status was found to be a strong predictor of good 
quality HIV/AIDS service with an adjusted POR much higher than that seen on bivariate 
analysis. Apart from their association with good quality HIV care, the other socio-demographic 
variables including better education, being single and divorced, and each facility input, except 
minimum number of staff, all independently had a positive statistical association with HAART 
itself. This means that the effect of HAART was diluted by the shared effect of the above 
variables on bivariate analysis, but when these variables were controlled on multivariate analysis, 
the association became extremely high. The evidence of a causal relationship between HAART 
and quality of HIV service based on strength of association is therefore very high. 
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As explained in the facility input section, adequate training of staff, availability of adequate 
infrastructure and supplies, a functional supply management system, as well as availability of 
job aids, lead to good quality HIV/AIDS services on bivariate analysis, but its effect was 
cancelled out by the effect of staffing levels which resulted in lower quality of care. The strength 
of this paradoxical effect of having minimally sufficient staff (as compared to insufficient staff) 
was further noted by the high adjusted risk ratio on multivariate analysis (0.167) as opposed to 
no statistical association for the above variables on multivariate analysis. Previously we 
speculated that this paradoxical effect could be because the measurement of adequacy of staff did 
not consider the workload of the staff, therefore it could be that facilities with more staff would 
attract greater utilisation and hence result in a greater workload and by implication result in a 
lower quality of care. However given the high adjusted odds ratio this plausible assumption, even 
if true, does not provide a full explanation of the counter-intuitive effect of ‘less staff results in 
higher quality of care’ and suggests that there must be some other currently unknown 
explanation for this phenomenon. A possible further partial explanation is that the facilities that 
had a minimum number of staff were also the ones which had inadequacies of other inputs such 
as trained staff, infrastructure, supplies, supply management system and job aids and hence it 
was these causing the lower quality observed. This is indeed the case as shown in table 3 where 
facility ‘Z’ although having sufficient staff is deficient in many of the other input resources. 
However this is still not a sufficient explanation for the strong negative association of having a 
minimum number of staff shown on multivariate analysis, hence the real factor/s presumably 
causing this presumed residual confounding effect is either ‘high workload’ and/or some other 
unidentified factor. 
 
8.1.5. Retention in care and outcome of HIV/AIDS patients 
Looking at the overall outcome distribution of HIV/AIDS patients who initiated HAART at one 
year follow up, 91% of these patients were retained in care at the end of the year (alive and were 
on treatment). This finding was higher than that of a hospital based follow up study in the same 
region that found a 63% one and half year retention in care (Mulissa, Jerene & Lindtjørn, 2010), 
a wider more representative national study which showed a 74% one year retention rate for HIV 
patients seen from 2006-2008 (Assefa et al., 2011), and to a study in Cameron (77% 1 year 
survival) (Sieleunou et al. 2009).   The consistently lower retention rates in the two national 
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studies could be explained by the timing of program implementation as both were assessed in the 
earlier period of ART initiation in the country when HIV infection stigma and discrimination 
prevailed people’s awareness of the benefit of ART was lower, access to services were limited, 
and the overall HIV/AIDS care and treatment program had not matured enough yet. Conversely, 
the observed improvement in retention rate in our study could be a reflection of the improvement 
in HIV/AIDS service delivery including improved quality of and access to services, engagement 
of multiple actors with increasing resources, improved community awareness of treatment 
options and a lessening of socio-cultural barriers over time (FHAPCO, 2012). 
 
One of the goals of any HIV program should be to increase survival and reduce mortality among 
infected individuals. Thus, survival and mortality of HIV/AIDS patients are key impact 
indicators (WHO, 2006b). Of the HIV/AIDS patients who were started on ART, 94% had a 
follow-up outcome recorded for at least one year and 97% of these were alive at one year. For 
the remaining 6% for whom we do not have follow-up records, we do not know the one-year 
survival outcome is unknown, but we suspect it would be lower than for those who were 
retained. 
 
Globally, HIV/AIDS has posed a significant mortality and morbidity in recent decades. 
However, the introduction of HAART has made a significant contribution to the survival of 
people infected with HIV. This was shown by a study conducted in the USA comparing the 
mortality trends during various time periods: pre HAART era (1990 - 1996), early HAART era 
(1997 - 1999) and late HAART Era (2000 - 2003) which revealed a 10.3%, 2.8% and 0.2% 
annual mortality in 1995, 1999 and 2003 years respectively, with increasing mortality trend in 
the pre-HAART era and a declining trend in the post HAART eras (Crum et al., 2006). A wider 
study from seven demographic surveillance sites in eastern and southern African  countries 
further analyzed the mortality trend in adults (ages 15 – 64) by HIV status before and after the 
introduction of HAART and found a crude mortality rate of 77.8 per 1000 for HIV positive 
individuals as compared to 6.7 per 1000 for HIV negatives in the pre-HAART era (years 2000 – 
2003) with a relative risk of 11.6 (95% CI, 10.7 – 12.7), whereas after the wide scale 
introduction of HAART the crude mortality for HIV positives dropped down to 31.6 per 1000 
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and 9.5 for HIV negatives with a corresponding relative risk of 3.3 (95% CI:3.1 -3.5) in the years 
2009 -2011 (Reniers et al., 2014). The documented mortality rate in the first year of treatment in 
our study was similar to the South Africa one at 3% (or 30 per 1000) which probably reflects the 
effectiveness of HAART. The finding is much better than the11.3% mortality seen in a study in 
the same region (Mulissa et al., 2010) and to the 6% mortality in a wider national study (Assefa 
et al., 2011). It is also much lower than the average mortality rates (8 – 26%) in sub-Saharan 
African countries, than the 3 -13 % in HIV programs in Latin America and Caribbean, and 11 - 
13 % in HIV programs in South-East Asia (Lauren, Meintges, Mcllleron, Harries & Wood, 
2013). However, many of the above studies may have used a different denominator including 
patients whose outcome were not known or documented resulting in lower mortality rates (as 
they have a larger denominator) than what we found in our study, where we only analyzed 
mortality of patients who had a documented outcome status (noted alive or dead). 
 
Out of the HIV/AIDS patients who initiated ART, 6% had an unknown outcome status at the end 
of one year; this could be because of death, being lost to follow up or as a result of poor 
documentation. The above finding, however, is better than a national study that revealed 19% 
with unknown status at one year (Assefa et al., 2011) but the corresponding figure for pre-ART 
patients was very high (unknown status of 45%) and points out the need for better recording of 
annual survival data. It is also a significant number to worry about looking at the distribution of 
lost to follow up in a previous study in the same region, which showed that out of the 13.4% lost 
to follow up, 41% have died, 20% were under follow up at another facility, 14% stopped 
treatment, 10% left the region, 9% were on traditional treatment and 6% were status unknown 
“true lost” (Mulissa et al., 2010). A study in rural Malawi also revealed the same: 54% were 
dead and 20% moved away, with their main reasons for defaulting being stigma (43%), care 
dissatisfaction (34%) and improved health (28%) (McGuire et al., 2010). So in addition to better 
recording of survival data, it is also necessary to find the causes for lost to follow-ups to design 
adapted solutions. 
 
On bivariate analysis, a few of the socio-demographic or facility characteristics that showed 
statistically significant  associations  were  borderline  and  most  failed  to  show  a  meaningful 
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association with survival of patients, possibly because this may require an extended period of 
observation (not just one year) to show the existing effect. As a result, multivariate analysis was 
not done for this specific outcome. 
 
8.2. TB clinic 
 
8.2.1. Resources for TB services 
A nurse and a laboratory technician is the standard minimum required to run a TB clinic, so in 
general facilities that have a TB DOTs service would, by default, have these service providers, so 
it is unlikely that there would be any difference across the facilities with regards to staff 
availability. As a result, we did not use minimally adequate number of staff as an independent 
variable, but instead we used adequately trained service providers as measure of both staff 
number and training. That gave us five indicators to weigh training adequacy (Tuberculosis 
training, TB/HIV training, provider initiated HIV counseling and testing training, HIV testing 
and AFB microscopy training for a laboratory technician) to use to calculate a composite score 
of adequately trained and inadequately trained providers. This would allow us to assess the effect 
of trained providers on any other outcome variables of interest. 
 
In reference to the Donabedian model of quality: structural factors include the organizational and 
managerial factors at health facilities that define the availability, accessibility and convenience of 
HIV/TB care to patients (Donabedian, 2003). In our study these structural factors are represented 
as facility inputs and include most of the above elements. Resources are needed to provide 
adequate inputs for facilities to provide quality TB/HIV services. In this regards, International 
donor funding for TB control has increased by 50% since 2006, but still falls far short of the 
required funding needed for comprehensive TB services throughout the country (WHO, 2011). 
The same source also noted that funding for TB/HIV collaborative activities is increasing, but 
since it is usually channeled to the national HIV programmes and non-governmental 
organizations, rather than to national TB control programmes, the national TB programme still 
suffers from a paradoxical shortage of funds. In Hawassa town administration, three out of four 
facilities had inadequate overall inputs required for good quality TB care and the fourth barely 
managed to achieve adequate status. Most of the inputs, including staff training, availability of 
information education and communication materials and job aids, were inadequate in most of the 
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facilities (3/4) and infrastructure and supplies, supply management system and health system 
procedures, were present in only half of the facilities. However, laboratory infrastructure and 
availability of forms and registers for TB/HIV and TB care were adequate in all of the facilities. 
Similar finding was seen in a cross sectional study in Northern Ethiopia which assessed 7 
hospitals, 9 health centers and 28 clinics (Mengiste, 2009). The study found that the required 
inputs (structural factors) have not been available or implemented optimally, and specifically 
found that none of the TB focal persons were trained, teaching materials were scarce in most 
health facilities, and only 18% of providers were supervised (of these only 11% received written 
feedback), however there was no interruption of TB drug supply and standard patient treatment 
registers were available in all facilities 
 
Unlike the HIV/AIDS service inputs, the TB inputs that were deficient were inputs that are 
required to provide integrated TB and HIV services. As a result the inadequacy of overall inputs 
affected the low performance of HIV case finding and management practices (those with 
adequate inputs were 1.6 times more likely to have adequate HIV case finding and management 
practices), but interestingly it failed to show statistical association with TB treatment outcomes 
and quality of care for TB patients. Despite this lack of effect of inputs on outcomes in this 
study, the absolute deficits in inputs for TB clinics suggests that managers and donors should be 
alerted that HIV/AIDS investments need to go beyond HIV/AIDS clinics and strengthen other 
entry points such as TB clinics, in order to improve integration of HIV and TB services, and 
indeed to impact on overall health services quality. 
 
8.2.2. HIV case finding and management among TB patients 
The HIV epidemic has led to a dramatic increase in the incidence of TB cases with a global co- 
infection rate of 23% and with a much higher rate in the African region (44%) which accounts 
for 82% of the global TB cases among people living with HIV (WHO, 2011). The national 
TB/HIV co-infection rate for Ethiopia was 15% in 2010 (FHAPCO, 2012). Our study finding is 
slightly higher (17%) than the national report, but comparable to the 18% prevalence in the 
SNNPR region in 2005 where the urban rural prevalence was 25% (versus 16% in the rural 
areas) (Datiko, 2008), our study finding showed a declining TB/HIV co-infection rate in 
SNNPR. The fact that our study contains more urban patients (2/3 of TB patients) makes the 
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difference more significant. Lower TB/HIV co infection rate (11.4%) was documented in rural 
health centers in North-West Ethiopia (Tadesse & Tadesse, 2013) and a higher prevalence (20%) 
was reported in private health facilities in Addis Ababa (Alemie and Gebreselassie, 2014). The 
wide variation in the prevalence is explained by the difference in HIV prevalence in the specific 
regions as the rate of TB/HIV co infection depends on the prevalence of HIV infection in the 
community (Datiko et al., 2008). As high as 55% TB/HIV co-infection rate was observed in 
South Africa and Kenya (Chehab et al., 2013; Chakaya, 2008). The HIV epidemic provides the 
fuel for spreading TB disease, which means that the containment of both requires a concerted 
effort from all actors within both the TB and HIV programs and the joint programs (where they 
exist). 
 
Globally, there has been a large increase in HIV testing among TB patients (WHO, 2011). In 
2010, 35% of TB patients were tested for HIV globally, while 59% in the African region (WHO, 
2011) and 43% in Ethiopia were tested for HIV (FHAPCO, 2012). In our study, HIV testing was 
at a very high level with 98% of those who were offered a test actually consenting and being 
tested. This is after 96% of all TB patients were provided with HIV testing preparatory 
counselling. A lower testing rate (78.2%) was documented in rural health centres in North-West 
Ethiopia under routine program conditions (Tadesse & Tadesse, 2013) and in private health 
facilities in Addis Ababa (70%) (Alemie & Gebreselassie, 2014). The finding is also above the 
national target of providing HIV testing and counselling to all TB patients and testing at least 
80% of those counselled (FMOH, 2007a), suggesting that there was an excellent performance in 
terms of providing HIV testing services and a commensurate positive uptake by patients, which 
could be taken as reasonable evidence of the successful implementation of integrated TB/HIV 
care in Hawassa town. Similar successful achievements were documented on HIV testing of TB 
patients after scale up of TB/HIV collaborative activities in Rwanda (from 48% in 2005 to 97% 
in 2009) (Pevzner, 2011) and Kenya (from 60% in 2006 to 88% in 2008) (CDC, 2010). 
 
Unfortunately, the overall HIV case finding and HIV management practices (implementation of 
collaborative TB/HIV activities) in TB clinics in Hawassa town was inadequate. Major 
deficiencies were noted in the provision of co-trimoxazole and HAART for TB/HIV co-infected 
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patients, where 73% were provided with co-trimoxazole and only 64% were provided with 
HAART. However, it is better than the national performance of 69% co-trimoxazole 
prophylactic therapy, 39% antiretroviral therapy (ART) (FHAPCO, 2012) and the low (46%) 
global coverage of HAART for TB/HIV co-infected patients. Our performance was slightly 
lower but comparable to a national study in South Africa in 2011 which showed provision of 
CPT and HAART to 77% and 38% of TB/HIV co-infected patients respectively (Chehab et al., 
2013). However, after scale up of TB/HIV collaborative activities impressive achievements were 
shown in co-trimoxazole provision in Rwanda from a baseline of 2.5% in 2005 to 92% in 2009, 
and high performance was maintained in Kenya from a baseline of 87% in 2006 to 92% in 2009. 
On the contrary, provision of HAART, although improved from baseline, remained low in both 
countries (Rwanda from 12.5% in 2005 to 49% and Kenya from 26% to 34% from 2006 to 2009) 
(Pevzner, 2011; CDC, 2010). Though our findings revealed an encouraging performance in 
Hawassa town, it did not achieve the expected target set in the national strategic framework 
(CPT to all TB/HIV co-infected patients) (FMOH, 2007a) and the WHO’s recommendation to 
provide HAART to all TB patients living with HIV, regardless of their CD4 cell count (WHO, 
2011). Overall, the combined evidence indicates that efforts to identify HIV positive TB patients 
in many countries and settings were encouraging, but were not necessarily linked to providing 
proper care for the identified TB/HIV co-infected patients. 
 
Although both TB and HIV treatments require a chronic care model, TB treatment is usually 
completed in 6 to 9 months while HIV treatment is indefinite and requires lifelong follow-up and 
engagement of patients with the health service. In addition to this TB and HIV treatments are 
often separated, which means that they are provided by different sets of staff at either different 
facilities or at different rooms within the same facility. Thus, HIV testing of TB patients could 
serve as an opportunity for co-infected patients to enter into and continue with a continuum of 
care after the completion of their TB treatment. The continuum of care includes at a minimum: 
HIV diagnosis, monitoring of HIV patients for HAART eligibility assessment, opportunistic 
infection screening and management, initiation of HAART when required, HAART adherence 
support, HIV health education, STI prevention and treatment, family planning, antenatal HIV 
prophylaxis  and  care  and  viral  suppression/immune  recovery monitoring.  When  individuals 
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move from one stage to the other, there are significant drop-offs at each stage of the continuum 
of care, thus closely examining these drop-offs by program managers and service providers will 
help them to pin point gaps that may exist and to implement systems improvements that supports 
HIV/AIDS individuals to have a sustained high quality of care. In our study from the identified 
TB/HIV co-infected patients, 22% were not enrolled into chronic HIV care. This was better than 
a national study finding that failed to link 36% of TB/HIV co infected patients into chronic HIV 
care and treatment services (FMOH, 2009). Given the challenge that patients’ face due to the 
separate TB and HIV clinics that results in HIV positive TB patients having to go to the HIV 
clinic to get their HAART medication and TB positive HIV patients having to go to the TB clinic 
to get their anti-TB medication within the same facility, it seems sensible to provide one stop 
combined HIV and TB services. These one stop combined HIV and TB services would probably 
make it more likely for facilities to achieve the national target of linking all TB/HIV co-infected 
patients to chronic HIV care and treatment services (FMOH, 2007a). Therefore, there is a need to 
consider a mechanism which allows patients get one stop shopping services (receive both anti- 
TB and HAART drugs at the same service point within each of the clinics) or alternatively (and 
probably second best) to investigate the existing referral linkages between the HIV and TB 
services and design improvement measures. Failure to link significant proportions of TB patients 
with HIV to HAART, despite excellent case finding, also indicates a huge missed opportunity, as 
the facility and service providers invested their resources to identify these cases. In this regard it 
is important to note that HIV is for most of the time an asymptomatic disease and therefore it is a 
huge challenge to identify and treat people who have the HIV infection. These patients came 
into direct contact with the health facility while looking for help for their TB symptoms, hence 
making it easier to uncover their HIV infection without requiring the extra resources one would 
need to have in order to identify asymptomatic HIV infected people within the community. Thus, 
failure to treat TB patients diagnosed with HIV contradicts the primary theory behind 
integration, which promises that dual intervention reduces TB case fatality, improves patient 
treatment outcomes, improves general health services delivery through enhanced referral 
networks and allows better use of resources (Antonuccia et al., 2000; WHO, 2004b). It also 
promises to decreases the incidence of TB, if HIV positive patients are provided with 
prophylaxis against TB. 
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8.2.3. TB care and treatment outcomes 
The overall goals of Tuberculosis treatment are to cure the individual and to minimize the 
transmission of mycobacterium tuberculosis to other people (CDC, 2010). Thus successful 
treatment of tuberculosis has benefits for both the individual patient and the community in which 
the patient resides. In view of this, ensuring individual patient and programme success requires 
periodic measurement of outcomes to guide improvement measures. The outcome of TB 
treatment in Hawassa town administration was favourable, with 90% of all new TB patients 
either proven to be cured of TB or having completed TB treatment course. The finding was 
higher than the SNNPR region average (82%) seen over the past 10 years (2003—2012) for all 
new TB cases (Dangiso, 2014), the Arsi zone of Oromia region average (84.8%) seen over the 
past 14 years (1997 – 2011) for new sputum positive TB patients (Shallo, et al., 2014), and also 
surpassed the national performance benchmark (84%) and the WHO target (85%) for new 
sputum positive TB patients (FMOH, 2007a). Similarly high performance was shown in Tigray 
region (90.38%) (Berhe et al., 2013) but as low as 72.2% TB treatment success rate was also 
seen in Gambela region over a period of 5 years (2006 – 2010) (Demeke, Legesse & Bati, 2013) 
indicating wide variations across regions in the country. As stated in the source, the 
unsatisfactory performance in Gambela region could be the result of the mobility of the 
community from place to place before completion of their treatment and/or it could be due to a 
weak TB prevention and control program. Likewise, a comparable treatment success rate was 
seen in rural Nigeria (84.7%) (Jombo, 2008), in southern India (85.7%) (Vasudevan, JayaKumar, 
& Gnanasekaran, 2014) and in Shanghai, China (82.4%) (Shen et al., 2009). Our study finding 
was also higher than the average performance in the African region (81%) which has recorded a 
steady improvement since 1997 and the global performance (87%) for sputum positive TB 
patients in 2009 (WHO, 2011). Overall, it is a reflection of the significant progress that had been 
made in the past years within the TB control program in the SNNPR region (success rate from 
82% in 2003 to 92% in 2012), in other regions, and in the country as a whole (success rate from 
78% in 2006 to 84% in 2009) and parallels the expansion of the DOTs programme coverage 
(Dangiso, 2014; Shallo et al., 2014; FMOH, 2007a; WHO, 2011). Thus, if the observed 
performance is maintained and replicated in other low performing regions such as seen in 
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Gambela region, it would not take long for Ethiopia, which is one of the high burden TB 
countries (HBD) to meet the national and global target of a 85% success rate in treating TB 
cases. 
 
In our study 3% of TB patients died during TB treatment. A comparable mortality rate (3%) was 
observed in the SNNPR region (Dangiso, 2014), in Addis Ababa region (3.7%) (Getahun et al., 
2011), in Gambela region (2.4%) (Demeke, Legesse & Bati, 2013) and in Tigray region (3.9) 
(Berhe et al., 2013) in Ethiopia. In other countries such as in Nigeria (3.3), India (2.7%), and 
Shanghai, China (2.7%) (Shen et al, 2009) similar mortality rates were noted. However, a higher 
annual mortality (7 %) was observed in a 14 year long prospective cohort study in Arsi zone of 
Oromia region (Shallo et al., 2014). The high death rate in this study was partly due to HIV 
infection as shown by its independent statistical association with poor treatment outcome and the 
higher mortality noted among high HIV prevalent districts in the study which was also 
statistically significant. The mortality is better than the 2006 national performance (5.3% for 
sputum positive TB patients) and lies within the target set for 2010 (< 5%) (FMOH, 2007a). 
Complementing the performance of low mortality, the defaulter rate in our study (5%) was also 
better than in Oromia (7.8%) and SNNPR (9%) regions, but much lower rates were found in 
Gambela (2.9%) (Demeke, Legesse & Bati, 2013) and Tigray (3.3%) (Berhe et al.,  2013) 
regions. Similarly, a comparable defaulter rate was seen in other settings in rural Nigeria (5.5%) 
and Shanghai, China (5.9%) (Shen et al., 2009). These findings could be explained by the high 
treatment success rate and good quality of TB service provided in all facilities in Hawassa town. 
With the emergence and spread of Multi Drug Resistant TB in recent years in Ethiopia 
(Biadglegne et al., 2014) identification of treatment failures in the routine DOTs program 
becomes highly necessary. In our study 2% of TB patients treated under DOTs had failed 
treatment and the figure was higher than those reported in SNNPR (0.2%), Gambela (0.4%) and 
Arsi regions (0.4%), but lower than in the Tigray (3.7%) region but with a similar performance 
to that noted in India (2.1%) and Nigeria (2.5%). Given the unsatisfactory or in most cases 
unavailable diagnostic facilities in the region and the country (Biadglegne et al., 2014), it is 
possible for the reported treatment failure proportion to be underestimated. 
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As expected, living in an urban residence, but rather surprisingly receiving TB services at 
hospitals were both found to have a statistically significant association with a successful TB 
treatment outcome. Health centers had higher defaulter rates (13%) and less treatment 
completion rate (83%) as compared to hospitals, where there were no defaulters and a 94% 
completion rate. This was unexpected because hospitals had more HIV positive TB patients 
(HIV prevalence 20.6%) as compared to health centres (HIV prevalence 9.8%) and HIV 
adversely affects TB treatment compliances because of overlapping drug adverse effects (Lawn 
et al., 2013) with subsequent less TB treatment success rates for TB/HIV co infected patients 
(which are found more in the hospitals) (Pevzner, E., 2011) In addition, hospitals in our study 
had inadequate HIV case finding and management practices compared to health centers. In 
support of the above reasoning and contrary to our study finding, a more recent and 
representative regional study which looked into the distribution of performance by geographic 
area, found a better TB treatment outcome in rural as opposed to urban areas (Dangiso, 2014). 
The finding may likely be related to patient factors which were not assessed in our study such as 
difference in socio-economic status, awareness about the disease and treatment, and closer 
distance and more accessible transport to the hospitals, which could be characteristic to Hawassa 
town as the capital of SNNPR and may not represent the entire urban regional condition. So our 
results could simply represent the town administration and not the entire regional scenario. 
However, on multivariate analysis only the quality of sputum positive TB service was a strong 
predictor of successful TB treatment outcome and none of the above socio-economic and 
location factors were found to be strong predictors of TB treatment outcomes. 
 
Although not statistically significant, HIV positive TB patients had higher mortality (5.5%) and 
failure rates (5.5%) compared to HIV negatives (3% mortality and 1% failure rates). The higher 
mortality among TB/HIV co-infected patients than HIV negative TB patients in the current study 
substantiates a previous report of higher mortality among TB/HIV co-infected patients in the 
same region (Shaweno and Worku, 2012; Shallo et al., 2014) and in Rwanda (Pevzner, 2011). 
These two combined, warrants the need for more emphasis to be placed on the care of HIV 
infected TB patients, especially given the observed inadequate overall HIV case finding and 
management practice in health facilities in the town. 
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8.2.4. Quality of TB services for sputum positive TB patients 
Using the composite score for “quality of TB care for all TB patients” we found that all except 
one patient received good quality TB services in all facilities. This indicates an excellent 
performance in the process aspect of TB quality of care, which shows providers’ adherence to 
national standards of care. However, we cannot rule out the possible limitation in our 
measurement tool as the variables used for weighing quality might not be inclusive of all the 
important process variables and even the variables captured were evidence of documentation of 
processes and not evidence of the actual activity having being performed. Thus, the tool may 
have overestimated the actual practices by using only the easily captured and routinely 
performed activity measures and some activities might be well documented, but might not 
necessarily have been performed as indicated. Nonetheless, taken together with the favourable 
treatment outcome, it indicates the existence of an established foundation for good practices 
within the TB DOTs program (process factors related to quality of care are good), despite most 
facilities having inadequate inputs, and hence this could serve as an opportunity for integration 
of HIV/AIDS services within the existing established TB DOTs program. 
 
A study that used a prospective assessment of quality of TB services in four regional referral 
hospitals’ in Zimbabwe, revealed that inpatient management of TB in all hospitals did not meet 
the local and international standards of quality because of structural and process deficiencies 
(Hongoro, 2005). The structural factors correlate to ‘inputs’ in our study while the process 
factors correlate to quality of TB services delivered by providers in our study. Although the 
prospective approach might have directly or indirectly introduced a Hawthorne effect, it was able 
to provide insight into hospital level quality issues for monitoring and improving quality of 
services (Hongoro, 2005). On the contrary, a quality audit tool used to assess access and quality 
of care in the TB control program in Cape Town, South Africa, showed mostly high quality of 
care, at baseline assessment, where quality was defined as adherence to local protocols and 
standards for TB care (Scott, 2012). Although quality was assessed by individual indicators of 
components of quality of care and not via a composite score of quality of care, the quality audit 
tool identified various gaps in performance levels with respect to specific indicator variables, 
which required improvement measures and helped to draw general conclusions about the overall 
quality of TB services provided. Regardless of the method and tools used, periodic assessment of 
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the quality of care provided and feeding of the results into quality improvement efforts, with the 
participation of all key stakeholders and patients in the program, would serve as a means to 
increase the success of the TB/HIV program. 
Since in this current study almost all patients received good quality TB services, using the above 
composite score, which applied to all types of TB, we used a different composite score with a 
higher number of variables to assess the “quality of TB services for sputum positive TB patients 
only”. This showed that 8% of sputum positive TB patients received poor TB care while the 
remaining 92% sputum positive TB patients received good quality TB care. Thus, even 
increasing the number of process variables to look deeper into the process of TB care hasn’t 
brought much change in the measured level of TB quality, which remains high and hence this 
provides further evidence of the existence of a high quality TB DOTs service in Hawassa town 
administration. On bivariate analysis, age less than 30 years and HIV case finding and 
management had a statistically significant, but borderline association, with good quality of TB 
services for sputum positive TB patients, however no potentially causative factor showed any 
association with good quality of TB care on multivariate analysis. A study in 44 public health 
facilities in Ethiopia showed provider training and availability of a daily TB service as 
independent positive predictors of good quality TB care (Mengiste, 2009). However, our ability 
to detect any association was severely hampered by the effective small sample size (as shown by 
the wide confidence intervals in table 28) since only a small proportion of patients (8%) did not 
receive good quality care. 
 
 
 
 
88  
 
VIII. Limitations of the study 
 
Our study has both strengths and weakness. One of the strengths was that we were able to find a 
good number of records (93%) of our sample size in HIV clinics and reviewed 99% of sampled 
register data in TB clinics. The other strength of our study was that we used mixed methods to 
capture information on TB/HIV practice which included record review, facility observation and 
interview with facility managers and service providers to get as detailed information as we could 
and above all we included many outcome indicators such as quality, integration, CD4 count, 
weight, functional status, survival, mortality, retention in care and TB treatment success which 
would provide as a comprehensive look into the program. 
 
The limitations of our study include: respondent bias where the facility managers might consider 
the information we were looking for as an indirect measure of their overall facility management 
performance and could blend and shape their answers to what they think was the right “fake” 
answer. In addition, we cannot rule out the possible limitation in our measurement tool as the 
variables used for weighing quality might not be inclusive of all the important process variables 
and even the variables captured were evidence of documentation of processes and not evidence 
of the actual activity being performed. 
 
Since a cross sectional study gives a snapshot estimate of measure – in this case program 
performance in terms of service quality, continuity and integration - it may not help to conclude 
the observed level of performance as had been there or would be there for some time before or 
after the time of the assessment. It requires carrying out repeated measurements/regular 
monitoring of the performance to confidently declare the observed performance over a certain 
period of time. In addition, as measurements of exposures and effects – in our case input and 
outcome indicators were made at the same time, it would make it difficult to assess the reasons 
for associations demonstrated and this would affect exposures that were not fixed characteristics 
of individuals, in our case facility level input factors, as it would be difficult to know whether 
these factors were there long before the effect/service. 
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In assessing program performance including quality of service given, it’s important to include 
patients’ as well as providers’ (insiders) perspective. Assessing provider’s perception of quality 
of care is used to see the perceived quality from the provider’s angle with expected compliance 
to standard practice and real practice, and this is usually assessed in process evaluation to detect 
gaps in the perception of quality of care with the real practice and standard. It is best assessed 
using a qualitative method, but this study falls short of assessing this – limiting the 
comprehensive nature of the overall insights into the program performance status. 
 
Lastly, we could not rule out the possible threats of absence and incompleteness of data in the 
charts on the validity of our study, because of the poor recording practices observed in our 
setting as noted in data capturing. To the extent that the characteristics or management of those 
individuals with poor data in the charts might be different from the general group, this might 
have biased our conclusions. 
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IX. Conclusion 
 
Despite the WHOs recommendation of integrated care as an effective means to control the 
HIV/AIDS and TB epidemic and the Ethiopian government’s commitment to this, there was little 
evidence of integrated TB and HIV/AIDS care in Hawassa town administration, despite 
increasing resources and service scale ups. Listed below for both HIV/AIDS and TB clinics are 
the existing areas of strengths and weaknesses in the implementation of integrated TB/HIV 
activities found by this study. 
 
HIV/AIDS clinic: Most of the health facilities in Hawassa town administration were deficient in 
overall resources for integrated TB/HIV care, mainly because of the unavailability of IEC 
materials, and there was no homogeneity across the facilities. Within the HIV/AIDS program 
itself HIV/AIDS investments were geared towards structural components of the health system 
such as laboratory facilities and services which were better upgraded and equipped, but this 
appeared to be at the expense of general health services and appeared not to stimulate integrated 
care. Having a minimum number of staff was counter intuitively associated with providing a 
lower quality of care, lower TB case finding practices and less survival outcome. However, as 
the exposures and outcomes were assessed at the same time it is difficult to draw plausible 
reasons for these associations and it requires a closer look into what caused this paradoxical 
effect. 
 
Patient monitoring was done fairly well at patient’ entry into the health system, but declined in 
subsequent visits with pronounced gaps observed in health centres as opposed to hospitals, which 
was also shown in previous national studies. HIV patients on HAART received better quality of 
services and had improved TB case finding compared to those who are on pre-ART. This was 
not affected by facility type and its effect was clearly reflected in better patient treatment 
outcomes such as increase in CD4 count, weight gain and functional status improvement. 
HAART status was also found to be the strongest predictor of TB case finding amongst HIV 
patients. In line with this, TB case finding and management of HIV/TB co infected patients 
appears to have become a routine practice in health facilities in Hawassa town which was a 
promising finding given the high TB/HIV co-infection rate in the town and given that the 
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country is one of the high TB burden countries globally and home to large absolute numbers of 
HIV patients in Africa. However, IPT provision to HIV patients shown to be TB free lagged way 
behind the national and international targets for this service. Overall, greater focus was given to 
TB treatment as opposed to TB prevention, despite global emphasis on TB prevention. 
 
The study also showed a fairly good quality of HIV care unlike previous local and national 
studies. In all cases, the performance varied by HAART status, type of facility and geographic 
region, as well as timing of service (during initial visit versus later in the follow up period). 
Patients on HAART and those who received services from hospitals received better quality of 
HIV care than those on Pre ART and those who received services from health centres, while 
regions with weak TB program such as Gambela provided low TB quality. However, the 
existing good quality of HIV care should be complemented with providers and patients 
perspective in order to be representative of the overall insight into performance status. 
Consequently, the observed quality HIV/AIDS service in our study appeared to have resulted in 
successful treatment outcomes with high survival, low mortality as well as high retention of 
patients in care, which were better than previous years and better than that seen in other parts of 
the world with similar socio-economic circumstances. However, the significant number of 
patients with unknown outcome status, which was alarmingly higher among Pre-ART patients as 
opposed to HAART patients, pointed to poor documentation practices. 
 
TB clinic: Consistent with a previous national study in Ethiopia, resources for the TB program 
were deficient in Hawassa. The deficiency was primarily reflected in the low performance of 
HIV management practices, but did not adversely affect the TB DOTs service, which was shown 
to be of an excellent quality and nor did it affect HIV case finding which was very high at 98% . 
The finding of poor HIV management was concerning given the high prevalence of HIV among 
TB patients in Hawassa and might reflect the channeling of increasing TB/HIV program funding 
through the HIV program only, instead of channeling it to the TB program as well. 
It is noted that evidence from other countries shows that it is possible to achieve high 
performances in the provision of co-trimoxazole and HAART if programs are well planned, 
implemented and monitored. 
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Our study also showed very high quality TB service provision and this was reflected in the 
favourable overall TB treatment outcome with a high success and low mortality rate. These 
combined favourable outcomes clearly indicated the existence of an established TB DOTS 
program in the town. 
Lastly, it was noted that the adapted integrated TB/HIV evaluation tool was able to indicate the 
level of TB/HIV quality of care and integration, and identified the input, structural and process 
deficiencies in HIV and TB services with reference to national and international standards of 
care. Thus, it can be continuously improved and used to periodically assess the level and quality 
of integrated TB/HIV care. 
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X. Recommendations 
 
Procedures which allow patients to receive one stop shopping services (receive both anti-TB and 
HIV care at the same service point within each of the clinics) needs to be implemented, or 
alternatively (and second best) the existing referral linkages between the HIV and TB services 
need to be improved. 
 
HIV/AIDS investments need to be more widely distributed across all HIV/AIDS program 
elements and in particular extend beyond specific HIV/AIDS clinics to strengthen other HIV 
entry points, such as TB clinics. 
 
Efforts to improve HIV patient monitoring at subsequent visits with a greater emphasis being 
placed on Pre-ART patients and on health centres should be prioritized. 
 
Facilities need to improve provision of IPT to HIV positive patients without TB in HIV clinics, 
and improve provision of co-trimoxaxole and HAART to TB/HIV co infected patients in the TB 
clinics. 
 
Further operational research is needed to investigate “factors contributing to weak Pre-ART care 
and measures to improve it” and “reasons for very low TB prevention among HIV/AIDS patients 
without active TB”. 
 
The ministry of health should carry out similar regular integrated TB/HIV program evaluations 
periodically to ensure maintenance of existing good performances, identify performance gaps 
and implement continuous quality improvement measures, that supports sustained high quality of 
care for patients infected with TB and/or HIV. 
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XII. Annexes 
Annex 1. Result tables 
 
Table A shows the distribution of minimum required personnel of different cadre in health 
facilities in Hawassa town administration. To assess the minimum required number of 
multidisciplinary health care providers’ team we used the Federal Ministry of Health’s standard 
for accreditation of facilities for providing HAART services. The criterion was set based on the 
grade/level of the facility within the national health care system. Thus facilities were classified as 
those that fulfilled the expected minimum required health care providers’ team and those that did 
not. 
 
Table:  A.  Minimum  Personnel  Required  in  HIV/AIDS  Clinics  of  Health  Facilities  in 
Hawassa Town Administration, 2010/11 
 
Cadre of health 
worker 
Facility W Facility X Facility Y Facility Z 
Expecte 
d 
Availabl 
e 
Expecte 
d 
Availabl 
e 
Expecte 
d 
Availabl 
e 
Expecte 
d 
Availabl 
e 
Medical  doctor/Health 
officer/BSC nurse 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
Nurses 2 3 2 1 1 1 1 1 
Pharmacy 
technician/pharmacist 
 
2 
 
3 
 
2 
 
2 
 
1 
 
2 
 
1 
 
2 
Lab 
Technician/technologis 
t 
 
 
2 
 
 
6 
 
 
2 
 
 
3 
 
 
1 
 
 
4 
 
 
1 
 
 
4 
The facility has 
minimum required 
personnel (Yes/No) 
 
 
Yes 
 
 
No 
 
 
Yes 
 
 
Yes 
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Table B shows the availability of infrastructure and supplies for HIV/AIDS care. Three out of the 
four facilities had adequate infrastructure and supplies for HIV/AIDS care. Half of the facilities 
had no examination coach for patient examination and none of them had functional otoscope for 
ear and throat examination. 
 
Table: B. Availability of Infrastructure and Supplies for HIV/AIDS Care in Health 
Facilities in Hawassa Town Administration, 2010/11 
 
Lists of infrastructure and supplies 
Fill “1” if its yes and observed or fill “0” if not 
Facility W Facility X Facility Y Facility Z 
Is/are there separate room/s dedicated for HIV/AIDS care 
and treatment/ART? 
 
1 
 
1 
 
1 
 
1 
Is the room private? (Restricted access / client cannot be seen 
or overheard by people outside the room)? 
 
1 
 
1 
 
1 
 
1 
Is there flowing water, for hand washing in HIV clinic? 1 1 1 0 
Is there a working scale at the ART room? 1 1 1 0 
Is there an examination couch? 0 1 1 0 
Is there a separate waiting area for HIV clinic? 1 1 1 1 
Is there a functional otoscope for ear and throat examination? 0 0 0 0 
Is the light adequate for examination? 1 1 1 1 
 
Overall score (adequate >= 75%; inadequate <75%) 
6/8 
(75%) 
7/8 
(87.5%) 
7/8 
(87.5%) 
4/8 
(50%) 
 
Table C shows the availability of functional laboratory infrastructure for TB/HIV care. All the 
four health facilities in the district had adequate lab services with functional laboratories to 
provide TB/HIV care 
 
Table: C. Availability of Functional Laboratory Infrastructure for TB/HIV Care in Health 
Facilities in Hawassa Town Administration, 2010/11 
Types of lab services with functional 
equipment and reagent 
Fill “1” if its yes and observed or fill “0” if not 
Facility W Facility X Facility Y Facility Z 
Full blood count (Hgb, WBC and Diff) 1 1 1 0 
AFB smear 1 1 1 1 
Microscopy for Ova or Parasite 1 1 1 1 
Malaria smear 1 1 1 1 
Pregnancy test 1 1 1 1 
Serology for HIV 1 1 1 1 
RPR/VDRL 1 1 1 1 
Overall   score   (adequate   >=   75%; 
inadequate <75%) 
7/7 
(100%) 
7/7 
(100%) 
7/7 
(100%) 
6/7 
(86%) 
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NB: The laboratories in the health centres were not expected to have CD4 count or clinical 
chemistry machines. They performed these tests by transporting samples to the hospitals. 
Therefore the overall score is calculated out of seven lab services. 
Table D shows the availability of supplies and functional supply management systems for 
HIV/AIDS care. Half of the facilities had adequate supplies and functional supply management 
system to provide HIV/AIDS care. Half of the facilities didn’t have protective hand gloves and 
soap and towel for hand washing and despite the presence of male condom, in all of the facilities, 
dido was found in only one. 
 
Table: D. Availability of Supplies and Supply Management System for HIV/AIDS Care in 
Health Facilities in Hawassa Town Administration, 2010/11 
 Fill “1” if it’s no or fill “0” if yes to the first four 
questions and Fill “1” if it is yes and observed or 
fill “0” if not 
Facility W Facility X Facility Y Facility Z 
Was  there  a  stock-  out  of  HIV  rapid  test  kits 
(screening or confirmatory) in the last month? 
 
1 
 
1 
 
1 
 
0 
Was there stock-outs of Co-trimoxazole (Bactrim) in 
the last month? 
 
1 
 
1 
 
0 
 
1 
Was there a stock- out of Isoniazid for TB prevention 
in the last month? 
 
1 
 
1 
 
1 
 
0 
Was there a stock- out of Anti TB drugs (Regimen 1) 
in the last month? 
 
1 
 
1 
 
1 
 
0 
Is there a mechanism in place to monitor stock levels 
of each of these items (bin cards and electronic 
systems) 
 
 
1 
 
 
1 
 
 
1 
 
 
1 
Are there protective hand gloves in the HIV/AIDS 
clinic? 
 
1 
 
0 
 
1 
 
0 
Are soap and towel present for hand washing in the 
HIV/AIDS clinic? 
 
1 
 
0 
 
1 
 
0 
Are there protective materials (safety box) in the HIV 
clinic? 
 
1 
 
1 
 
0 
 
1 
Are  male  condoms  available  in  the  HIV/AIDS 
rooms? 
 
1 
 
1 
 
1 
 
1 
Is there a dildo in the HIV/AIDS rooms? 0 1 0 0 
Overall  score  (adequate  >=  75%;  inadequate 
<75%) 
9/10 
(90%) 
8/10 
(80%) 
7/10 
(70%) 
4/10 
(40%) 
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Table E shows the availability of information education and communication materials on various 
topics targeting patients. Over all there appeared to be serious shortage of client’s education 
materials in the HIV/AIDS clinics in the district. 
 
Table: E. Availability of Information Education and Communication Materials for 
HIV/AIDS Care in Health Facilities in Hawassa Town Administration, 2010/11 
 
Lists of IEC materials 
If the material is available  and observed score “1” if not 
available score “0” 
 Facility W Facility X Facility Y Facility Z 
STI transmission and treatment 0 1 0 0 
Prevention of Mother to Child 
Transmission of HIV 
 
1 
 
0 
 
0 
 
1 
Nutritional advise for HIV patients 1 0 1 0 
Family Planning methods 1 0 1 0 
ARV treatment adherence 1 1 1 0 
HIV prevention 1 0 1 0 
TB prevention , screening and treatment 1 0 1 0 
Overall  score  (Adequate  >=  75%; 
inadequate <75%) 
 
6/7 (86%) 
 
2/7 (29%) 
 
5/7 (71%) 
 
1/7 (14%) 
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Table F shows the availability of provider support job aids for HIV/AIDS care. All the 
facilities had the necessary job aids for HIV care and treatment service. 
 
Table F: Availability Job Aids for HIV/AIDS Care in Health Facilities in Hawassa 
Town Administration, 2010/11 
 
Lists of guidelines and protocols 
If the material is available and observed score “1” if not 
available score “0” 
Facility W Facility X Facility Y Facility Z 
National ART management guideline 1 1 1 1 
National OI management guideline 1 1 1 1 
National Pediatric HIV/AIDS guideline 1 1 1 1 
National PMTCT guideline 1 0 0 0 
TB/HIV implementation guideline 1 1 1 0 
National CPT guideline 0 1 1 0 
Counseling and testing guidelines 1 1 1 0 
Overall   score   (Adequate   >=   75%; 
inadequate <75%) 
6/7 
(86%) 
6/7 
(86%) 
6/7 
(86%) 
3/7 
(43%) 
 
Table G shows the availability of forms and registers for HIV/AIDS care. All had the 
necessary forms and registers for HIV care and treatment service. Most (3/4) of the 
facilities didn’t have IPT register at the ART clinics. 
 
Table: G. Availability of forms and registers for HIV/AIDS Care in Health 
Facilities in Hawassa Town Administration, 2010/11 
 
Lists of forms and registers 
If the material is available and observed score “1” if not 
available score “0” 
Facility W Facility X Facility Y Facility Z 
ART/Pre ART register 1 1 1 1 
Pre ART register 1 1 1 1 
HIV/AIDS intake forms 1 1 1 1 
HIV/AIDS follow up forms 1 1 1 1 
IPT register at the ART clinic 1 0 0 0 
Referral forms within facility 1 1 0 0 
Referral forms outside facility 1 1 1 1 
Quarterly reporting forms HIV care 1 1 1 1 
Quarterly reporting forms TB/HIV 1 1 1 1 
Overall   score   (Adequate   >=   75%; 
inadequate <75%) 
9/9 
(100%) 
8/9 
(89%) 
7/9 
(78%) 
7/9 
(78%) 
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Table H. Distribution and classification of quality of care for HIV positive patients 
 
Variable Mean SD Median IQ range Cut   off   %   for   quality 
(adequate, inadequate) 
Quality of HIV care for 
all patients 
13.5 2.9 14 13-16 75% of 16 (>/= 12; < 12 
Quality of HIV care for 
patients on HAART 
16.9 1.4 17 16-18 75% of 18 (>/= 13.5; 13.5) 
Quality of HIV care for 
patients not on HAART 
12 3.3 13 9 - 15 75% of 16 (>/= 12; < 12 
 
Table I provides the scoring for the variable “staff training” and has as items the various types of 
staff working in the TB programme with the types of training provided in Hawassa. In most of 
the facilities in the district (75%), providers working in the TB program received inadequate 
training considered necessary for them to perform their duties and the overall training profile in 
the district TB clinics was inadequate. 
 
Table: I. Training Profile of Health Professionals Currently Working in TB Clinics of 
Health Facilities in Hawassa Town Administration, 2010/11 
Lists  of  health  professionals  currently 
working in TB clinics by training 
Score “1” if >/= 75%; score “0” if < 75% 
Facility W Facility X Facility Y Facility Z 
Proportion of Nurse trained on Tuberculosis 1 (1/2) 0 (1/2) 1 (1/1) 1 (1/1) 
Proportion of Nurse trained on TB/HIV 1 (2/2) 0 (1/2) 1 (1/1) 1 (1/1) 
Proportion of Nurse trained on PIHCT 1 (2/2) 1 (2/2) 1 (1/1) 0 (0/1) 
Proportion of Laboratory technician trained 
on AFB microscopy 
 
0 (2/8) 
 
1 (3/3) 
 
1 (4/4) 
 
0 (0/4) 
Proportion of Laboratory technician trained 
on HIV testing 
 
0 (2/8) 
 
1 (1/3) 
 
1 (4/4) 
 
0 (1/4) 
Overall score adequate >= 75%; 
inadequate <75% 
3/5 
60% 
3/5 
60% 
5/5 
100% 
2/5 
40% 
 
NB: in all the facilities there was no physician or health officer assigned in the TB clinic to provide DOT. 
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Table J shows the availability of “infrastructure and supplies for TB care” as an input variable. 
Half of the facilities had inadequate infrastructure and supplies for TB care. Out of the four 
facilities, only one had an examination coach. 
 
Table: J. Availability of Infrastructure and Supplies for TB Care in Health Facilities in 
Hawassa Town Administration, 2010/11 
 
Lists of infrastructure and supplies 
Fill “1” if its yes and observed or fill “0” if not 
Facility W Facility X Facility Y Facility Z 
Is/are  there  separate  room/s  dedicated  for 
TB/DOTS service? 
 
1 
 
1 
 
0 
 
1 
Is the room private? (Restricted access / 
client cannot be seen or overheard by people 
outside the room)? 
 
 
1 
 
 
1 
 
 
1 
 
 
1 
Is there flowing water, for hand washing in 
TB clinic? 
 
1 
 
1 
 
1 
 
0 
Is there a working scale at the TB room? 1 1 1 1 
Is there an examination couch? 0 0 1 0 
Is  there  a  separate  waiting  area  for  TB 
clinic? 
 
1 
 
1 
 
0 
 
1 
Overall score adequate >= 75%; 
inadequate <75% 
5/6 
(83.3%) 
5/6 
(83.3%) 
4/6 
(66.6%) 
4/6 
(66.6%) 
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Table K shows the availability of supplies and supply management systems for TB care. Half of 
the facilities had inadequate supplies and supply management systems for TB care. Male 
condoms were available in all of the facilities but a dildo was not found in any of the facilities. 
 
Table: K. Availability of Supplies and Supply Management System for TB Care in Health 
Facilities in Hawassa Town Administration, 2010/11 
 Fill “1” if it’s no or fill “0” if yes to the first three 
questions and 
Fill “1” if it is yes and observed or fill “0” if not 
Facility W Facility X Facility Y Facility Z 
Was  there  a  stock-  out  of  HIV  rapid  test  kits 
(screening or confirmatory) in the past one month? 
1 1 1 0 
Was there stock-outs of Cotrimoxazole (Bactrim) 
in the past one month? 
1 1 0 1 
Was there stock-outs of Anti TB drugs in the past 
one month? 
1 1 1 0 
Is there a mechanism in place to monitor stock 
levels of each of these items (bin cards and 
electronic systems) 
1 1 1 1 
Are there protective hand gloves in the TB clinic 
on the day of assessment? 
1 1 0 0 
Are soap and towel present for hand washing in 
the TB clinic on the day of assessment? 
1 1 1 0 
Are there protective materials (safety box) in the 
TB clinic on the day of assessment? 
1 1 0 1 
Are condoms available in the TB rooms on the 
day of assessment? 
1 1 1 1 
Is there a dildo in the TB rooms on the day of 
assessment? 
0 0 0 0 
Overall  score  adequate  >=  75%;  inadequate 
<75% 
8/9 
(88.8%) 
8/9 
(88.8%) 
5/9 
(55.5%) 
4/9 
(44.4%) 
 
. 
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Table L shows the status of health system procedures in TB clinics. Half of the facilities had 
adequate health system procedures to provide TB care. Three out of four facilities had regular 
supervision of TB/HIV activity. However none of the facilities had action plans arising from the 
previous supervision. 
 
Table: L. Status of Health System Procedures for TB Care in Health Facilities in Hawassa 
Town Administration, 2010/11 
 Fill “1” if its yes and observed or fill “0” if not 
Facility W Facility X Facility Y Facility Z 
Is TB DOTS service offered every day, throughout 
the opening hours of facility? 1 1 1 1 
Does the clinic have a mechanism for TB contacts 
tracing? 1 0 1 1 
Does the TB clinic have a mechanism for defaulter 
tracing? 1 1 1 1 
Is there a quality assurance system at the facility 
for AFB sputum examination? 1 1 1 1 
Is there a quality assurance system at the facility 
for TB medication management and monitoring? 1 0 1 1 
Is there a regular supervision of TB/HIV activity at 
the TB clinic in the facility? 1 1 1 0 
Are   action   plans   arising   from   the   previous 
supervision available? 0 0 0 0 
Overall  score  (adequate  >=  75%;  inadequate 
<75%) 
6/7 
(85.7%) 
4/7 
(57%) 
6/7 
(85.7%) 5/7 (71.4%) 
 
 
 
 
115  
Table M shows the availability of information education and communication materials in 
different facilities. Only one facility had adequate IEC materials and none of the facilities had 
IEC materials on STI transmission and treatment 
 
Table: M. Availability of Information Education and Communication Materials for TB 
Care in Health Facilities in Hawassa Town Administration, 2010/11 
 
 
 
Lists of IEC materials 
If the material is available and observed score “1” if not 
available score “0” 
Facility W Facility X Facility Y Facility Z 
TB prevention , screening and treatment 1 1 1 1 
STI transmission and treatment 0 0 0 0 
HIV counseling and testing 1 1 1 0 
Nutrition 0 0 1 0 
TB treatment adherence 1 1 1 0 
Overall score adequate >= 75%; 
inadequate <75% 3/5 (60%) 3/5 (60%) 4/5 (80%) 1/5 (20%) 
 
Table N shows the availability of national guidelines and protocols in different facilities in Hawassa town 
administration. Only one out of the four facilities had adequate national guidelines and protocols 
 
Table: N. Availability of guidelines and protocols for TB Care in Health Facilities in 
Hawassa Town Administration, 2010/11 
 
 
 
 
Lists of guidelines and protocols 
If the material is available and observed score “1” if not 
available score “0” 
Facility W Facility W Facility W Facility W 
National Tuberculosis, TB/HIV and 
Leprosy guideline 1 1 1 1 
TB/HIV implementation guideline 0 0 0 1 
National CPT guideline 0 0 1 0 
National HIV Counseling and testing 
guidelines 0 1 1 0 
Overall score adequate >= 75%; 
inadequate <75% 1/4 (25%) 2/4 (50%) 3/4 (75%) 2/4 (50%) 
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Table O shows the availability of forms and registers for TB care. All of the facilities had 
adequate forms and registers for TB care. 
 
Table: O. Availability of Forms and Registers for TB Care in Health Facilities in 
Hawassa Town Administration, 2010/11 
 
 
 
Lists of forms and registers 
If the material is available and observed score “1” if not 
available score “0” 
Facility W Facility W Facility W Facility W 
Unit TB register 1 1 1 1 
Referral forms within facility 1 0 0 1 
Referral forms outside facility 1 1 1 1 
Quarterly reporting forms TB 1 1 1 1 
Quarterly reporting forms ( TB/HIV) 1 1 1 1 
Overall score adequate >= 75%; 
inadequate <75% 5/5 (100%) 4/5 (80%) 
4/5 
(80%) 5/5 (100%) 
 
 
Table  P.  Distribution  of  quality  of  TB  care  for  TB  Patients  in  Hawassa  Town 
Administration, 2010/11 
 
Variable Mean SD Median IQ range Cut-off % for quality 
(adequate; inadequate) 
Quality of TB care for all 
TB patients 
8.5 0.7 9 8-9 80% of 8 (>/= 6.4, <6.4) 
Quality of TB care for 
sputum positive TB 
patients 
9.6 1.8 9 8-12 80% of 12 (>/= 9.6, < 9.6) 
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Table: Q. Bivariate Analysis Comparing Socio-Demographic and Health Service Related 
Factors to Quality Services in HIV/AIDS Clinics in Hawassa Town Administration, 
2010/11 
socio-demographic and health service 
related characteristics 
Adequate 
quality 
Inadequat 
e quality 
Crude 
Prevalence 
Ratio 
95% C.I. 
Number Number 
Age in years < 30 88 30 0.975 (0.852 - 1.116) 
>/= 30 127 39 
Sex Male 78 21  
1.054 
(0.923 - 1.204) 
Female 136 46 
Marital status Married + Widowed 146 54 0.857 (0.757 - 0.970) 
Single + Divorced 69 12 
Residence Urban 174 50 1.142 (0.933 - 1.399) 
Rural 34 16 
Education Tertiary + Secondary 88 15 1.195 (1.054 - 1.354) 
Uneducated + Primary 118 47 
Employment Employed 83 20  
1.130 
(0.983 - 1.298) 
Not employed 107 43 
Type of facility Hospital 151 27  
1.405 
(1.190 - 1.659) 
Health center 64 42 
Treated with HAART Yes 146 6 1.780 (1.510 - 2.098) 
No 68 58 
TB status No active TB 169 52 0.881 (0.775 - 1.001) 
Has active TB 46 7 
Staff training Adequate 196 49 1.642 (1.183 - 2.280) 
Inadequate 19 20 
Minimum number of 
staff 
Available 146 62 0.773 (0.690 - 0.866) 
Not Available 69 7 
Infrastructure Adequate 196 49 1.642 (1.183 - 2.280) 
Inadequate 19 20 
Supplies  and  supply 
management system 
Adequate 151 27  
1.405 
(1.190 - 1.659) 
Inadequate 64 42 
Health system 
procedures 
Adequate 127 42 0.982 (0.859 - 1.122) 
Inadequate 88 27 
IEC materials Adequate 82 20 1.100 (0.966 - 1.253) 
Inadequate 133 49 
Job aids Adequate 196 49 1.642 (1.183 - 2.280) 
Inadequate 19 20 
Facility input 
(Overall) 
Adequate 127 42 0.982 (0.859 - 1.122) 
Inadequate 88 27 
NB: all facilities had adequate stationeries for HIV/AIDS services and in all health facilities 
there were adequate lab infrastructure. Thus these two variables were not included in  the 
bivariate analysis 
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Table: R. Bivariate Analysis Comparing Socio-Demographic and Health Service Related 
Factors to change in CD4 count in HIV/AIDS Patients in Hawassa Town Administration, 
2010/11 
socio-demographic  and  health  service 
related characteristics 
Improved 
CD4 
Didn’t 
improve 
Crude 
Prevalence 
Ratio 
 
 
95% C.I. 
Number Number 
Age in years < 30 34 28 0.857 (0.651 - 1.130) 
>/= 30 55 31 
Sex Male 33 12 1.360 (1.058 - 1.749) 
Female 55 47 
Marital status Married + Widowed 60 37 1.088 (0.818 - 1.447) 
Single + Divorced 29 22 
Residence Urban 79 48 1.166 (0.713 - 1.908) 
Rural 8 7 
Education Tertiary + Secondary 45 18 1.394 (1.070 - 1.816) 
Uneducated + Primary 41 39 
Employment Employed 38 23 1.098 (0.831 - 1.450) 
Not employed 42 32 
Type of facility Hospital 68 46 0.966 (0.712 - 1.310) 
Health center 21 13 
Treated with 
HAART 
Yes 78 21 3.510 (2.065 - 5.965) 
No 11 38 
TB status No active TB 65 52 0.671 (0.532 - 0.847) 
Has active TB 24 5 
Staff training adequate 88 56 2.444 (0.446 - 13.413) 
inadequate 1 3 
Minimum 
number of staff 
Yes 64 33 1.346 (0.983 - 1.843) 
No 25 26 
Infrastructure Adequate 88 56 2.444 (0.446 - 13.413) 
Inadequate 1 3 
Supplies & 
supply 
management 
system 
Adequate 68 46 0.956 (0.712 - 1.310) 
Inadequate 21 13 
Health system 
procedures 
Adequate 63 30 1.433 (1.049 - 1.958) 
Inadequate 26 29 
IEC materials Adequate 43 20 1.261 (0.974 - 1.633) 
Inadequate 46 39 
Job aids Adequate 88 56 2.444 (0.446 - 13.413) 
Inadequate 1 3 
Facility input 
(Overall) 
Adequate 63 30 1.433 (1.049 - 1.958) 
Inadequate 26 29 
Quality  of  HIV 
care 
Adequate 88 56 2.444 (0.446 - 13.413) 
Inadequate 1 3 
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Table: S. Bivariate Analysis Comparing Socio-Demographic and Health Service Related 
Factors to change in body weight in HIV/AIDS Patients in Hawassa Town Administration, 
2010/11 
socio-demographic and health service related 
characteristics 
Improved 
 
weight 
Didn’t 
improve 
Crude 
Prevalence 
Ratio 
 
 
95% C.I. 
Number Number 
Age in years < 30 48 33 0.811 (0.656 - 1.001) 
>/= 30 87 32 
Sex Male 47 21 1.041 (0.852 - 1.271) 
Female 87 44 
Marital status Married + Widowed 94 46 0.983 (0,798 - 1.209) 
Single + Divorced 41 19 
Residence Urban 108 49 1.003 (0.783 - 1.285) 
Rural 24 11 
Education Tertiary + Secondary 55 23 1.091 (0.895 - 1.331) 
Uneducated + Primary 73 40 
Employment Employed 52 24 1.026 (0.835 - 1.262) 
Not employed 66 33 
Type of facility Hospital 89 43 0.997 (0.814 - 1.221) 
Health center 46 22 
Treated with HAART Yes 99 36 1.324 (1.041 - 1.684) 
No 36 29 
TB status No active TB 105 52 0.922 (0.740 - 1.150) 
Has active TB 29 11 
Staff training Adequate 122 54 1.280 (0.874 - 1.873) 
Inadequate 13 11 
Minimum  number  of 
staff 
Yes 91 44 0.996 (0.811 - 1.222) 
No 44 21 
Infrastructure Adequate 122 54 1.280 (0.874 - 1.873) 
Inadequate 13 11 
Supplies   and   supply 
management system 
Adequate 89 43 0.997 (0.814 - 1.221) 
Inadequate 46 22 
Health system 
procedures 
Adequate 78 33 1.097 (0.901 - 1.336) 
Inadequate 57 32 
IEC materials Adequate 45 22 0.993 (0.809 - 1.218) 
Inadequate 90 43 
Job aids Adequate 122 54 1.280 (0.874 - 1.873) 
Inadequate 13 11 
Facility input (Overall) Adequate 78 33 1.097 (0.901 - 1.336) 
Inadequate 57 32 
Quality of HIV care Adequate 131 62 1.188 (0.621 - 2.273) 
Inadequate 4 3 
Change in CD4 Improved 67 19 1.402 (1.077 - 1.826) 
Not improved 30 24 
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Table: T. Bivariate Analysis Comparing Socio-Demographic and Health Service Related 
Factors to TB Case Finding at last clinical visit in HIV/AIDS Patients in Hawassa Town 
Administration, 2010/11 
socio-demographic and health service 
related characteristics 
TB case 
finding done 
No  TB  case 
finding done 
Crude 
Prevalence 
Ratio 
 
 
95% C.I. 
Number Number 
Age in years < 30 101 15 1.019 0.927 - 1.120 
>/= 30 141 24 
Sex Male 83 15 0.977 0.883 - 1.082 
Female 156 24 
Marital status Married + Widowed 169 30 0.944 (0.859 - 
1.036) Single + Divorced 72 8 
Residence Urban 193 29 1.060 0.922 - 1.219 
Rural 41 9 
Education Tertiary + Secondary 91 12 1.036 (0.942 - 
1.139) Uneducated + 
Primary 
139 24 
Employment Employed 85 17 0.969 0.870 - 1.080 
Not employed 129 21 
Type of facility Hospital 161 15 1.186 1.059 - 1.328 
Health center 81 24 
HAART Yes 146 6 1.257 1.133 - 1.396 
No 94 29 
Adequacy of staff 
training 
Adequate 210 32 1.058 0.906 - 1.235 
Inadequate 32 7 
Availability of 
minimum staff 
number 
Available 171 36 0.861 0.796 - 0.931 
Not available 71 3 
Infrastructure and 
supplies 
Adequate 210 32 1.058 0.906 - 1.235 
Inadequate 32 7 
Supplies  and  supply 
management system 
Adequate 161 15 1.186 1.059 - 1.328 
Inadequate 81 24 
Health systems 
procedure 
Adequate 139 29 0.908 0.830 - 0.993 
Inadequate 103 10 
IEC materials Adequate 90 12 1.039 0.946 - 1.141 
Inadequate 152 27 
Job aids Adequate 210 32 1.058 0.906 - 1.235 
Inadequate 32 7 
Facility input 
(overall) 
Adequate 139 29 0.908 0.830 - 0.993 
Inadequate 103 10 
Quality of HIV care Adequate 211 4 2.089 1.616 - 2.702 
Inadequate 31 35 
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Table:  U.  Bivarate  analysis  comparing  socio-demographic  and  health  service  related 
factors to survival of HIV/AIDS Patients in Hawassa town administration 2010/2011 
socio-demographic and health service 
related characteristics 
Alive Dead Crude 
Prevalence 
Ratio 
 
 
95% C.I. Number Number 
Age in years < 30 83 1 1.028 (0.986 - 1.072) 
>/= 30 123 5 
Sex Male 69 3 0.979 (0.928 - 1.034) 
Female 136 3 
Marital status Married + Widowed 143 4 1.004 (0.954 - 1.056) 
Single + Divorced 63 2 
Residence Urban 161 3 1.064 (0.969 - 1.167) 
Rural 36 3 
Education Tertiary + Secondary 81 2 1.001 (0.958 - 1.047) 
Uneducated + Primary 116 3  
Employment Employed 79 1 1.026 (0.981 - 1.074) 
Not employed 102 4 
Type of facility Hospital 137 1 1.065 (1.000 - 1.134) 
Health center 69 5 
HAART Yes 138 5 0.979 (0.939 - 1.022) 
No 68 1 
TB status No active TB 162 4 0.999 (0.949 - 1.052) 
Has active TB 42 1 
Staff training Adequate 183 3 1.112 (0.967 - 1.279) 
Inadequate 23 3 
Infrastructure and 
supplies 
Adequate 183 3 1.112 (0.967 - 1.279) 
Inadequate 23 3 
Supplies and supply 
management system 
Adequate 137 1 1.065 (1.000 - 1.134) 
Inadequate 69 5 
Health systems 
procedure 
Adequate 119 3 1.009 (0.962 - 1.058) 
Inadequate 87 3 
IEC materials Adequate 73 1 1.024 (0.982 - 1.067) 
Inadequate 133 5 
Job aids Adequate 183 3 1.112 (0.967 - 1.279) 
Inadequate 23 3 
Facility input overall Adequate 119 3 1.009 (0.962 - 1.058) 
Inadequate 87 3 
Quality of HIV care Adequate 196 2 1.386 (0.995 - 1.931) 
Inadequate 10 4 
    Fischer’s 
test 
 
Minimum staff 
number 
Available 142 6 0.102  
Not available 64 0 
 
 
 
 
122  
Table: V. Bivariate Analysis Comparing Socio-Demographic and Health Service Related 
Factors to Quality of TB Services for Sputum positive TB patients in Hawassa Town 
Administration, 2010/11 
 
socio-demographic  and  health  service 
related characteristics 
Good 
quality 
Poor 
quality 
 
Crude 
Prevalence 
Ratio 
 
 
 
95% CI Number Number 
Age in years < 30 55 1 1.163 (1.021 - 1.325) >/= 30 38 7 
Sex Male 61 5 1.014 (0.894 - 1.149) Female 31 3 
TB residence Urban 42 5 0.955 (0.843 - 1.080) Rural 44 3 
Type of facility Hospital 45 4 0.995 (0.887 - 1.116) Health center 48 4 
HIV test Positive 13 1 0.987 (0.846 - 1.153) Negative 79 5 
Staff training Adequate 20 1 1.044 (0.928 - 1.174) Inadequate 73 7 
Infrastructure  and 
supplies 
Adequate 45 4 0.995 (0.887 - 1.116) Inadequate 48 4 
Supplies and 
supplies 
management 
system 
Adequate 45 4  
0.995 
 
(0.887 - 1.116)  
 
Inadequate 
48 4 
Health system 
procedures 
Adequate 26 1 1.064 (0.958 - 1.181) Inadequate 67 7 
IEC materials Adequate 20 1 1.044 (0.928 - 1.174) Inadequate 73 7 
Job aids Adequate 20 1 1.044 (0.928 - 1.174) Inadequate 73 7 
Overall TB input Adequate 20 1 1.044 (0.928 - 1.174) Inadequate 73 7 
HIV  case  finding 
and management 
Adequate 92 6 2.816 (0.568 - 13.965) Inadequate 1 2 
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Table: W. Bivariate Analysis Comparing Socio-Demographic and Health Service Related 
Factors to outcome of TB treatment in TB Clinics in Hawassa Town Administration, 
2010/11 
 
socio-demographic   and   health 
service related characteristics 
Successful outcome Unsuccessful 
outcome 
 
Crude 
Prevalence 
Ratio 
 
 
 
95% CI Number Number 
Age in years < 30 125 10 1.076 (0.979 - 1.183) >/= 30 80 13 
Sex Male 126 18 0.931 (0.858 -1.011) Female 78 5 
Residence Urban 116 8 1.162 (1.031 - 1.309) Rural 62 15 
TB type Pulmonary 140 19 0.935 (0.861 - 1.014) Extra pulmonary 65 4 
Type of 
facility 
Hospital 135 8 1.146 (1.031 - 1.275) Health center 70 15 
HIV test Positive 31 5 0.946 (0.823 - 1.275) Negative 162 16 
Staff training Adequate 28 7 0.871 (0.735 - 1.035) Inadequate 177 16 
Infrastructure 
and supplies 
Adequate 135 8 1.146 (1.031 - 1.275) Inadequate 70 15 
Supplies   and 
supplies 
management 
system 
Adequate 135 8  
1.146 
 
(1.031 - 1.275)  
 
Inadequate 
 
 
70 
 
 
15 
Health system 
procedures 
Adequate 106 8 1.061 (0.975 - 1.155) Inadequate 99 15 
IEC materials Adequate 42 8 0.872 (0.735 - 1.035) Inadequate 163 15 
Job aids Adequate 28 7 0.872 (0.735 - 1.035) Inadequate 177 16 
Overall 
facility input 
Adequate 28 7 0.871 (0.735 - 1.035) Inadequate 177 16 
Quality of TB 
services 
Adequate 81 9 2.100 (0.890 - 4.954) Inadequate 3 4 
 
NB: classification of outcome of TB treatment is as follows: successful treatment outcome for 
those who cured and completed TB treatment and unsuccessful outcome for those who died 
defaulted or failed treatment. 
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Annex. 2. TB/HIV data extraction tool 
 
1. Facility Manager Questionnaire 
 
Identification: 
Date: Seria                      
l number:     
Facility code:     
Name and signature of data collector:     
A: Staffing 
 
Program coordination 
1. Is there a specific health care provider allocated to coordinate HIV/AIDS programme in the 
facility? 
o Yes, 
o No 
o Staff category (if yea): ____________________ 
2. Is there a specific health care provider allocated to coordinate the TB programme in the 
facility 
o Yes, 
o No 
o Staff category (if yea): ____________________ 
3. Is there a specific health professional allocated to coordinate TB/HIV collaborative activity 
in the facility 
o Yes, 
o No 
o Staff category (if yea): ____________________ 
 
 
 
 
 Table: 1. Training profile of staff working in HIV and TB clinics 
 
Instruction: the first few sections (Staff code; Staff category and place of work) need to be filled in by the facility manager whereas 
the remaining data need to be collected from every staff member listed 
Use the following staff category accordingly: Physician, health officer, Nurse, Pharmacist/technician, HMIS officer/data clerk, 
Adherence supporter/case manager, Lab technician/technologist, HIV programme coordinator and TB program coordinator 
 
Staff 
Code 
Staff 
Category 
Work in 
HIV or 
Work in 
TB 
clinic 
Had 
HIV 
training 
Had 
TB/HIV 
integration 
training 
Had basic 
ART for 
pharmacist 
training 
Had 
HMIS 
trainin 
g 
Had Lab 
training 
on CD4 
count and 
clinical 
chemistry 
Had HIV 
treatment 
adherence, 
care and 
support 
Had HIV 
counselling 
and testing 
training 
Had TB 
DOTs 
training 
Had 
sputum 
AFB 
microscopy 
training 
            
            
            
            
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
125 
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B. Infrastructure 
1. HIV/AIDS room 
 
1. Is/are there separate room/s dedicated for HIV/AIDS care and treatment/ART? 
o Yes, observed 
o No 
o If yes, how many:    
2. Is the room private? (Restricted access / client cannot be seen or overheard by people outside 
the room): 
o Yes, observed 
o No 
 
3. Is there a waiting area for HIV clinic? 
o Yes, observed 
o No 
4. Is a flowing water sink, present for hand washing in HIV clinic? 
o Yes, observed 
o No 
5. Is there a working scale at the ART room? 
o Yes, observed 
o No 
6. Is there an examination coach? 
o Yes, observed 
o No 
7. Is there functional Otoscope for ear and throat examinations? 
o Yes, observed 
o No 
8. Is the adequate light for clinical examination (defined as fixed or mobile angle-poised 
o Yes, observed 
o No 
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2. TB room 
 
1. Is/are there separate room/s dedicated for TB/DOTS service? 
o Yes, observed 
o No 
o If yes, how many:    
2. Is the room private? (Restricted access / client cannot be seen or overheard by people outside 
the room): 
o Yes, observed 
o No 
3. Is there a separate waiting area for TB clinic? 
o Yes, observed 
o No 
4. Is a flowing water sink, present for hand washing in TB clinic? 
o Yes, observed 
o No 
5. Is there a working scale at the TB room of the clinic? 
o Yes, observed 
o No 
6. Is there an examination couch? 
o Yes, observed 
o No 
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3. Laboratory: 
 
 
1. Is the laboratory able to do full blood count (Hgb, WBC and Diff)? 
o Yes, observed 
o No 
o NA 
2. Does the laboratory has functional microscope to do AFB smear? 
o Yes, observed 
o No 
o NA 
3. Is the laboratory able to do microscopy for Ova or Parasite? 
o Yes, observed 
o No 
o NA 
4. Is the laboratory able to do malaria smear 
o Yes, observed 
o No 
o NA 
5. Is the laboratory able to do pregnancy test 
o Yes, observed 
o No 
o NA 
6. Is the laboratory able to do serology for HIV 
o Yes, observed 
o No 
o NA 
7. Is the laboratory able to do RPR/VDRL 
o Yes, observed 
o No 
o NA 
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8. Is the laboratory able to do clinical chemistry (BUN, Creatinine, LFT, Indian ink) 
o Yes, observed 
o No 
o NA 
9. Does the laboratory has functional machine to do CD4 count 
o Yes, observed 
o No 
o NA 
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C:  Drugs an 
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o If yes, describe: _ 
 
 
HIV/AIDS clinic 
 
1. Are there protective materials (safety boxes) for sharp instruments in the HIV/AIDS 
o Yes, observed 
o No 
2. Are there protective hand gloves in the HIV/AIDS clinic? 
o Yes, observed 
o No 
3. Is there soap and towel present for hand washing in the HIV/AIDS clinic? 
o Yes, observed 
o No 
4. Are male condoms available in the HIV/AIDS rooms 
o Yes, observed 
o No 
5. Is there a dildo in the HIV/AIDS rooms 
o Yes, observed 
o No 
 
TB clinic 
 
1. Are there protective materials (safety box) in the TB clinic 
o Yes, observed 
o No 
2. Are there protective hand gloves in the in the TB clinic 
o Yes, observed 
o No 
3. Is there soap and towel present for hand washing in the TB clinic? 
o Yes, observed 
o No 
4. Are condoms available in the TB room 
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o Yes, observed 
o No 
5. Is there a dildo in the TB room? 
o Yes, observed 
o No 
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D:  Health Systems procedures 
HIV/AIDS unit 
1. Is HCT offered every day, throughout the OPD opening hours? 
o Yes, observed 
o No 
2. Which days of the week is the HIV clinic open and which times of the day? 
Monday 
o Open, time:    
o Closed 
Tuesday 
o Open, time:    
o Closed 
Wednesday 
o Open, time:    
o Closed 
Thursday 
o Open, time:    
o Closed 
Friday 
o Open, time:    
o Closed 
Saturday 
o Open, time:    
o Closed 
Sunday 
o Open, time:    
o Closed 
3. Does the HIV clinic have a mechanism for defaulter tracing? 
o Yes, observed 
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o No 
If yes, what is the mechanism?    
4. Is there a quality assurance system at the facility for HIV management and monitoring? 
if yes, then describe………............................................................................................... 
 
TB unit 
 
1. Which days of the week is the TB clinic open and which times of the day? 
Monday 
o Open, time:    
o Closed 
Tuesday 
o Open, time:    
o Closed 
Wednesday 
o Open, time:    
o Closed 
Thursday 
o Open, time:    
o Closed 
Friday 
o Open, time:    
o Closed 
Saturday 
o Open, time:    
o Closed 
Sunday 
o Open, time:    
o Closed 
2. Does the clinic have a mechanism for tracing TB contacts tracing 
o Yes 
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o No 
If yes, what is the mechanism? 
3. Does the TB clinic has a mechanism for defaulter tracing? 
o Yes 
o No 
If yes, what is the mechanism?    
4. Is there a quality assurance system at the facility for TB medication management and 
monitoring? 
o Yes 
o No 
If yes, then describe………............................................................................................. 
 
Laboratory 
 
1. Is there a quality assurance system at the facility for HIV Testing? 
o Yes 
o No 
If yes, then describe………............................................................................................. 
 
2. Is there a quality assurance system at the facility for AFB sputum examination 
o Yes 
o No 
If yes, then describe………............................................................................................. 
 
TB/HIV collaborative services 
 
1. Is there regular supervision of collaborative TB/HIV services in the facility? 
o Yes 
o No 
o If yes describe:    
2. Are action plans arising from the previous supervision available? 
o Yes, observed plans 
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o No 
3. Are action plans drawn out of the supervision implemented and monitored? (look for 
evidence of implementation such as report on training, new system, new process and 
monitoring such as existence of new systems or process in place? 
o Yes 
o No 
o If yes describe:    
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E. Information systems on TB/HIV (Guidelines, forms, registers and tools) 
 
/Consulting Room Observations/ 
 
 
1. HIV/AIDS clinic 
 
Are there educational leaflets and/or posters in the local language (Amharic)? 
 
1. STI transmission and treatment 
o Yes, observed 
o No 
2. Prevention of Mother to Child Transmission of HIV 
o Yes, observed 
o No 
3. Nutritional advice for HIV clients 
o Yes, observed 
o No 
4. Family Planning methods 
o Yes, observed 
o No 
5. ARV treatment adherence 
o Yes, observed 
o No 
6. HIV prevention 
o Yes, observed 
o No 
7. TB prevention, screening and treatment 
o Yes, observed 
o No 
Are there guidelines/algorithms/standard operating procedures (SOPS) in the room on? 
 
8. ART management 
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o Yes, observed 
o No 
o If yes, where are they placed?    
9. Opportunistic Infection management 
o Yes, observed 
o No 
o If yes, where are they placed?    
10. Pediatric HIV/AIDS care and treatment 
o Yes, observed 
o No 
o If yes, where are they placed?    
11. National PMTCT 
o Yes, observed 
o No 
o If yes, where are they placed?    
12. TB/HIV implementation (guideline or algorism on TB diagnosis and/or screening)? 
o Yes, observed 
o No 
o If yes, where are they placed?    
13. Co-trimoxazole Preventive Therapy: 
o Yes, observed 
o No 
o If yes, where are they placed?    
14. Isoniazid preventive therapy 
o Yes, observed 
o No 
o If yes, where are they placed?    
15. HIV Counseling and testing 
o Yes, observed 
o No 
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o If yes, where are they placed?    
Are there stationeries for HIV/TB care? (Forms, registers and tools and etc…) 
 
16. ART register? 
o Yes, observed 
o No 
 
17. Pre ART register? 
o Yes, observed 
o No 
18. HIV/AIDS care intake forms? 
o Yes, observed 
o No 
19. HIV/AIDS care follow up form? 
o Yes, observed 
o No 
20. IPT register at the ART clinic? 
o Yes, observed 
o No 
21. Within facility referral form? 
o Yes, observed 
o No 
22. Outside facility referral form? 
o Yes, observed 
o No 
23. Quarterly reporting forms (ART/Pre ART) 
o Yes, observed 
o No 
24. Quarterly reporting forms (TB/HIV)? 
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2. TB clinic 
 
Are there educational leaflets and/or posters in the local language (Amharic)? 
 
1. TB prevention, screening and treatment 
o Yes, observed 
o No 
2. STI transmission and treatment 
o Yes, observed 
o No 
3. HIV counseling and testing 
o Yes, observed 
o No 
4. Nutrition 
o Yes, observed 
o No 
5. TB treatment adherence 
o Yes, observed 
o No 
Are there HCT and TB/HIV guidelines/algorithms/SOPS in the room on? 
 
6. Tuberculosis, TB/HIV and Leprosy (national guideline; 
o Yes, observed 
o No 
If yes, where are they placed?    
7. TB/HIV implementation (national guideline or algorism on TB diagnosis and/or screening 
o Yes, observed 
o No 
If yes, where are they placed?    
 
8. CPT 
o Yes, observed 
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o No 
If yes, where are they placed?    
9. HIV counseling and testing 
o Yes, observed 
o No 
If yes, where are they placed?    
Are there stationeries for TB and TB/HIV care? (Forms, registers and tools and etc…) 
 
10. TB unit register 
o Yes, observed 
o No 
o If yes, where are they placed?    
11. Within facility referral forms 
o Yes, observed 
o No 
o If yes, where are they placed?    
12. Outside facility referral forms 
o Yes, observed 
o No 
o If yes, where are they placed?    
13. TB quarterly reporting forms 
o Yes, observed 
o No 
o If yes, where are they placed?    
14. TB/HIV quarterly reporting forms? 
o Yes, observed 
o No 
o If yes, where are they placed?    
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2. General HIV/AIDS, ART Care Folder Review 
 
 
 
 
A. Identification: 
 
Date: Seria                      
l number:     
Facility code:     
Name and signature of data collector:     
 
B. Socio demographic characteristics: 
Age (in completed years):    
Sex 
o Male 
o Female 
Marital status 
o Single 
o Married 
o Cohabitating 
o Widowed 
o Divorced 
Residence 
o Urban 
o Rural 
Educational status: highest education standard achieved:    
Employed? 
o Yes 
o No 
If employed, 
o Full time 
o Part time 
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o Formal 
o Informal 
o Self employed 
 
 
C. Service delivery 
 
For all HIV clients (Both ART/Pre ART): 
1. Date of first assessment (EC):    
2. Are all contact details for the client entered on the HIV care intake 
form? (Name, Surname, home/and/or work address, house number and 
telephone number) 
o Yes 
o No 
3. Was a care giver identified and contact details completed? 
o Yes 
o No 
4. Have hemoglobin test been conducted and results available in the folder? 
o Yes 
o No 
5. Have ALT/AST tests been conducted and results available in the folder? 
o Yes 
o No 
6. Did client undergo WHO clinical staging at Baseline? 
o Yes 
o No 
7. Did client undergo WHO clinical staging at least once per year? 
o Yes 
o No 
8. Was CD4 count done at baseline? 
o Yes 
o No 
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9. Was CD4 count done in the last six months? 
o Yes 
o No 
10. CD4 count (count/mm3) at: 
i. Baseline:    
ii. Six months:    
 
iii. Year:    
11. Was the functional status assessed at baseline? 
o Yes 
o No 
12. Was the functional status assessed at least once per year? 
o Yes 
o No 
13. Functional status (Working, Ambulatory, Bedridden) at: 
i. Baseline:    
ii. Six months:    
iii. Year:   
14. Was the weight recorded at baseline? 
o Yes 
o No 
15. Was the weight recorded at the last clinical visit? 
o Yes, fill the number below 
o No 
16. Weight at 
i. Baseline:     
ii. Six months:     
iii. One Year:    
17. Was the client assessed for meeting the criteria for ARVs eligibility? 
At baseline: (both the medical and social criteria) 
o Yes 
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o No 
At last visit 
o Yes 
o No 
18. Is there a record of screening for TB at baseline? (minimum symptom screen of weight loss 
and cough; appropriate tests (AFB and/or CXR)  done and recorded if symptomatic) 
o Yes 
o No 
19. Is there a record of screening for TB at the last clinical visit? (minimum symptom screen of 
weight loss and cough; appropriate tests (AFB and/or CXR) done and recorded if 
symptomatic? 
o Yes 
o No 
20. Is client diagnosed with active TB? ("NA" if not screened for TB, skip to question 23 if no ) 
o Yes 
o No 
o NA 
21. If client diagnosed to have active TB, was he/she provided with Co-trimoxazole at time of 
diagnosis 
o Yes 
o No 
22. If client diagnosed to have active TB, was he/she provided with DOTS? 
o Yes 
o No 
23. If the client is not diagnosed with active TB, was he/she provided with IPT for six months? 
o Yes 
o No 
24. Was a follow-up appointment date and management plan noted at the last visit? 
o Yes 
o No 
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25. Does the client require ARVs? 
o Yes 
o No 
26. Has client been commenced on ARVs? 
o Yes 
o No 
o NA 
27. Did client undergo at least 2 information/counseling sessions prior to commencing ARVs? 
o Yes 
o No 
o NA 
28. Were other necessary investigations (CBC and/or, ALT/AST, BUN and Creatinine done prior 
to ARV initiation and results recorded? 
o Yes 
o No 
29. Survival status: (for both Pre ART and ART patients) 
o Alive 
o Dead, date of death: _   
30. Treatment status: (for those on ARVs) 
o Still on treatment 
o Stopped treatment; date:   
o Defaulted; date:   
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3. TB register review 
 
A. Identification: 
Date: Seria                      
l number:     
Facility code:     
Name and signature of data collector:     
 
B. Socio demographic characteristics: 
 
Age (in completed years):    
Sex 
o Male 
o Female 
Marital status 
o Single 
o Married 
o Cohabitating 
o Widowed 
o Divorced 
Residence 
o Urban 
o Rural 
Educational status: highest education standard achieved:    
Employed? 
o Yes 
o No 
If employed, 
o Full time 
o Part time 
o Formal 
o Informal 
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o Self employed 
C. Service delivery: 
 
1. Date of first assessment (EC):   
2. Are all contact details for the client entered on the TB register? (Name, Surname, 
home and work address and telephone numbers of client and next of kin details) 
o Yes 
o No 
3. Is a contact person for the patient identified and contact details completed? 
o Yes 
o No 
4. Is patient categorized from I- IV (Annex-4) based on severity, site and previous 
treatment history to decide on appropriate treatment regimen and result noted? 
(Confirm against client history) 
o Yes 
o No 
5. Has the correct regimen been prescribed as per the category? 
A. For initiation phase? 
o Yes 
o No 
B. For continuation phase? 
o Yes 
o No 
6. Is initial sputum smear result filled or result noted? 
o Yes 
o No 
o NA 
7. Result of sputum smear 
o AFB positive 
o AFB negative 
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8. If sputum AFB smear positive at baseline 
 
A. Was second month smear result in folder? 
o Yes 
o No 
o If yes what was the result:   
B. Was 5th month smear result in folder? 
o Yes 
o No 
o If yes what was the result:   
C. Was final (end of treatment) sputum smear result in folder? 
o Yes 
o No 
o If yes what was the result:   
9. Is patient’s weight determined and recorded? 
o Yes 
o No 
If yes weight in kg:    
10. Is there a record that the client had an HIV test offered? (Current or previous) 
o Yes 
o No 
11. Is client HIV-positive? ("NA" if not tested) 
o Yes 
o No 
o NA 
12. A. If HIV-positive, has the patient been enrolled in HIV care? 
o Yes 
o No 
B. Does the patient require ARV? 
o Yes 
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o No 
C. If require ARV, has the patient been commenced on ARVs? 
o Yes 
o No 
o NA 
D. If HIV-positive, is Co-trimoxazole prophylaxis prescribed? 
o Yes 
o No 
o NA 
13. Is patient’s treatment outcome documented? 
o Yes 
o No 
o NA 
14. What was the outcome of TB treatment? Select the one that applies 
o Cured 
o Completed treatment 
o Failed treatment 
o Died 
o Defaulted treatment 
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Annex -3. Operational definitions of terms 
 
1. Trained on TB/HIV: health care provider (could be a doctor, health officer or a nurse) 
who undertook a five days in service training course on TB/HIV collaborative activities 
using national curriculum. 
2. Trained on Tuberculosis: health care provider (could be a doctor, health officer or a 
nurse) who undertook a five days in-service training course on tuberculosis screening, 
diagnosis, care and treatment as well as prevention and recording and reporting 
activities using a national curriculum. 
3. Trained on HIV/AIDS clinical training (IMAI/Basic ART): health care provider 
(could be a doctor, health officer or a nurse) who undertook a ten days in-service IMAI 
training course or a 7 days basic ART training course on HIV/AIDS care and treatment 
using the national IMAI curriculum or basic ART curriculum developed by 
CDC/PEPFAR partners respectively. 
4. Trained on Basic ART for pharmacy: a pharmacist or pharmacy technician who 
undertook a six days in-service training course on basic ART. 
5. Trained on CD4 count and clinical chemistry: a laboratory technician or technologist 
who undertook a 10 days in-service training course on ART treatment monitoring using 
CD4 count and clinical chemistry tests such as ALT, AST, blood urea nitrogen (BUN) 
and serum creatinine testing 
6. Trained on AFB microscopy: laboratory technician or technologist who undertook a 3 
days in-service training course on Acid Fast Bacili (AFB) sputum microscopy 
7. Trained on HIV counseling and testing (HCT): health care provider (could be a 
doctor, health officer or a nurse) who undertook either a three weeks Voluntary HIV 
Counseling and Testing (VCT) or a three days Provider Initiated HIV Counseling and 
Testing (PIHCT) in-service training courses using a national curriculum. 
8. Quality of care: in this particular study quality of care is defined as the score of quality 
measurement scale based on the points given to the levels of activities across the 
various sections of services in TB and HIV clinics as identified by the review of TB 
and HIV records. Using experts’ opinion, we set a cut off level of 80% to categorize the 
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relative service quality received by individuals and provided by facilities into two. A 
quality 
score value = and above 80% is defined as good quality of care; while a quality score 
value below 80% score value is defined as poor quality of care. 
9. TB/HIV program integration: The term ‘programme integration’ refers to joining 
together different kinds of services or operational programmes in order to maximize 
outcomes, e.g. by organizing referrals from one service to another or offering one-stop 
comprehensive services. Specific to TB/HIV, it implies provision of TB case finding 
and management among HIV clients and HIV case finding and management among TB 
patients. In this particular study Integration is represented as the provision of HIV 
testing service in TB clinic and TB screening service in HIV care and treatment clinic 
in lieu of applicability of these two variables for all TB and HIV cases. Whereas details 
of integration for specific groups of patients (TB/HIV co infected patients) will be 
presented under the section of “TB case finding and management in HIV clients” and 
“HIV case finding and management in TB patients” 
10. Functional status: is the ability of a client to perform specific activities and is used to 
assess the clinical condition of the client in chronic HIV care. It is assessed by looking 
at general condition of the client including how he presented to medical care and 
enquiring him as to what activities he is able to perform and it is assessed at initial and 
every clinical visit by a health care provider. Clients’ functional status is classified into 
different levels, these are: Working: is defined as able to perform usual work in or out 
of the house, harvest. Ambulatory: able to perform activities of daily living. 
Bedridden: not able to perform activities of daily living. 
11. Action plan: is a plan drawn out of a supervisory observation and it includes 
information on specific outputs expected and activities that will be carried out to result 
in the proposed out puts, with details including the responsible unit, budget and timing. 
12. Adherence supporters/: These are people living with HIV that are trained on 
adherence counseling, referral linkage as well as tracing defaulters who voluntarily 
support the chronic HIV/AIDs care and support services in the health facilities 
13. Within facility referral form: is a referral form used to link services between various 
HIV care entry points (testing centers) and ART clinic within the health facility 
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14. Outside facility referral form: is a referral for used to facilitate referral between the 
health facility and other facilities outside the hospital and vice versa 
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Annex -4. Questionnaire items used for developing scores 
 
1. Input factors 
A. Personnel 
 
Q. No Question score values 
 Score “1” if >= 50%; score “0” if < 50% 1 0 
1 Proportion of staff (by category) working in HIV/AIDS clinic Yes No 
2 Proportion of staff (by category) working in TB clinic Yes No 
3 Proportion of staff (by category) working in both HIV/AIDS and TB clinics Yes No 
Total number of score points = 8 
 
Trained health care providers working in HIV/AIDS clinics 
 
Q. No Question 
Score “1” if >/= if 75%; score “0” if <75% 
1 Proportion of physician trained on HIV clinical management and TB/HIV 
2 Proportion of health officer trained on HIV clinical management and TB/HIV 
3 Proportion of nurse trained on HIV clinical management and TB/HIV 
4 Proportion of pharmacy technician/pharmacist trained on ART…. 
5 Proportion of laboratory technician trained on CD4 and Clinical chemistry 
6 Proportion of health care provider allocated to manage the HIV/AIDS programme in the facility? 
7 Proportion of HMIS officer/data clerk trained on HMIS 
8 Proportion of adherence supporters/peer educator trained on Tx adherence and care and support 
Proportion of all staff adequately trained 
 
Trained health care providers working in TB clinics 
Q. No Question 
Score “1” if >/= if 75%; score “0” if <75% 
1 Proportion of physician trained on Tuberculosis management, TB/HIV and HCT 
2 Proportion of health officer trained on Tuberculosis management, TB/HIV and HCT 
 
3 
Proportion of nurse trained on Tuberculosis management, TB/HIV and HCT in each of the 
examination room? 
4 Proportion of laboratory technician trained on AFB microscopy 
5 Proportion of health care provider allocated to manage the TB programme in the facility? 
Proportion of all staff adequately trained 
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B. Infrastructure 
HIV/AIDS clinic 
Q. No Question score values  
  1 0 
1 Is/are there separate room/s dedicated for HIV/AIDS care and treatment/ART? Yes, observed Else 
Is the room private? (Restricted access / client cannot be seen 
2 or overheard by people outside the room) ? Yes, observed Else 
3 Is there a separate waiting area for HIV clinic? Yes, observed Else 
4 Is there flowing water, soap and towel for hand washing in HIV clinic? Yes, observed Else 
5 Is there a working scale at the ART room? Yes, observed Else 
6 Is there an examination couch? Yes, observed Else 
7 Is there functional Otoscope for ear and throat examinations Yes, observed Else 
  Yes, observed Else 
Total number of score points = 7 
 
TB clinic 
 
Q. No Question score values 
  1 0 
1 Is/are there separate room/s dedicated for TB/DOTS service? Yes, observed Else 
Is the room private? (Restricted access / client cannot be seen 
 or overheard by people outside the room)? Yes, observed Else 
3 Is there a separate waiting area for TB clinic Yes, observed Else 
4 Is there flowing water, soap and towel for hand washing in TB clinic? Yes, observed Else 
5 Is there a working scale at the TB room of the facility? Yes, observed Else 
6 Is there an examination couch? Yes, observed Else 
Total number of score points = 6 
 
Laboratory 
 
Q. No Question score values  
  1 0 
1 Is there a functional CD4 machine in the facility? Yes, observed Else 
 
2 
Is there a functional photometer to perform liver function tests 
(AST and ALT) and renal function tests (BUN and Creatinine)? Yes, observed Else 
3 
4 
Is there a functional complete blood count (CBC) machine in the facility? 
Is there a functional microscope for sputum smear examination in the facility? 
Yes, observed 
Yes, observed 
Else 
Else 
  Total number of score points = 4   
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C. Drugs and supplies 
HIV/AIDS clinic 
 
Q. No Question score values 
 
0 1 
 
1 Was there stock- outs of HIV rapid test kits (screening or confirmatory)? Yes No 
2 Was there stock- outs of Cotrimoxazole (Bactrim)? Yes No 
3 Was there stock- outs of Isoniazid for TB prevention? Yes No 
4 Was there stock- outs of Anti TB drugs (Regimen 1 or 2)? Yes No 
5 Was there stock- outs of any ARV drugs? Yes No 
Is there a mechanism in place to monitor stock levels of each of these items 
6 (bin cards and electronic systems) Yes, observed No 
7 Are there protective hand gloves in the HIV/AIDS clinic? Yes, observed No 
8 Are soap and towel present for hand washing in the HIV/AIDS clinic? Yes, observed No 
9 Are there protective materials (safety box) in the HIV clinic? Yes, observed No 
10 Are condoms available in the HIV/AIDS rooms? Yes, observed No 
11 Is there a dildo in the HIV/AIDS rooms? Yes, observed No 
Total number of score points = 9 
 
TB clinic 
 
Q. No  Question score values  
   1 0 
 1 Was there stock- outs of HIV rapid test kits (screening or confirmatory)? Yes No 
 2 Was there stock- outs of Cotrimoxazole (Bactrim)? Yes No 
 3 Was there stock- outs of Anti TB drugs (Regimen 1 or 2)? Yes No 
 4 
 
5 
Was there stock- outs of any ARV drugs? 
Is there a mechanism in place to monitor stock levels of each of these items 
(bin cards and electronic systems) 
Yes 
Yes, observed 
Yes, observed 
No 
No 
No 
 6 Are there protective hand gloves in the in the TB clinic? Yes, observed No 
 7 Are there protective materials (safety box) in the TB clinic? Yes, observed No 
 8 Are condoms available in the TB room? Yes, observed No 
 9 Is there a dildo in the TB room? Yes, observed No 
Total number of score points = 9 
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D. Health systems Procedures 
HIV/AIDS clinic 
 
Q. 
No Question score values 
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E. Information systems 
HIV/AIDS clinic 
Q. 
No 
 
Question 
 
Score values 
 
  1 0 
Are there educational leaflets or posters in the local language (Amharic) in the room on? 
1 STI transmission and treatment? Yes, observed No 
2 Prevention of Mother to Child Transmission of HIV Yes, observed No 
3 Nutritional advice for HIV clients Yes, observed No 
4 Family Planning methods Yes, observed No 
5 ARV treatment adherence Yes, observed No 
6 HIV prevention Yes, observed No 
7 TB prevention, screening and treatment Yes, observed No 
If yes to 5 or more then score “2”; if yes to 1-4 then score “1” if yes to none 
score “0” 
Are there guidelines/Algorithms/SOPS in the room on? 
1 ART management? Yes, observed No 
2 OI management   
3 Pediatric HIV/AIDS care and treatment? Yes, observed No 
4 PMTCT? Yes, observed No 
5 TB/HIV implementation (guideline or algorism on TB diagnosis   
 and/or screening? Yes, observed No 
6 National Co-trimoxazole Preventive Therapy? Yes, observed No 
7 HIV Counseling and testing? Yes, observed No 
If yes to 5 or more then score “2”; if yes to 1-4 then score “1” if yes to none 
score “0” 
Are there stationeries for HIV/TB care in the examination room? 
1 ART register in the room? Yes, observed No 
2 Pre ART register in the room? Yes, observed No 
3 HIV/AIDS care intake and follow up forms? Yes, observed No 
4 IPT register? Yes, observed No 
5 Within facility referral forms? Yes, observed No 
6 Outside facility referral forms? Yes, observed No 
7 TB/HIV referral form (External)? Yes, observed No 
8 Quarterly reporting forms (ART/Pre ART)? Yes, observed No 
9 Quarterly reporting forms (TB/HIV)? Yes, observed No 
If yes to 7 or more then score “2”; if yes to 1-6 then score “1” if yes to none 
  score “0”  
  Total number of score points = 6   
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TB clinic 
 
Q. 
No 
 
Question 
 
score values 
 
  1 0 
Are there suitable educational leaflets in the local language (Amharic)? 
1 TB prevention, screening and treatment? Yes, observed Else 
2 STI transmission and treatment? Yes, observed Else 
3 HIV counseling and testing? Yes, observed Else 
4 Nutrition? Yes, observed Else 
5 TB treatment adherence? Yes, observed Else 
If yes to 4 or more then score “2”; if yes to 1-3 then score “1” if yes to 
none score “0” 
Are there HCT and TB/HIV guidelines /algorithms/SOPS in the room on? 
1 Tuberculosis, TB/HIV and Leprosy (guideline)? Yes, observed Else 
2 TB/HIV implementation (guideline)? Yes, observed Else 
3 CPT? Yes, observed Else 
4 HIV Counseling and testing? Yes, observed Else 
If yes to 3 or more then score “2”; if yes to 1-2 then score “1” if yes to 
none score “0” 
Are there stationeries for TB and TB/HIV care? (Forms, registers and tools) 
1 Unit TB register? Yes, observed Else 
2 CPT register? Yes, observed Else 
3 Outside facility referral forms? Yes, observed Else 
4 Within facility referral forms? Yes, observed Else 
5 Quarterly reporting forms (TB/HIV)? Yes, observed Else 
6 Quarterly reporting forms (TB)? Yes, observed Else 
If yes to 5 or more then score “2”; if yes to 1-4 then score “1” if yes to 
  none score “0”  
  Total number of score points = 6   
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2. TB/HIV service quality in HIV clinics 
 
Q. 
No 
 
Question 
 
score values 
 For all HIV clients (both ART and Pre ART) score with the following questions 1 0 
1 Are all contact details for the client entered on the HIV care intake form? Yes No 
2 Was a care giver identified and contact details completed? Yes No 
3 Were Hgb and/or ALT/AST tests conducted and results available in the folder? Yes No 
4 Did client undergo WHO clinical staging? (Baseline and at last clinical visit) Yes No 
5 Has a CD4 count been done at baseline and in the last six months)? Yes No 
6 Was the functional status recorded at baseline and at the last clinical visit? Yes No 
7 Was the weight recorded at baseline and at the last clinical visit? Yes No 
8 Was the client been assessed for meeting the criteria for ARVs eligibility Yes No 
9 Is there a record of screening for TB at the last clinical visit? Yes No 
10 Was a follow-up appointment date and management plan noted at the last visit? Yes No 
Total number of score points = 10 
If a client has started ARVs score with the following questions 
 
1 
Did client undergo at least 2 information/counselling sessions prior to commencing 
ARVs? 
 
Yes 
 
No 
 
2 
Were necessary investigations (CBC and/or ALT/AST, BUN and Creatinine done 
prior to ARV initiation and results recorded? 
 
Yes 
 
No 
  Total number of score points = 2   
  Overall total score for pre ART patients = 10 and for ART patients = 12   
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3. TB/HIV service quality in TB clinics 
 
Q. No Question score values 
  1 0 
1 Are all contact details for the client entered on the TB register? Yes No 
2 Is a contact person for the patient identified and contact details completed? Yes No 
3 Is patient categorized and result noted? Yes No 
4 Has the correct regimen been prescribed as peer the category for the intensive phase? Yes No 
 
5 
Has the correct regimen been prescribed as peer the category for the continuation 
phase? 
 
Yes 
 
No 
6 Is initial sputum smear result filled or result noted? Yes No 
7 Is patient’s weight determined and recorded? Yes No 
8 Has the correct drug dosage been given for the intensive phase? Yes No 
9 Has the correct drug dosage been given for the continuation phase? Yes No 
10 Is there a record that the client had an HIV test (Current or previous)? Yes No 
11 Documented outcome of TB treatment for smear positive new TB patients? Yes No 
Total number of score points = 11 
For patients sputum smear positive at baseline score with the following 
questions 
1 Was 2nd  month smear result in folder? Yes No 
2 Was 5th  month smear result in folder? Yes No 
3 Was final (end of treatment) smear result in folder? Yes No 
Total number of score points = 3 
Overall total score for patients with sputum smear positive at baseline = 14 and for 
  patients with sputum smear negative at baseline = 11   
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Annex - 4. National protocols and guidelines on AIV/AIDS and TB/HIV 
management 
 
 
 
 
Guideline for Implementation of Antiretroviral Therapy in Ethiopia, Ministry of Health, 2005. 
 
 
 
Guideline for Management of Opportunistic Infections and Antiretroviral Treatment in Adults and Adolescents in 
Ethiopia, Federal HIV/AIDS Prevention and Control Office, Federal Ministry of Health, July,2007. 
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ARV ELIGIBILITY CRITERIA 
 
Clinical criteria: 
CD4 count 
WHO stage 
Social criteria 
Resident of catchment area 
No identified barriers for adherence 
A person needs to fulfill both the clinical and social criteria to be eligible to initiate ARV 
 
Federal Ministry of Health of Ethiopia, HIV care/ART clinic intake form: G. ART ASSESSMENT AND PLAN 
 
 
 
 
 
Guideline for Cotrimoxazole Prophylaxis in HIV/AIDS Care and Treatment, HIV/AIDS prevention and control 
office (HAPCO), Federal Ministry of Health, February, 2006 
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Guideline for Management of Opportunistic Infections and Antiretroviral Treatment in Adults and Adolescents in 
Ethiopia, Federal HIV/AIDS Prevention and Control Office, Federal Ministry of Health, July,2007. 
 
 
 
 
165  
 
 
Guideline for Management of Opportunistic Infections and Antiretroviral Treatment in Adults and Adolescents in 
Ethiopia, Federal HIV/AIDS Prevention and Control Office, Federal Ministry of Health, July,2007. 
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Annex – 5. Consent form 
 
 
 
 
CONSENT FORM 
 
Title of Research Project: Assessment of an integrated TB/HIV programme at health facilities 
in Hawassa district, Ethiopia. 
The study has been described to me in language that I understand and I freely and voluntarily 
agree to participate. My questions about the study have been answered. I understand that my 
identity will not be disclosed and that I may withdraw from the study without giving a reason at 
any time and this will not negatively affect me in any way. 
Participant’s name……………………….. 
Participant’s signature………………………………. 
Date……………………… 
Should you have any questions regarding this study or wish to report any problems you have 
experienced related to the study, please contact the study coordinator: 
Study Coordinator’s Name: Shumet Adnew Lonsako 
Student at the University of the Western Cape/South Africa/ 
Hawassa, Ethiopia 
Telephone: 
 
Cell: (251) 911 196473 
 
Email: shume96@yahoo.com 
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Annex - 6. Information sheet 
 
INFORMATION SHEET 
Project title: Assessment of an integrated TB/HIV programme at health facilities in Hawassa district, Ethiopia. 
This is a research project being conducted by Shumet Adnew a master student at the University 
of the Western Cape. As you are managing this facility, we are inviting you to participate in this 
research project in which we plan to assess the implementation of integrated TB/HIV 
collaborative activities in health facilities. The purpose of this research project is to demonstrate 
to service providers, facility leaders and district TB/HIV coordinators the existing areas of 
strengths and weaknesses in the implementation of collaborative TB/HIV activities in health 
facilities, and outline a set of feedbacks and recommendations to address the identified 
shortcomings, if any, for future programme improvement. 
 
If you agree to participate in this study, you will be asked to respond to some questions on 
staffing, infrastructure, drugs and supplies, existence of health systems procedures, and 
information systems for the TB/HIV programme. The study will be conducted in three health 
centers and one hospital in the district, we expect you to participate in the interview for 20-30 
minutes and to fill the questionnaire in 20 minutes. Some of the questions that we are asking you 
are, number of staff trained on ATT, TB/HIV and PIHCT, number of full time providers, 
presence of TB/HIV focal person and its functionality, presence of mechanisms for TB contact 
and defaulter tracing, presence of quality assurance system, availability of IEC materials, etc. We 
will also have to access the folders of some patients with TB and HIV/AIDS. 
 
If you participate in this study your participation will be kept confidential and we will not request 
personal information from you. The confidentiality of the patients will be strictly maintained. 
Your facility identity will not be revealed either. 
 
There are no known risks associated with participating in this research project, we will arrange 
you a convenient place and time for the interview. 
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This research is not designed to help you personally, but the results may help the investigator 
learn more about the current implementation status of TB/HIV collaborative activities in 
Hawassa district. We hope that in the future, the study assists the health facility team to 
continuously seek effective strategies to improve identified problems in service provision. In 
addition, the finding of the study will help government and other organizations to plan for 
possible intervention measures and might assist other researchers as baseline data for subsequent 
studies. 
 
Your participation in this research is completely voluntary. You may choose not to take part at 
all. If you decide to participate in this research, you may stop participating at any time. If you 
decide not to participate in this study or if you stop participating at any time, there will be no 
adverse consequences 
 
If you later have any questions about the research study itself, please contact me at 
Shumet Adnew Lonsako 
P. O. Box 631 
Hawassa, Ethiopia 
Tel: 251 9 11 196473 
Email: shume96@yahoo.com 
Should you have any questions regarding this study and your rights as a research participant or if 
you wish to report any problems you have experienced related to the study, please contact 
My supervisor Dr Gavin Reagon: 
University of the Western Cape 
Private Bag X17 
Bellville 7535 
Tel 
Fax 
Email 
This research has been approved by the University of the Western Cape’s Senate Research 
Committee and the Ethiopian Health Research Ethics Review Committee 
 
 
 
 
